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Abstract 
Characterization and Mosquito Infection of the Tengah Isolate of Japanese 
Encephalitis Virus  
 
Lucy Mwende Mackenzie-Impoinvil 
Japanese encephalitis (JE) is a brain infection caused by JE virus (JEV).  It has an estimated 
worldwide incidence of 68,000 cases and 10,000 to 15,000 deaths annually.  Despite large 
effective immunization campaigns, Japanese encephalitis remains a disease of global health 
concern, because the virus is spreading.  There are five genotypes of JEV (genotype I – V), each 
associated with different geographical areas and associated epidemiology.  The Muar strain of 
JEV, the fifth genotype, is believed to represent the oldest lineage from which genotype I - IV 
evolved.  Muar was isolated in Singapore in 1952.  At the same time as Muar was isolated; the 
Tengah strain of JEV was also isolated from a nearby location.  However, Tengah and the 
characteristics of Tengah have largely remained unknown.  Muar was considered the only 
known representative of genotype-V prior to 2009.  
Vector competence studies have examined genotype-I, II and III of JEV.  However, genotype-IV 
and genotype-V have never been investigated in vector competence studies.  Therefore, the 
infectivity of these viruses to mosquitoes is unknown. The competence of non-Asian 
mosquitoes to JEV has been demonstrated suggesting potential for emergence in some other 
regions.  In Great Britain, JEV is considered a potential threat to animals and public health.  
However, the level of competence of British mosquitoes to any arbovirus is not known.  
The overall objective of this thesis was to characterise Tengah, investigate molecular and 
mosquito factors that might relate to the lack of circulation of genotype-V isolates and assess 
the potential of arbovirus (JEV) emergence in Great Britain.  
Molecular characterization of Tengah strain showed that it is another isolate of genotype-V, 
with 99% sequence similarity to Muar.  Evolutionary analysis performed using the Bayesian 
Evolutionary analysis of Sampling Trees (BEAST) program estimated that JEV is evolving at a rate 
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of 3.53 × 104 nucleotide substitution per site per year.  Vector competence studies 
demonstrated Culex quinquefasciatus mosquitoes are able to transmit Muar with transmission 
rates of 23% at 21-days post infection. Comparison of transmission between Muar (genotype V) 
and Nakayama (genotype III) found no significant difference between the two genotypes.  
Ochlerotatus detritus, a British mosquito, was susceptible to JEV at both 23°C and 28°C as 
determined by the detection of virus in the saliva 7 days post infection. The overall transmission 
rate was 13% at 23°C and 25% at 28°C. There was no significant difference between the two 
temperatures.  Infection rates for Ochlerotatus detritus and Culex quinquefaciatus were similar.  
This thesis has shown that on account of its similarity to the Muar isolate, Tengah represents a 
variant of Muar and is another genotype-V isolate. Evolutionary analysis showed that JEV 
originated from its ancestral virus in the year 1120 while the Time to Most Recent Common 
Ancestor for genotype V was in the year 1840.  Muar has the ability to infect, replicate and be 
transmitted in Culex quinquefasciatus, suggesting that the limited distribution, isolation and 
circulation of genotype-V is probably not explained solely by mosquito factors.  Ochlerotatus 
detritus is competent to transmit JEV and would therefore pose a threat should this virus occur 
in Great Britain. 
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CHAPTER 1: Overview, literature review and aims 
1.1 Overview 
Japanese encephalitis virus (JEV) is a major cause of viral encephalitis worldwide with an 
estimated annual incidence of 68,000 cases occurring annually and 10,000 to 15,000 deaths 
(Solomon, 2006; Campbell et al., 2011). This mosquito-borne virus poses a major threat to 
public health (Mackenzie et al., 2004). Approximately 75% of these cases occur in children aged 
0–14 years (Ghosh & Basu, 2009). Approximately 25% of encephalitic patients die while about 
50% of the survivors develop permanent neurologic sequelae including memory loss, impaired 
cognition, behavioural disturbances convulsions, motor weakness or paralysis and 
abnormalities of tone and coordination (Solomon et al., 1998; Unni et al., 2011). 
Currently JEV is found throughout most countries in Asia, extending north into maritime Siberia, 
and it has shown the propensity to expand.  In recent years the virus’ geographical reach has 
expanded south into Australia in 1995 (Hanna et al., 1996), west into Pakistan in 1992 (Igarashi 
et al., 1994) and east into Saipan in 1990 (Paul et al., 1993). There has also been some evidence 
of viral activity in Italy where JEV RNA was isolated from Culex pipiens mosquitoes collected in 
Italy in 2010 (Ravanini et al., 2012).  It is likely JEV will appear in places it has never been 
reported before. JEV is composed of five genotypes. These genotypes are spread throughout 
different geographic regions except for genotype IV which is confined in the Indo-Malaysia 
region. It was believed that different genotypes occupied different geographic regions (Chen et 
al., 1990; Chen et al., 1992; Williams et al., 2000).  However, current studies show the 
genotypes are shifting in their distribution.  For example genotype III was the predominant 
genotype throughout Asia; however, over the past two decades, it has been displaced by 
genotype I viruses in a number of Asian countries including China (Wang et al., 2007), Thailand 
(Nitatpattana et al., 2008), South Korea (Nam et al., 1996), Japan (Ma et al., 2003), Malaysia 
(Tsuchie et al., 1997), Vietnam (Nga et al., 2004), India (Fulmali et al., 2011) and Taiwan (Chen 
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et al., 2011). It is still not clear what determines which genotype will appear where or what 
drives these genotypes to spread.  
One of the most curious genotypes of JEV is genotype V. Up until 2010, there had only been 
one isolate of genotype V the Muar strain.  Muar was isolated in Singapore from the brain of a 
patient in 1952.  This genotype is believed to be the most ancient JEV genotype since it is more 
divergent from the other genotypes with approximately 20% sequence divergence while the 
divergence between other genotypes is approximately 10 – 17% (Mohammed et al., 2011). At 
the same time and the same geographical location of Muar isolation, another JEV isolate 
Tengah strain, was also isolated.  This strain which has not been fully characterized is also 
thought to be a genotype V. Prior to 2010 genotype V had only been found in the Indo-Malaysia 
region which is the only region that all the JEV genotypes have been isolated. Hence, it is 
believed that this is where they emerged (Solomon et al., 2003).  After nearly 60-years, a JEV 
isolate from Culex tritaeniorhynchus mosquitoes in China in 2009 was found to belong to 
genotype V (Li, Fu, et al., 2011).  Another isolate was reported from Culex bitaeniorhynchus 
Korea in 2010 (Takhampunya et al., 2011). The implications of these further findings are 
unclear. 
Evolutionary studies can provide an insight into how viruses spread by presenting information 
such as evolutionary rate between and within genotypes. This information can be used to infer 
whether some genotypes evolve faster than others. However for this to be possible it is 
essential to have a good amount of sequence information representative of each genotype in 
order to make a reliable conclusion. To date, there are several complete genome sequences 
available for genotype I and genotype III, while there are only four for genotype II, only one 
complete genome sequence of genotype IV and only two complete genome sequences of 
genotype V. There is therefore a need to determine more complete genome sequences of JEV 
viruses especially for genotype II, genotype IV and genotype V. 
Across Asia JEV appears to use a wide range of mosquito vectors (Burke & Leake, 2000). 
Another approach to understanding how the virus has expanded its geographic range is to 
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compare the fitness of the different genotypes in mosquito vectors. It could be possible that 
some genotypes are transmitted more efficiently than others hence allowing the virus to 
establish in new areas, or displacing currently circulating genotypes. Such questions have never 
been experimentally addressed for JEV and would provide valuable information.  
For mosquito-borne viruses the term extrinsic incubation period (EIP) describes the duration 
between the acquisition of an infectious bloodmeal by the mosquito to the time the mosquito 
is able to transmit the virus. A study using West Nile virus (WNV) genotypes, reported that 
WN02 strain had an extrinsic incubation period (EIP) that was 4 days shorter than that of NY99 
strain. This difference in the EIP of WN02 and NY99 provided a possible explanation of the 
displacement of NY99 by WN02 which was transmitted much earlier hence leading to more 
infection rates (Moudy et al., 2007). In the case of JEV genotype-V one of the reasons for the 
long hiatus in its rediscovery may have been that the original genotype V had low infectivity 
rates compared to other genotypes.  Therefore it may have become relatively displaced. For 
this reason it is important to compare the infectivity of the original genotype V to other JEV 
genotypes such as the Nakayama strain which is not only the JEV prototype but also the 
belongs to the most isolated genotype, genotype III. The recent isolations of genotype V may 
indicate that it has now evolved and possibly is able to infect a variety of host and vectors that 
it did not initially.  In fact, the isolate from Korea was from Culex bitaeniorhynchus mosquitoes 
which are not usually the main vector for JEV.  Furthermore the 86% nucleotide sequence 
homology between Muar and the Chinese isolate (Li, Fu, et al., 2011) does indeed support the 
suggestion that evolution may have aided in the emergence in China and Korea. 
Some of the factors associated with the spread of viruses include climatic factors such as wind. 
It is believed that JEV may have spread into Australia through wind-borne mosquitoes (Ritchie 
& Rochester, 2001). Warmer temperatures can increase the distribution and density of vectors 
and also enhance transmission potential in temperate climates by elongating transmission 
seasons.   It can also lead to shorter extrinsic incubation times of the viruses in their vector 
(Weaver & Reisen, 2010). Another factor to consider is migratory birds. For instance viraemic 
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birds may have been responsible for the spread of JEV into India (Fulmali et al., 2011), Taiwan 
(Huang et al., 2010) or Papua New Guinea (Johansen et al., 2000). 
 Man-made factors such as importation of infected animals or air transportation of disease 
carrying vectors, changes in agricultural practises and land use may also be responsible for 
introduction and spread of viruses in places they were not found before. Once these viruses are 
introduced into an area, they are more likely to spread and become established if the climate is 
conducive to allow breeding of the vector, availability and abundance of susceptible hosts and 
the presence of competent vectors to transmit the viruses (Pfeffer & Dobler, 2010). This spread 
and emergence diseases is of most importance to countries where they have never been 
reported before because this countries provide a large number of naive hosts that would lead 
to major epidemics. Several vector competence studies have been conducted in different 
countries to evaluate the level of competence of local disease vectors that have been 
implicated for transmission elsewhere (Romi et al., 2004; Moutailler et al., 2008; Nett et al., 
2009; Abdel-Hamid et al., 2011; Kramer et al., 2011; Vega-Rua et al., 2013). 
Currently there is no circulation of any mosquito-borne viruses in Great Britain, however with 
JEV viruses emerging in other temperate regions of  Europe it is likely that they will in due time 
appear in Great Britain. There is also the abundance of mosquitoes in Great Britain with 34 
species recorded to date. Some of these species have been implicated in the transmission of 
other viruses elsewhere and most importantly there are 13 species that are capable of acting as 
bridge vectors (Medlock et al., 2005). Bridge vectors are mosquitoes that due to their ability to 
feed on both humans and birds can transmit viruses circulating in birds to humans. One such 
species in Great Britain is the Ochlerotatus detritus mosquito. This mosquito has been 
implicated for the transmission of WNV in Italy (Romi et al., 2004), Egypt (Abdel-Hamid et al., 
2011) and Portugal (Osorio et al., 2012). Other than acting as a bridge vector this mosquito also 
causes the greatest human biting nuisance of any British mosquito (Snow, 1990; Clarkson & 
Setzkorn, 2011) especially in residential areas near its breeding site i.e. the marshes.  Should a 
mosquito-borne virus appear in the Great Britain, this mosquito would be a suitable candidate 
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to transmit that virus to humans.  However it is not known if this mosquito is competent to 
transmit any viruses and hence evaluating its competence is of ultimate significance.  
1.2 Literature review  
1.2.1 History of JEV 
Japanese encephalitis virus (JEV) is an arthropod-borne virus belonging to the genus Flavivirus 
in the family Flaviviridae.  The genus Flavivirus is comprised of more than sixty-six virus species, 
many of which are arthropod-borne human pathogens (mainly mosquitoes and ticks) and are 
highly pathogenic for both humans and animals. The diseases caused by flaviviruses range from 
fevers and encephalitides to hemorrhagic fever. Yellow fever virus (YF) is the prototype 
member of the Flavivirus genus. 
The Flavivirus genus is divided into serological complexes that are related serologically, 
genetically, and etiologically (Table 1). JEV belongs to the JE serological complex (Table 2) which 
includes members from around the world. (Thiel H-J et al., 2005 ). JEV is the most important 
and widespread member of this sero-complex. 
Table 1: List of virus groups in the Flavivirus genus 
Flavivirus virus groups Dengue virus group 
 Yellow fever virus group 
 Japanese encephalitis virus group 
 Kokobera virus group 
 Ntaya virus group 
 Kedougou virus group 
 Edge Hill virus group 
 Mammalian tick-borne virus group 
 Seabird tick-borne virus group 
 Kadam virus group 
 Aroa virus group 
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Table 2: List of viruses in the Japanese encephalitis serological complex 
Japanese encephalitis serological complex Japanese encephalitis virus 
 St. Louis encephalitis virus 
 West Nile virus 
 Murray Valley encephalitis virus 
 Alfuy virus 
 Koutango virus 
 Cacipacore virus 
 Usutu virus 
 Kunjin virus 
 Yaounde virus 
 
JEV causes a disease called Japanese encephalitis (JE). JE was recognized in horses and humans 
as early as 1871. JE gained its recognition in 1924 when a great epidemic resulted in 
approximately 4000 deaths and 6000 cases reported in Japan (Rappleye, 1939). A filterable 
agent was extracted from human brain and passed to rabbits, although the agent could not be 
characterized. Every 10 years, major epidemics were reported in Japan affecting over 6000 
patients (Miyake, 1964). In 1934, Hyashi reproduced the disease in monkey by intra-cerebral 
inoculation. It was later isolated for the first time in 1935 from the brain tissue of a fatal 
encephalitis case in Tokyo, Japan (Mitamura et al., 1936; Erlanger et al., 2009; McArthur & 
Holbrook, 2011) and its virological and serological prototype, Nakayama strain, was established. 
JEV was also isolated from the brain of a sick horse in 1937. The seasonal occurrence of the 
disease in Japan suggested a vector relationship and in 1938 the virus was first isolated from 
Culex tritaeniorhynchus (Mitamura, Kitaoka, Mori, et al., 1938). The role of pigs and birds as 
reservoir in the transmission of JEV was established in 1959 (Buescher & Schere, 1959). The 
term Japanese B encephalitis was used to distinguish it from summer epidemics of Von 
Economo's encephalitis lethargica which is also known as type A encephalitis. Later the term 
type B was dropped and now it is known as Japanese encephalitis.  
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JEV causes encephalitis an inflammatory disease of the brain. JEV is the major cause of viral 
encephalitis with an estimated annual incidence of 68,000 cases and 10,000 to 15,000 deaths 
(Solomon, 2006; Campbell et al., 2011). This may be an underestimate, due to inadequate 
surveillance and reporting which may be a result of lack of funds or financial constraints or 
complex logistics.  About 19% of these cases occur in areas with little or no JE vaccination 
implementation, while 81% of these cases occur in areas with well-established or developing JE 
vaccination programmes. The high number of cases reported in areas with established or 
developing vaccinations programmes most likely reflects the areas with the highest risk of JEV 
transmission hence better reporting and surveillance for such areas. Approximately 75% of 
these cases occur in children aged 0–14 years and in countries like India it has been referred to 
as the “Kid killer” (Ghosh & Basu, 2009).  Most adults in endemic countries have natural 
immunity acquired from childhood infection (Campbell et al., 2011). However there is an 
increase in number of cases in the elderly, as protective immunity decreases.  
Approximately 25% of encephalitic patients die while about 50% of the survivors develop 
permanent neurologic sequelae including memory loss, impaired cognition, behavioural 
disturbances, convulsions, motor weakness or paralysis and abnormalities of tone and 
coordination (Solomon et al., 1998; Unni et al., 2011). 
1.2.1.1 Clinical manifestation in Humans 
JEV infection and disease are usually the result of the bite of an infected mosquito. The initial 
infection event is thought to be uptake of virus into the dendritic cells in the skin. The antigen 
presenting cells carry the virus to peripheral lymph nodes and viral replication occurs within the 
macrophages and other cells of the peripheral lymphatic system (Sapkal et al., 2007). This is 
followed by a short lived viremia usually less than a week, which precedes the entry of virus in 
to the central nervous system. In most patients the infection resolves at this stage. Nervous 
system involvement sufficient to produce clinical disease occurs in only 1:200 to 1:1000 cases 
and this is usually via penetration of the blood brain barrier through the vascular endothelium. 
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The JEV encephalitic illness classically is preceded by fever, headache and gastrointestinal 
symptoms, followed by deteriorating consciousness. JE has an incubation period of usually less 
than 1 week, but may be up to 16 days. Neck stiffness is present in about half of the cases. 
Sudden onset with fever and convulsions may occur in children and occasionally adults and is 
generally a bad prognostic feature (Mackenzie et al., 2007) 
1.2.1.2 Humoral immunity 
Humoral immunity plays an important role in JEV infection. Cell free virus is usually cleared by 
antibodies through neutralization of the virus and infectivity and phagocytic clearance of the 
virions (Griffin, 1995). For this reason, JEV is rarely isolated from peripheral blood in humans. 
Other reasons include low viremia and clinical symptoms being seen after the virus has invaded 
the central nervous system which is usually after the viremia has finished. Virus can be isolated 
from CSF early in the course of acute encephalitis, but this is consistent with a poor prognosis. 
Most viruses have been isolated from the brains of patients at autopsy. After infection most 
patients produce immunoglobulin M (IgM), both in serum and cerebrospinal fluid (CSF). IgM in 
CSF is detected as early as day 1 after the onset of the symptoms, and by seven days all patients 
have raised IgM titers (Burke, Nisalak, et al., 1985), while it is not detected in the serum until 9 
– 10 days. The presence of JEV specific IgM antibodies in the serum or CSF is necessary for 
laboratory confirmation of JEV infection (Solomon et al., 2008). Failure to mount IgM response 
is associated with viral isolation and fatal outcome (Leake et al., 1986). JEV specific IgM has 
been used for clinical diagnosis of JEV infected patients through IgM capture enzyme linked 
immunosorbent assay (IgM capture ELISA). In surviving patients immunoglobulin class switching 
occurs where IgM declines and immunoglobulin M (IgG) starts rising and by 30 days most 
patients have serum IgG against JEV (Burke, Nisalak, et al., 1985). However if a person has been 
infected with Dengue virus prior to JEV infection, high titres of IgGs have been reported (Innis 
et al., 1989) due to serological cross-reactions with other flaviviruses. Many other flaviviruses 
overlap with JE virus including Dengue and West Nile viruses and this can result in 
misinterpretation of test results. Therefore it is necessary to show a fourfold increase in 
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antibody titres to JE virus between paired serum samples collected 14 days apart to have a 
presumptive diagnosis of JE (Burke, Nisalak, et al., 1985) 
1.2.2 Transmission cycle  
JEV is transmitted through a zoonotic (enzootic) cycle between mosquito vectors and 
vertebrate hosts, particularly pigs and birds; humans get accidentally infected when bitten by 
an infected mosquito and are a dead end host meaning they do not participate in the spread of 
JE because of low level and short-lived viraemia (Rosen, 1986; Solomon & Vaughn, 2002; 
Weaver & Barrett, 2004). Therefore, JEV naturally cycles between mosquitoes and birds or 
mosquitoes and pigs (Figure 1.) (Lindenbach et al., 2007; van den Hurk et al., 2009). Although 
many vertebrate animals can be infected with JEV, domestic pigs are the major virus-amplifying 
host for virus transmission to humans, not only because they develop high titres and long-
lasting viraemia after natural infection but also because they live on farms in close proximity to 
human habitats (Yun & Lee, 2006). Other important amplifying hosts are herons, egrets and 
other ardeid birds that also act as maintenance hosts and may contribute to the long-distance 
dissemination of JEV into new geographic locations, since the virus does not cause any clinical 
signs in these natural hosts (Solomon et al., 2003; Nga et al., 2004). Of other vertebrate species, 
horses can develop central nervous system (CNS) infections but are a dead-end host; other 
domestic animals become infected, but show no evidence of viraemia; rodents are refractory to 
infection; and amphibians, reptiles and bats can become infected experimentally and virus can 
persist, but their role in overwintering and maintenance of the virus in the environment is not 
known (Mackenzie et al., 2004).  A variety of mosquito species may act as vectors in the 
enzootic cycle, but Culicine mosquitoes primarily Culex tritaeniorhynchus are the principal 
vector for human infection (Gubler et al., 2007). In addition to its mosquito-specific horizontal 
transmission, JEV is also vertically transmitted to the progeny of infected mosquitoes through 
eggs (Dhanda et al., 1989; Rosen et al., 1989).  Therefore Japanese encephalitis is largely a rural 
disease, with Culex tritaeniorhynchus mosquitoes breeding in rice paddies and pigs providing 
the main source of blood meals, with the consequence of transmission cycles in close proximity 
to human habitation. There are two epidemiological patterns of transmission: an endemic 
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pattern in tropical areas with virus circulation in most months of the year, but with a broad 
seasonal peak probably resulting from irrigation practices; and an epidemic pattern in more 
temperate areas with clear summer seasonality (Vaughn & Hoke, 1992a).      
                          
Figure 1: Japanese encephalitis virus transmission cycle (Yun & Lee, 2013) 
JEV is amplified in an enzootic cycle that involves mosquito vectors (mainly Culex species) and 
vertebrate hosts (primarily pigs and birds). Incidentally, JEV is also transmitted to dead-end 
hosts, such as humans and horses. 
1.2.3 Vectors of JEV 
Although JEV has been isolated from over 30 mosquito species, paddy-breeding mosquitoes of 
the Culex vishnui subgroup, particularly Culex tritaeniorhynchus, are the major vectors of the 
virus.  A number of other species, such as Culex gelidus, Culex fuscocephala and Culex 
annulirostris, Culex annulus, Culex sitiens have yielded numerous isolates, implicating them as 
important secondary or regional vectors (Peiris et al., 1992; Vythilingam et al., 1994; Ritchie et 
al., 1997). Mosquitoes belonging to the genus Anopheles such as: Anopheles peditaeniatus, 
Anopheles barbirostris and Anopheles subpictus have also been reported from India as 
harbouring JEV (Thenmozhi et al., 2006). Distinctive seasonal patterns of virus activity in 
mosquitoes occur, with increases in infection rates linked to the warmer summer months in 
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temperate areas (Buescher & Schere, 1959) and the onset of the monsoon season in tropical 
areas (Gajanana et al., 1997). Table 3 below gives a list of mosquitoes from which JEV has been 
isolated and also shows their level of efficiency in transmitting JEV. 
Table 3: List of mosquito species from which Japanese encephalitis virus has been isolated. 
Culex species (Cx.) Anopheles species (An.) Aedes species (Ae.) Mansonia species (M.) 
Cx. annulius An. barbirostris Ae. albopictus M. annulifera 
Cx. bitaeniorhychus An. hyrcanus Ae. curtipes M. bonneae/dives 
Cx. epidesmus An. sinesis Ae. togot M. uniformis 
Cx. fuscocephalas An. subpictus Ae. vexans  
Cx. gelidus An. tessalatus   
Cx. Pipiens fatigans    
Cx. p. pallens    
Cx. p. quinquefasciatus    
Cx. pseudovishnui    
Cx. tritaeniorhynchus    
Cx. vishnui    
Cx. whitmorei    
     High competence      Moderate 
competence 
       Low 
competence 
 
Other mosquito species from which JE virus has been isolated (Burke & Leake, 2000). The 
coloured mosquitoes are those that have been also been tested in the laboratory for 
competence of JEV 
1.2.4 Vertebrate hosts  
1.2.4.1 Avian vertebrates 
Birds are an important component in the transmission cycle of JE virus and they are thought to 
be the “basic” vertebrate hosts (Hammon, Sather, et al., 1958; Buescher, Scherer, Mc, et al., 
1959). The virus has been isolated in nature from a variety of wild species, and both wild and 
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domestic species have been shown to develop viraemia high enough to infect mosquitoes 
(Hasegawa et al., 1975; Dhanda et al., 1977; Soman et al., 1977). Some of these birds are night 
herons, plumed egrets, lesser egrets, pond herons and cattle egrets (Scherer, Buescher, et al., 
1959). In general, younger birds exhibit higher viraemia than older individuals of the same 
species (Boyle et al., 1983). Ducks and chickens have been shown to amplify virus to a 
transmissible level experimentally (Dhanda et al., 1977). The migratory patterns of herons 
coincide with the seasonal transmission of JE in Japan with herons migrating from China, 
Taiwan, the Philippines, and Java to Japan at the beginning of the summer and peak JE 
transmission season (Ogata et al., 1970). Culex tritaeniorhynchus can be successfully infected by 
feeding on viraemic birds and can in turn infect susceptible birds. It is suspected that they are 
relatively important as a source of human infection in India, where JE infection rates in swine 
are not as high as they are in many other endemic areas (Banerjee, 1975). 
1.2.4.2 Domestic pigs  
Pigs play an important role in the epidemiology of JE since they provide a significant source of 
infection for those mosquito species that transmit JE virus to humans and also due to their 
susceptibility for JE infection.  For that reason they are used to monitor the annual seasonal 
appearance of JE virus in Japan (Konno et al., 1966). Field studies have demonstrated that when 
JE naive swine are placed into a JE endemic area, they develop infection within one week of 
placement and develop a viraemia lasting for 4 or more days (Maeda et al., 1978). Given the 
rapid population turnover of pigs, this domestic animal is clearly a significant source of 
mosquito infection.  
1.2.4.2.1 Clinical manifestation in Pigs 
The most common symptom of Japanese encephalitis in pigs is the birth of stillborn or 
mummified foetuses, usually at term. Piglets born alive often have tremors and convulsions and 
die soon after birth. The foetuses from infected pigs are mummified and dark. Hydrocephalus, 
cerebellar hypoplasia, and spinal hypomyelinogenesis (defective formation of myelin in the 
spinal cord, brain, or peripheral nerves) may be seen. The mortality rate is high in piglets born 
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to infected sows, but close to zero in adult pigs (Cirad, 2007). Pregnant sows may also abort. 
Non- pregnant animals are usually asymptomatic or experience a transient febrile illness, but 
symptoms of encephalitis are occasionally seen in pigs up to six months of age (Spickler et al., 
2010). In addition, disturbances of spermatogenesis can cause infertility in boars; although this 
is usually temporary, it can be permanent in severely affected animals (Habu et al., 1977).  
1.2.4.2.2 Economic impact on Pigs 
Piglet acquires passively maternal antibodies which could be detected by neutralization test 
and hemagglutination inhibition (HI) assay. The neutralizing antibody against the JEV remains 
detectable in the majority of pigs until the age of 3–6 months and after this period, pigs 
become susceptible to virus (Geevarghese et al., 1987). Almost 2/3 (60.7%) of pigs are 
slaughtered at the age greater than or equal to 6 months. In pigs over 6 months, which is the 
reproduction age, the HI test was positive in 95.2%, highlighting the potential economic impact 
of JEV infection in swine particularly on those who basically rely upon pig rearing (Duong et al., 
2011) . These results also reinforce the important role of over 6 month-old pigs in the 
maintenance of virus in the nature as they become probably rapidly infected and repeatedly re-
exposed to the virus. Vaccines are available for swine in Japan and Taiwan and are expected to 
provide good immunity. 
 It is not known how JEV changes during swine infection and within the enzootic cycle of JEV 
between birds and swine and its transmission to humans. The effects of interspecies 
transmission of JEV from an avian host to swine and back again on mutation rates and 
recombination events are also not known.  Considering viruses such as the influenza virus that 
have an avian-swine transmission, swine is known to play an important role in the 
recombination events of this virus and its ability to infect humans (Stech et al., 1999). Swine are 
susceptible to infection with avian influenza due to the presence of a receptor similar to that 
found in birds. Upon infection, they serve as a mixing vessel that allows recombination events 
to occur which then lead to emergence of a dominant strain that has acquired the ability to 
infect humans (Webby et al., 2000).  It is not known if similar mechanisms apply to JEV. 
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1.2.4.3 Horses 
Equines can develop encephalitis following JE virus infection (Burns et al., 1949), and the clinical 
picture of JE disease is characterized by fever, anorexia, weakness, congested or jaundiced 
mucous membranes and neurologic signs varying from a mild lethargy to hyperirritability, 
ataxia and paralysis similar to human disease (Paterson et al., 1952). In the severe form of the 
disease, symptoms include, high fever, hyper-excitability, aimless wandering, violent and 
demented behaviour, occasional blindness, profuse sweating, and muscle tremors. While some 
horses will usually recover without complications, those that go on to develop encephalitis will 
usually die in 1–2 days from onset (Spickler et al., 2010). Viraemia in horses develops from 1 to 
4 days after infection and lasts 2 to 6 days. Horses represent a dead-end host for JE 
transmission, although experimental transmission of JE from birds to horses, from horse to 
horse, and horse back to birds by Culex tritaeniorhynchus has been demonstrated (Gould et al., 
1964). 
1.2.4.4 Other vertebrate hosts 
Cattle and water buffalo are hosts to the same mosquito species that feed on swine and can 
therefore be infected by JE virus with the development of JE antibody (Ilkal et al., 1988).  
Significant antibody titres to JE virus have been found in cattle and goats and have been 
correlated to the occurrence of human diseases (Peiris et al., 1993). JE antibody sero-
prevalence in domestic livestock was studied in Malaysia. The highest sero-prevalence was 
observed in swine (88.1 %), followed by buffalo (45%), cattle (42%), sheep (17.9%), and goats 
(13.8) (Oda et al., 1996).  Despite the fact that these domestic livestock appear to have the 
ability to be infected by JE, they do not contribute to the overall cycle of JE transmission due to 
low level of viraemia and are therefore considered dead-end hosts. Other possible vertebrate-
hosts for JE virus that have been examined include reptiles and amphibians which can be 
infected experimentally with JE virus and overwintering of the virus can occur in snakes, frogs, 
and bats (Oh et al., 1974). However since they are not the main source of blood meals for the 
principal JE vector, Culex tritaeniorhynchus there is inadequate contact for successful field 
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transmission. Rodents are refractory to JE virus infection and in ecologic studies have had no or 
very little JE antibody present (Williams & Imlarp, 1972). Several species of bats are susceptible 
to JE with sufficient viraemia to infect mosquitoes that last for 6 days. Bats have also 
demonstrated persistence of viral infection under low environmental temperatures suggesting 
an ability to overwinter the virus (Sulkin et al., 1970). A study in China reported that two JE 
viruses isolated from bats showed a close relationship to JE viruses isolated from mosquitoes 
and humans in the same region over two decades supporting the fact that bats may play an 
important role in human JE outbreaks in that region (Wang, Pan, Zhang, Fu, Wang, et al., 2009). 
1.2.5 Persistence of JEV in nature 
1.2.5.1 Virus survival and re-introduction 
 A variety of mechanisms may explain the ability of JEV to survive in areas such as Japan, China, 
and Korea where there are very cold winters. Possible mechanisms include persistence in 
enzootic foci within vertebrate hosts and/or mosquitoes and reintroduction of the virus by 
migratory birds and/or mosquitoes (van den Hurk et al., 2009). Given the regularity of 
appearance of JE virus each year in so many different types of habitat, it seems likely JEV 
survives adverse conditions in the vector either by overwintering in the adult or by being 
transovarially passed on to the next generation (Burke & Leake, 2000).  It is also suggested that 
infected mosquitoes from areas where transmission occurs throughout the year are blown 
north by the wind or the virus is carried north by viraemic or latently infected migrating birds or 
bats (Solomon et al., 2003; Nga et al., 2004).   A study in China reported subsequent long-
distance southern migration of Culex tritaeniorhynchus before winter in northern latitudes 
during autumn, with a potential dispersal of 200 km per night (Ming et al., 1993), And in 
another study Culex tritaeniorhynchus mosquitoes were collected up to 500 km offshore in the 
Pacific Ocean (Asahina, 1970). JE could have been introduced into Australia by wind-blown 
mosquitoes. This was indicated by backtrack simulations that indicated winds sufficient to 
transport mosquitoes from New Guinea to Badu Island occurred frequently during the large 
incursions of virus in 1995 and 1998 (Ritchie & Rochester, 2001). 
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1.2.6 Overwintering mechanisms 
The duration of viraemia of JEV in birds and pigs is too short for these animals to effectively 
maintain the virus during adverse conditions. On the other hand, bats that have been 
experimentally inoculated have been shown to sustain low levels of virus in the blood during 
simulated hibernation at low temperatures and later exhibited recurrent viraemia high enough 
to infect mosquitoes when they are removed from simulated hibernation (La Motte, 1958).  
Experimentally infected lizards, snakes, and frogs also develop a viraemia under simulated 
hibernation (Lee, 1971; Doi et al., 1983; Oya et al., 1983).  Since the major vector of JE virus to 
humans and domestic animals, Culex tritaeniorhynchus, survives the winter by hibernation of 
inseminated adult females, JE virus could be carried over the winter by mosquitoes that had 
acquired infection by feeding on a viraemic host before entering hibernation.  In fact, 
experimentally infected Culex tritaeniorhynchus and Culex quinquefasciatus were shown to 
transmit the virus to susceptible hosts following overwintering (Hurlbut, 1950; Mifune, 1965).  
However, there is limited evidence for maintenance of JEV in overwintering mosquitoes. JEV 
has only been isolated once from field-collected overwintering Culex tritaeniorhynchus in Japan, 
although only low numbers have ever been processed during the winter months (Hayashi et al., 
1975). In Korea, JEV has been isolated twice during winter from Culex pipiens (Lee, 1971). 
Importantly, the female Culex tritaeniorhynchus rarely takes a blood meal prior to hibernation, 
thus reducing its exposure to viraemic animals (Oda et al., 1981). Vertical transmission 
(transovarial) which occurs when an infected female mosquito passes the virus to its progeny 
can facilitate overwintering of JEV (Rosen, 1987). Laboratory transmission studies have 
demonstrated that vertical transmission occurs through the F1 generation of larvae and adults 
of numerous species, including Culex tritaeniorhynchus, Culex pipiens pallens, Culex pipiens 
molestus, Culex quinquefasciatus, Culex vishnui, Aedes albopictus, Aedes alcasidi, Aedes 
japonicus, Aedes togoi, Aedes vexans, and Armigeres flavus (Rosen et al., 1989; Takashima & 
Rosen, 1989). However, these results are difficult to interpret in terms of natural transmission 
cycles, as parenteral inoculation was used as the mode of infection in many instances and JEV is 
rarely isolated from field collected immatures or adult male mosquitoes.  Indeed, over a 3.5-
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year period in Taiwan, only one isolate of JEV was obtained from almost 400,000 Culex 
tritaeniorhynchus larvae, compared with 164 isolates obtained from about 142,000 adult 
females (Rosen, 1987) 
1.2.7 Molecular epidemiology of JEV 
1.2.7.1 JEV genome 
JEV is a spherical, enveloped virus about 50 nm in diameter with a single stranded, positive 
sense, RNA genome of ˜11 kb in length. The genome is organized into a capsid formed by 
multiple copies of capsid (C) protein; which is covered by a host derived lipid bilayer. The 
surface proteins are arranged in an icosahedral-like symmetry. 
      A.     B.            
Figure 2: Schematic diagram of a flavivirus particle. 
A) Enveloped, spherical, about 50 nm in diameter. Herringbone-like arrangement of 90 E 
protein dimers at the virion surface as determined by cryo-electron microscopy. The surface 
proteins are arranged in an icosahedral-like symmetry (Heinz & Stiasny, 2012). B) In its 
immature (prM-containing) and mature form after proteolytic cleavage of prM (Fritz et al., 
2008). 
The genome has one open reading frame (ORF) encoding for a single polyprotein of 3432 amino 
acids, which is cleaved by viral proteases into 3 structural proteins, the capsid (C), precursor to 
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membrane (prM), envelope (E) and 7 non-structural proteins NS1, NS2A, NS2B, NS3, NS4A, 
NS4B, NS5,. The ORF is flanked by 5’ and 3’ non-coding regions (NCRs), which are crucial cis-
acting elements for replication, transcription and translation. The genomic RNA has a type I cap 
at its 5’ end (m7GpppAmp) (a distinguishing feature of the Flavivirus genus since it is not found 
in other genera) and lacks a 3’-terminal poly (A) tract (Unni et al., 2011). See figure 3. 
 
Figure 3: Japanese encephalitis genome organization. 
The complete genome consists of 3 structural proteins  capsid (C), precursor to membrane 
(prM), envelope (E) and 7 non-structural proteins NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5,. The 
ORF is flanked on the sides by 5’ and 3’ non-coding regions (NCRs), (Saxena et al., 2013) 
The C protein has ≈ 120 amino acids and forms homodimers.  It is involved in packaging of the 
viral genome and formation of the nucleocapsid (Mukhopadhyay et al., 2005).The prM protein 
(≈165 amino acids is closely associated with the E protein and forms a heterodimer. It is 
thought that the prM acts as a chaperone for folding, assembly and impairing the function of 
the E protein until the virus is released. Just before the virion is released the prM gets cleaved 
by cellular furin-like protease to form M protein (≈75 amino acids) its mature protein form 
during the maturation of the flaviviruses in the Golgi complex (see figure 2).  This allows the 
formation of E protein homodimers which are thus activated (Stadler et al., 1997).  
 E protein is a large structural protein consisting of ≈495 amino acids, with two potential 
glycosylation sites. It contains cellular receptor-binding sites(s) and a fusion peptide and is 
important for the entry of the virus into the host cell. The E protein is the main target of 
neutralizing antibodies (Ding et al., 2003). Ninety homodimers of E protein present in the host 
derived lipid bilayer form the major mature virion component (Mukhopadhyay et al., 2005).  
The E gene sequences of flaviviruses have been considered responsible for virulence in 
experimental models. The E protein has a major role in determining the virulence phenotype 
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and a single amino acid substitution may result in loss of virulence or neuroinvasiveness (Ni & 
Barrett, 1996).  JEV E protein possesses the three domains characteristic of flavivirus E with 
symmetry operators that allow for generation of the canonical E dimer (Luca et al., 2012). 
 
 
Figure 4: Crystal structure of JEV E ectodomain. 
A JEV envelope diagram representation crystal structure. Domain I highlighted in red, domain II 
highlighted in yellow and domain III highlighted in blue. The fusion loop is shown in green, and 
the “k-l” loop and glycosylation site are indicated (Luca et al., 2012). 
NS1 is required for viral replication (Lindenbach & Rice, 1997), and high levels are produced 
during flavivirus infection, resulting in the production of specific antibodies (Konishi et al., 1991; 
Libraty et al., 2002). It has also recently been shown to have a potential role in 
immunomodulation hence a potential candidate for the development of vaccines and 
diagnostic reagents. NS1 is known to be more specific than the E protein in serological testing 
of flavivirus infections (Hua et al., 2013).  Novel vaccines containing only virus envelope 
proteins may raise fears over antibody mediated enhancement (ADE) of disease.  However, NS1 
is able to elicit protective immunity without the risk of antibody-dependent enhancement 
hence making it an attractive alternative immunogen. As such, much research is currently being 
devoted to NS1-based vaccine development. In one study a plasmid containing the coding 
sequence of NS1 was shown to be a successful genetic vaccination against tick borne 
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encephalitis in an experimental animal (Timofeev et al., 2004). NS2A is the first of four relatively 
small hydrophobic membrane associated proteins (NS2A, NS2B NS4A and NS4B) that are 
conserved in position and not in sequence. NS2A acts in a cis fashion to cleave the NS1-NS2A 
junction after translation and plays functional role in viral replication, viral assembly and 
secretion. It also modulates the antiviral response of the host by inhibiting the interferon (IFN) 
signaling pathway (Leung et al., 2008). NS2B remains as a heterodimer along with NS3 and 
helps in stabilization, substrate recognition and anchoring of this heterodimeric complex to the 
endoplasmic reticulum (ER) membrane. It acts as a cofactor for the NS2B-NS3 serine protease, 
which cleaves the viral polyprotein at the NS2A/ NS2B, NS2B/NS3, NS3/NS4A, and NS4B/NS5 
junctions (Bera et al., 2007). The non-structural protein 3 (NS3) of JEV has been proposed to 
originate from rough endoplasmic reticulum (rER), Golgi apparatus or the  trans-Golgi network 
(TGN), and serves as a reservoir for viral proteins during virus assembly (Sahoo et al., 2008). It 
also participates in viral replication and viral assembly by virtue of its RNA helicase and NTPase 
activity (Utama et al., 2000). High hydrophobicity of the NS4 protein supports the fact that this 
protein plays a role as a membrane component and the poorly conserved nucleotide sequence 
among JEV strains suggested that this region might be important to adapt each virus to 
different viral growth environments (Kim et al., 2007). This protein is also acts as an IFN 
antagonist (Lin et al., 2008). NS5 is the largest among all the proteins of JEV and the most highly 
conserved. It is the key component of the viral RNA replicase complex that presumably includes 
other viral nonstructural and cellular proteins, and carries both methyltransferase and RNA-
dependent RNA polymerase (RdRp) domains (Chambers et al., 1990).  It also acts as an IFN 
antagonist by blocking IFN induced JAK-STAT signalling cascade (Lin et al., 2006). 
1.2.8 Viral replication 
JEV enters the host cell by receptor mediated endocytosis. Host cells that are targeted include 
monocytes, macrophages and dendritic cells (Mason, 1989).  Subsequent fusion of the lipid 
membrane of the virus with the endosome membrane caused by low pH allows viral RNA to 
penetrate into the cytoplasm of the infected cell (Chambers et al., 1990). Viral RNA replication 
occurs in the endoplasmic reticulum and the Golgi-derived membranes called vesicle packets 
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(Salonen et al., 2005). The newly synthesized viral RNA is either packaged within progeny 
virions or used to translate additional viral proteins. Flaviviruses assemble within the ER to form 
immature particles that display the prM protein. Following transport through the trans-Golgi 
network, furin-mediated cleavage of prM to M generates mature, infectious virions that are 
released by exocytosis (Mukhopadhyay et al., 2005) 
1.2.9 Phylogenetic variation 
All JEV viruses fall under one serotype as reported by Tsarev and others in 2000 after 
performing phylogenetic analysis involving 92 sequences of JEV using the complete envelope 
region. The sequences were obtained from samples collected in different geographical regions. 
In this study the occurrence of a different serotype i.e. the minimum amino acid difference 
threshold that must be crossed to lose cross-protection, was 18% as reported for Poliovirus 
type 1-3 or 22% as reported for dengue serotypes 1-4. In this case the maximum observed 
differences for JEV was 12% which was less than the estimated serotype threshold hence 
consistent with the proposition that JEV isolates belong to one serotype (Tsarev et al., 2000). 
This is unlike viruses such as dengue which now has five serotypes (Normile, 2013). 
Several techniques have been used to examine strain variation among JEV isolates from various 
regions. Using complement fixation, haemagglutination-inhibition and antibody-absorption, 
two immunotypes were differentiated (Okuno et al., 1968).  While using polyclonal antiserum, 
JE isolates in the northern Thailand were grouped into four subtypes (Ali & Igarashi, 1997).   
Another technique that was used was oligonucleotide fingerprints of viral RNA.  This 
methodology suggested that geographic boundaries limited migration of the JE virus and that 
viruses isolated at approximately the same time were quite similar (Hori, 1986). However a 
later study using the same method did not find any relationship between geographic 
boundaries and migration (Banerjee & Ranadive, 1989). 
The availability of the entire nucleotide sequence of the genome of JEV strain JaOArS982 in 
1987 demonstrated the feasibility of undertaking detailed nucleotide sequence studies on JE 
viruses (Sumiyoshi et al., 1987). Phylogenetic analysis performed for JEV using complete 
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genome, envelope, NS-1, NS-3, NS-5, pre-M, M region showed similar topologies; however, the 
number of sequences available for each region varied greatly.  In GenBank, the most sequences 
available were for the envelope (E) protein gene (Tsarev et al., 2000).  The E protein of the 
flaviviruses is the major antigen for the viruses and is also believed to be associated with virus 
binding and entry to host cells. Envelope (E) gene analysis was shown to be a good 
representative of the phylogenetic analysis of JEV. The choice of the E protein for analysis also 
provides the best chance of finding variability related to serotypic groups of the virus. 
Variability in this region should therefore be directly correlated to changes in viral surface 
epitopes (Monath & Heinz, 1996). 
To date, five genotypes of JEV (genotype I, II, III, IV and V) have been described based on 
phylogenetic analysis of the viral envelope gene (Ni & Barrett, 1995; Williams et al., 2000; Uchil 
& Satchidanandam, 2001; Solomon, 2003; Nitatpattana et al., 2008). The maximum difference 
between genotypes was found to be 12% amino acids and the maximum within genotypes was 
6% amino acids 
Several studies have reported that JEV originated in the Indonesia-Malaysia region from an 
ancestral virus common to JEV and MVEV (Solomon et al., 2003; Mohammed et al., 2011; Schuh 
et al., 2013). From this ancestral virus JEV genotypes IV and V diverged, followed by the more 
recent genotypes I, II, and III. This is supported by the fact that all five genotypes are found in 
this region and no large epidemics have been reported in these areas (Solomon et al., 2003). 
These studies also showed that genotype V formed the oldest genotype. A study by Bakonyi 
and others suggested that Asian JEV and Australian Murray Valley encephalitis virus may have 
evolved from a virus related to the African Usutu virus in the Southeast Asia-Australasia region 
based on the results of an amino acid signature analysis (Bakonyi et al., 2004). 
There are no reports of difference of virulence of different genotypes. This was tested in a 
study by Solomon and others in 2003, where mice were inoculated intracerebrally using 
representative strains of JEV. The results showed no significant differences between genotypes 
in mouse neurovirulence (Solomon et al., 2003).  
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1.2.10 Geographic distribution 
JEV is found throughout most of Asia, extending north into maritime Siberia. In recent years the 
geographical distribution of JEV has expanded, reaching south into Australia in 1995 (Hanna et 
al., 1996), west into Pakistan in 1992 (Igarashi et al., 1994) and east into Saipan in 1990 (Paul et 
al., 1993). Transmission of JEV in temperate zones is epidemic with the majority of cases 
occurring in summer months, while transmission in tropical zones is endemic and occurs year-
round at lower rates (Innis, 1995). 
The molecular epidemiology of JEV has changed and the geographical distribution of JEV has 
expanded in recent years.  Previously, studies, suggested that genotypes I and III occurred 
principally in temperate, epidemic areas, and genotypes II and IV occurred principally in 
tropical, endemic regions based on their geographic distribution (Chen et al., 1990; Chen et al., 
1992; Williams et al., 2000), conversely, further analysis found several anomalies, especially 
with respect to movement from epidemic to endemic areas. For example, isolates of epidemic 
genotype III were found in various endemic areas, such as Indonesia, southern Vietnam 
(Williams et al., 2000) and Malaysia (Tsuchie et al., 1997). Epidemic genotype I isolates were 
found in Malaysia (Tsuchie et al., 1997), and the same genotype has also recently become 
established in the Torres Strait of northern Australia (Pyke et al., 2001). In addition to these 
anomalies, from the isolation of the prototype Nakayama strain of JEV in 1935, GIII was the 
predominant genotype throughout Asia; however over the past two decades, it has been 
supplanted by genotype I viruses in a number of Asian countries including China (Wang et al., 
2007), Thailand (Nitatpattana et al., 2008), South Korea (Nam et al., 1996), Japan (Ma et al., 
2003), Malaysia (Tsuchie et al., 1997), Vietnam (Nga et al., 2004), India (Fulmali et al., 2011) and 
Taiwan (Chen et al., 2011).  Further, following the isolation of the GV Muar isolate (Uchil & 
Satchidanandam, 2001; Mohammed et al., 2011), in 1952 from an encephalitic patient 
originating in Malaysia, the genotype remained undetected for almost 60 years until a pool of 
Culex tritaeniorhynchus collected in the Tibetan Province of China in 2009 yielded the GV 
XZ0934 isolate (Li, Fu, et al., 2011) and a pool of Culex bitaeniorhynchus collected in South 
Korea in 2010 yielded the GV 10-1827 isolate (Takhampunya et al., 2011).   
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To address all these anomalies, a study was conducted in 2013 using Bayesian phylogeographic, 
categorical data analysis and phylogeny-trait association test techniques to determine whether 
the viruses circulating in the temperate and tropical geographical zones were genetically 
distinct (Schuh et al., 2013). This study utilized the envelope (E) gene of 487 isolates collected 
from 12 countries over 75 years which is the largest JEV dataset compiled to date. This study 
also represents the most recent description of the geographical distribution of JEV as detailed 
below. 
1.2.10.1 Genotype I  
Genotype I is currently divided into two groups genotype I-a and genotype I-b. Both groups 
emerged in tropical Asia around the mid-20th century. Genotype I-a includes samples from 
tropical regions which are Cambodia, Thailand and northern Australia between 1967 and 2005, 
and genotype I-b includes samples from temperate regions i.e., Japan, S. Korea, China and 
Taiwan between 1979 and 2009. Genotype I-b, a temperate genotype, has recently displaced 
genotype III as the dominant viral genotype of JEV throughout Asia like genotype III, genotype I-
b may be maintained in temperate Asia throughout the winter months in hibernating 
mosquitoes, vertical transmission in mosquitoes, poikilothermic vertebrates, and/or bats. This 
suggests that the spread and establishment of genotype I-b throughout Asia may have been 
due to its ability to efficiently overwinter in temperate Asia 
1.2.10.2 Genotype II  
Genotype II is geographically distributed in tropical climates such as N. Australia, Indonesia, and 
Malaysia between 1951 and 1999. Like genotype I, it also evolved in tropical Asia around the 
early 20th century. The Bennett isolate, isolated in Korea around 1951, is the only example of a 
genotype II virus collected outside of tropical Asia (Schuh et al., 2010).  It is suggested that the 
isolation of this single strain may represent a single imported case from nearby Japan or that 
genotype II became endemic in Korea for a period of time and subsequently disappeared 
(Schuh et al., 2010). 
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1.2.10.3 Genotype III  
Genotype III includes samples mainly from temperate climates such as China, N. India, Japan, S. 
Korea, Sri Lanka, Taiwan and Vietnam between 1935 and 2009.This genotype evolved in 
temperate Asia (Japan) around the late 19th century. Due to the relatedness of genotype III 
viruses sampled years apart, it is suggested that GIII is most likely maintained year-to-year by 
hibernating mosquitoes, vertical transmission in mosquitoes, poikilothermic vertebrates and/or 
bats. 
1.2.10.4 Genotype IV  
Genotype IV includes seven isolates collected from mosquitoes only between 1980 and 1981 
and is geographically confined to Indonesia. This genotype is estimated to have existed in the 
late 20th century. It is not known why this genotype has not spread to other regions. However 
some of the reasons suggested are that the vector competence of Culex tritaeniorhynchus for 
genotype IV may be low, the replicative ability of genotype IV in birds may be low, there could 
be a narrow host/vector range for genotype IV, or the genotype IV transmission cycle may 
involve a non-migratory amplifying host (Schuh et al., 2010).  
1.2.10.5 Genotype V  
Genotype V includes three isolates sampled from temperate and tropical locations which are 
China, South Korea and Malaysia between 1952 and 2010. It is estimated that genotype V 
evolved in Malaysia in the early 20th century. JEV was first described in the 1940s in Malaysia 
when an outbreak occurred during the Second World War among British prisoners of war 
(Cruickshank, 1951). It is thought that genotype V may have circulated undetected in tropical 
Asia for much longer, causing only sporadic cases of encephalitis that may have been mistaken 
for cerebral malaria or other encephalitic diseases. Prior to 2009, only one isolate of genotype V 
had been described that was isolated in 1952 in Malaysia. So it was quite surprising when after 
almost 60 years of undetected virus circulation, a pool of Culex  tritaeniorhynchus collected in 
the Tibetan Province of China in 2009 yielded the genotype V XZ0934 isolate (Li, Fu, et al., 2011) 
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and a pool of Culex bitaeniorhynchus collected in South Korea in 2010 yielded the genotype V 
10-1827 isolate (Takhampunya et al., 2011). Interestingly, despite surveillance that was 
established in 1951 (Wang, Li, et al., 2009) neither JEV nor Culex tritaeniorhynchus had been 
detected in Tibet prior to 2009 (Li, Li, et al., 2011). Tibet, had been internationally recognized as 
a Japanese encephalitis (JE)–non-endemic area because the average altitude  (above 4,500 
meters) was thought to be too high to facilitate the cycle of Japanese encephalitis virus (JEV) 
between mosquitoes and vertebrates (Brunette et al., 2010). Therefore genotype V of JEV may 
have entered Tibet shortly before it was initially isolated in 2009. It is possible that GV arrived in 
Tibet via JEV-infected migratory birds or perhaps by wind-blown mosquitoes (Schuh et al., 
2013). 
A map is provided showing the currently known distribution of JEV genotypes in figure 5.
  
Figure 5: Distribution of Japanese encephalitis virus 
The map shows the different countries JEV has been reported. The genotypes that circulate in 
these countries are shown beside them  
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1.2.11 The emergence and spread of JEV 
JEV is a prominent emerging neurotropic disease. The expansion of JEV over the past decades 
has seen the progression of genotypes I and II to the east into New Guinea, across the Torres 
Strait into northern Australia (Hanna et al., 1999; Mackenzie et al., 2002b). There has also been 
the replacement of genotype III by genotype I in Asia (Pan et al., 2011b) and further the 
isolation of two genotype V isolates from China (Li, Fu, et al., 2011) and Korea (Takhampunya et 
al., 2011). The emergence of genotype V in this two areas  is thought to be due to JEV gaining 
fitness to a new competent vector Culex bitaeniorhynchus in Korea or greater host availability 
resulting from the increase in pig farming in Tibet (Li, Li, et al., 2011) It is possible that genotype 
V arrived in Tibet via JEV-infected migratory birds or perhaps by wind-blown mosquitoes which 
is similar to the introduction of JEV  into Australia (Ritchie & Rochester, 2001).  In regards to 
genotype I, its rapid and widespread expansion was associated closely with increases in human 
populations, in acreage of irrigated rice, and in pig farming (Erlanger et al., 2009; van den Hurk 
et al., 2009). Other studies also suggested that following changes in agricultural practices in the 
19th century, there was a dramatic expansion of the Asiatic cattle egret across Asia which 
coincided with the expansion of genotype I (Hancock & Kushlan, 1984). 
1.2.12 Factors associated with emergence 
1.2.12.1 Environmental factors 
1.2.12.1.1 Land-cover and land-use 
Changing agricultural practices, can lead to the spread of JEV such as increasing irrigation which 
provides mosquito breeding sites and animal husbandry which provides host animals (Tsai, 
1997). In Asia paddy field surfaces have constantly extended since the early 1960s 
(http://faostat3.fao.org/) hence driving the JE risk and incidence. Given that paddy fields 
provide long-term Culex sp. breeding sites and attract many wading birds for foraging and 
resting, they enhance the circulation and expansion of mosquito and wading bird populations 
(Elphick et al., 2010). Likewise, the increase in amount of pigs since the 1960s 
(http://faostat3.fao.org/), has provided a continuous potential source of blood meals for 
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mosquitoes. In Nepal, the percentage of irrigated land was significantly associated with 
confirmed JE cases. This was possibly because irrigated land provided a habitat for mosquito 
development and water bird foraging in Nepal (Impoinvil et al., 2011).  
1.2.12.1.2 Climatic variables (rainfall, temperature and wind) 
The major climatic variables capable of influencing the level of JEV transmission are rainfall and 
temperature. They have been shown to strongly affect vector density (McMichael et al., 2006).  
Recently, Miller et al., identified an optimal range of temperature of 22.8 to 34.5 during the wet 
season that is favourable to the Culex tritaeniorhynchus biology and also found that most of JE 
cases were located in areas of high probability of vectors. A study in China observed that 
districts with high temperature in the preceding months of the JEV transmission season had 
higher JE incidence (Mogi, 1983).  It was suggested that the high temperature decreased 
development time for larval and pupal mosquito stages and also increases the rate of virus 
replication and dissemination. However, in a study to identify potential environmental drivers 
of Japanese encephalitis virus (JE) transmission in Nepal, it was reported that districts with low 
precipitation in the preceding months of the JEV transmission season also had higher JE 
incidence (Impoinvil et al., 2011). In this case, it was thought that drought increased the 
association between mosquito vectors and birds by reducing the number of water sites 
available, hence concentrating birds and mosquitoes in one area (Landesman et al., 2007). 
Another climatic variable is wind. It is believed that JEV may have spread into Australia through 
wind-borne mosquitoes (Ritchie & Rochester, 2001).  JE vectors have been found at altitudes 
over 380 m above ground (Ming et al., 1993) and collected 500 km offshore in the Pacific Ocean 
(Asahina, 1970).  It would seem likely for wind to be involved in transport of mosquitoes to such 
extreme altitudes and distance from land. 
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1.2.12.2 Non-environmental factors  
1.2.12.2.1 Trade 
In south-eastern Asia, trade of live animals occurs between farms, local markets, and more 
importantly within the Indo-chinese peninsula and China, and also to Hong Kong and Singapore 
(Di Nardo et al., 2011). These movements of either naive or infected animals through trade and 
transportation can influence human exposure to JEV. 
1.2.12.2.2 Bird migration 
Migrating birds, have a complex migration system over a large geographical area,. Considering 
hosts of JEV in Asia particularly the black-crowned night heron (Nycticorax nycticorax) and the 
Asiatic cattle egret (Bubulcus ibis coromandus), are thought to be important in the virus’ 
dispersal to new geographic areas (Innis, 1995). Viraemic birds, for instance, may have been 
responsible for JEV spread and introductions into India (Fulmali et al., 2011), Taiwan (Huang et 
al., 2010) or Papua New Guinea (Johansen et al., 2000).  However, little is known on the large-
scale movement patterns of the main wading birds species implicated in JEV transmission (Le 
Flohic et al., 2013). 
1.2.12.2.3 Vaccination 
Immunization of humans with JE is the only reliable and effective method to control the disease 
with efficacies of up to 98% reported (Hennessy et al., 1996). Vaccination is mainly focused on 
children 1-15 years old who are at most risk of developing JE disease. However human 
immunization does not contribute to the interruption of virus transmission in animal reservoir 
cycles. Vaccinating pigs is thought to decrease the amplification of the virus, and help protect 
horses and humans (Rosen, 1986). However, pig vaccination is not practical and sustainable 
because of the rapid turnover in pigs, the relative cost of vaccines, and not necessarily effective 
in piglets (they must be immunized after the disappearance of maternal antibodies) (Igarashi, 
2002). In addition, pigs represent a relevant sentinel model used to predict potential JE 
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outbreak in a human population nearby hence immunizing sentinel pigs would also impede the 
detection of such a threat (Nitatpattana et al., 2011). 
1.2.13 JEV vaccines  
Despite the use of effective vaccines including both inactivated whole virus and live attenuated 
vaccines, JEV remains as an important cause of arthropod-transmitted viral encephalitis. The 
first JE vaccines available were inactivated vaccines prepared using the prototype Nakayama 
strain, in mouse brains or primary hamster kidney cells with protection efficacy of 76% to 95% 
(Halstead & Thomas, 2010) and was manufactured and exported by the Biken Institute in Japan 
(Shlim & Solomon, 2002). Use of this vaccine together with vector control and alternative 
agricultural practices almost eliminated the incidence of disease in Japan (Igarashi, 2002), Korea 
(Sohn, 2000), and Taiwan (Wu et al., 1999). Inactivated cell culture vaccines prepared in 
primary hamster kidney (PHK) or African green monkey kidney (Vero) cells, and a live 
attenuated SA14-14-2 vaccine have been used in China (Liu et al., 2006). The SA14-14-2 vaccine 
has also been used successfully in Nepal (Tandan et al., 2007)and in India (Beasley et al., 2008). 
Recently, a new purified inactivated JE vaccine derived from Vero cell-adapted SA14-14-2 strain 
(IXIARO, Intercell AG, Vienna, Austria) has been licensed in the US, Europe, Canada, and 
Australia (Tauber et al., 2007). In addition, a live chimeric vaccine containing prM and E proteins 
of JEV in a backbone of attenuated YFV 17D strain has been developed by Sanofi Pasteur 
(Chimerivax/IMOJEV, Lyon, France)(Guy et al., 2010). The Chimerivax/IMOJEV showed 
outstanding immunogenicity without adverse effects, thus, it was recently licensed in Australia 
and is currently under review in Thailand (Halstead & Thomas, 2011). 
1.2.14 Potential future trends  
Air transport of mosquitoes was the probable cause of JEV outbreaks on isolated Pacific Islands 
such as Guam (Hammon, Tigertt, et al., 1958) and Saipan (Mitchell et al., 1993), so the 
possibility of long-distance spread cannot be discounted. Countries with a significant pig 
population would perhaps be at most risk of human disease (Mackenzie et al., 2002b). This also 
demonstrates the potential of this virus to invade new areas such as the west coast of the USA. 
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Here the particular risk for the introduction of JEV is due to the fact that California is a large 
state functioning as a hub for international travel and commerce with Asia and potentially 
allowing the introduction of mosquitoes infected with JEV. Of importance is the availability of a 
significant number of susceptible mosquito vectors and vertebrate hosts (Nett et al., 2009). 
Other areas of the Pacific could be at risk of JE in the future as indicated by the spread of JE to 
India and Pakistan in the west and Australasia in the east. Certainly, many islands in the Pacific 
have potential vectors and vertebrate hosts for JE virus transmission (Mackenzie et al., 2002b).  
With the spread of JEV into much of the Indian subcontinent, other destinations served by 
frequent routes of commerce or passenger air travel, such as Africa and Europe, also could be 
at risk (Weaver & Reisen, 2010). 
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1.2.15 Vector competence of Japanese encephalitis virus 
1.2.15.1 General vector competence concepts 
Vector competence is the intrinsic ability of a vector to biologically transmit a pathogen (Higgs 
& Beaty, 2005).  The biological transmission of a pathogen occurs when the pathogen actively 
reproduces or develops in the vector prior to being transmitted to the next host.  In the case of 
arboviruses, they usually undergo propagative development, which simply means that 
pathogen propagates in the vector remaining in its same developmental form.  However, more 
units of the virus are usually transmitted than the number of virus that was actually able to 
infect the vector.  A diagram of the cycling of virus through the mosquito is shown (Figure 6).  In 
the biological transmission of arboviruses, the virus is ingested when the mosquito feeds on an 
infected vertebrate host.  The virus usually undergoes an eclipse phase where levels of virus are 
untraceable because the virus undergoes inactivation in the midgut or infecting virions are 
entering into the mosquito cells and starting to undergo replication.  After the virus replicates, 
it disseminates to other mosquito tissues and organs, and once it reaches the salivary glands, 
the mosquito can go on to transmit the virus to another vertebrate host by bite.      
 
Figure 6: Virus cycle in mosquito (modified from (Higgs & Beaty, 2005). 
Virus is ingested (I) when the mosquito bites an infected vertebrate host.  The virus usually 
undergoes an eclipse phase (E) where levels of virus detection are untraceable because the 
virus is being inactivated in the midgut.  After replication (R) in mosquito cells, the mosquito 
will go on to transmit (T) the virus to another vertebrate host. 
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The concept of vector competence includes several factors such as the extrinsic incubation 
period (EIP), infection susceptibility, pathogen reproduction and development, and 
transmission efficiency.  Therefore, vector competence studies directly describe the pathogen-
vector interaction.   
The first key concept in the biological transmission of pathogen in a vector is EIP.  EIP is the 
period from ingestion of the pathogen to the point where onward transmission is possible.  EIP 
is important as it determines at what point the vector will be infectious and able to transmit 
infectious virus. In poikilothermic vectors, the duration of EIP varies with temperature, with the 
general trend of higher temperature leading to faster pathogen replication and dissemination 
and hence shorter EIP duration and lower temperature leading to slower pathogen replication 
and dissemination, and hence longer EIP longer duration.  However, the intrinsic nature of the 
vector and /or the virus can also influence EIP.  For example, it is typical to observe alphaviruses 
with very short EIP (Dubrulle et al., 2009) duration relative to flaviviruses (Takahashi, 1976) or 
bunyaviruses (Higgs & Beaty, 2005).  Mosquito species have also been shown to have different 
EIP duration at the same extrinsic incubation temperature (Turell et al., 1984; Turell et al., 
1985).  The significance of EIP is that if a vector does not survive longer than the EIP, then it will 
not be able to transmit the pathogen. 
Other key concepts in the biological transmission of a pathogen in a vector are infection 
susceptibility, pathogen reproduction and development, and transmission efficiency.  These 
factors are related to EIP since the pathogen must infect, replicate and be transmitted by the 
host.  For example, in a mosquito-arbovirus system once virus is ingested in a blood meal the 
virus must infect and replicate in the midgut epithelia then spread to secondary tissues and the 
mosquito hemolymph (blood system) for further infection and replication.  The desired 
destination for the virus is the salivary gland, because once virions are shed into the salivary 
ducts of the mosquito the virus can now be transmitted by bite.  However, the virus may 
encounter barriers which prevent it from being transmitted.  Two main mosquito barriers to 
arboviruses are the midgut and the salivary gland. However, 4 scenarios exist in the ability of 
the virus to cross the barrier(s) at the cellular level (see figure 7).  The permissive infection 
34 
 
represents the ability to cross into subsequent tissues and replicate within those cells.  The 
infection and escape barriers represent the inability to transverse into subsequent tissues with 
or without replication.  The leaky gut phenomenon is a scenario where promptly after exposure 
to a pathogen, the pathogen can then be found in the hemocoel before the pathogen has 
replicated.  It is thought that damage to the midgut causes this phenomenon.  It is important to 
note that these barriers are not absolute and other factor such as viral dose-response and 
environmental factors such as temperature may influence competence.  
 
 
Figure 7: Mosquito barriers to arbovirus transmission modified from (Higgs & Beaty, 2005). 
 
1-Hemocoel; 2- basement membrane; 3-Midgut epithelium; 4- Brush border; 5- Gut lumen. 
A=Permissive-Virus is able to cross into subsequent tissues and replicate within those cells and 
infects tissues in hemocoel including salivary glands. 
B=cell infection barrier-lack of specific viral receptors on the brush border may prevent access 
to mosquito cell. 
C=Cell escape barrier or Midgut escape barrier –prevents viruses that have penetrated into 
and replicated within the cells of the midgut epithelium from escaping from them into the 
hemocoel. 
D=Leaky -promptly after exposure to virus, the virus by passes gut cells  and can then be found 
in the hemocoel before the replication in the midgut. 
 
When measuring vector competence, three common parameters that are measured are 
infection rate, dissemination rate and transmission rate.  These are usually associated with the 
barriers to virus infection mentioned above.  Infection rate is defined as the number of 
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mosquitoes that are infected over the total number of mosquitoes that are tested.  The 
dissemination rate is number of mosquitoes that have a disseminated infection over the total 
number of mosquitoes tested.  Dissemination refers to when the infection in the mosquito is no 
longer confined to the midgut but has indeed infected other secondary organs or tissues of the 
mosquitoes.  This is usually measured by testing mosquito legs (Anderson et al., 2010) or other 
mosquito organs.  The transmission rate is the number of mosquitoes that are actually able to 
transmit virus over the total number of mosquitoes tested. These are mosquitoes in which the 
virus has penetrated the salivary glands and are able to transmit the virus by bite. This measure 
is perhaps the most relevant measure in vector competence studies as it indicates the 
proportion of mosquitoes that are able to transmit virus.  Methods used to quantify 
transmission rates include forced salivation of mosquitoes into capillary tubes and feeding 
infected mosquitoes on naïve animals.  
In regards to mosquitoes, intra- and inter-specific variation in competence exist which is likely 
related to co-evolution between the virus and the mosquito.  For example, in the case of inter-
specific variation some viruses have become more associated with a particular vector and its 
particular behaviour and physiology.  While it may be able to infect other vectors outside its 
typical range the efficiency is usually lower.  In the case of intra-specific variation in vector 
competence, geography and genetics most likely are the major determinants where again the 
variability in behaviour and physiology of conspecific (same species) mosquitoes influences 
competence.   
1.2.15.2 Vector competence studies of JEV: Mosquito determinants  
Over the years, there have been several vector competence studies using JEV and a wide array 
of mosquitoes.   These studies have been reviewed to some extent (Burke & Leake, 1988; 
Vaughn & Hoke, 1992b; Endy & Nisalak, 2002; Bosco-Lauth, 2010).  One conclusion that can be 
collectively drawn from these studies is that JEV does not appear limited to a specific range of 
vectors.  Rather, given its ability to replicate in several mosquito species and other insects 
(Wang et al., 2007; Pan et al., 2011a), it can be concluded that JEV has the potential to be 
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transmitted by a wide array of vectors.  However, the mosquito that has been studied in 
greatest detail is Culex tritaeniorhynchus.  Detailed studies of this vector showed that it could 
be infected with relatively low viraemia (Takahashi, 1976) and transmit virus to a wide array of 
vertebrate hosts including pigs, birds and horses (Gresser, Hardy, Hu, et al., 1958).  Generally, 
Culex tritaeniorhynchus is considered to have high infection and transmission efficiency based 
on laboratory experiments; though, variation in competence has been demonstrated 
(Takahashi, 1980a).  While, Culex tritaeniorhynchus is considered the primary vector of JEV 
globally, other species have been shown to be important vectors, regionally.  For example, in 
areas such as India Culex vishnui, Culex pseudovishnui, and Culex tritaeniorhynchus are usually 
taken as a complex (i.e. Culex vishnui complex) (Hati & Bhattacharya, 1987; Toma et al., 2000).  
The reason for this is that these mosquitoes are very difficult to distinguish microscopically, 
share similar behaviour and are similar in their competence to JEV.  Therefore, this trio of 
mosquitoes likely works together to vector JEV transmission in areas where the 3 mosquitoes 
coexist.  With the expansion of JEV into Papua New Guinea, the Torres Strait region of Australia 
and the tip of northern mainland Australia, Culex annulirostris has been identified as the 
mosquito likely to vector JEV transmission in Australia and its northern territory (Hanna et al., 
1996; Mackenzie et al., 2002a; van den Hurk et al., 2003); this is due to the abundance and 
distribution of this mosquito in the region, and the lack of Culex tritaeniorhynchus in Australia 
(van den Hurk et al., 2009).   
While there have been several studies done with mosquitoes within the transmission range of 
JEV, several vector competence studies have been done on mosquitoes outside of the known 
JEV transmission range.  The countries where these studies have been done include the US 
(Reeves & Hammon, 1946; Bosco-Lauth, 2010), mainland Australia (van den Hurk et al., 2003), 
New Zealand (Kramer et al., 2011) and Uzbekistan (Turell, Mores, Dohm, Komilov, et al., 2006).  
The early vector competence studies in the US were likely due to recognition of the potential 
for arboviruses to expand beyond their existing range.  Later studies in other countries are likely 
the result of the emergence of JEV in Australia and emergence of West Nile virus in the US. 
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Table 4 below summarises studies of vector competence of different vectors for JEV.  This table 
also highlights the differences in vector competence methods used by different authors.  For 
the infection rate some studies used MID50 (midgut 50%infective dose) which is the infectious 
virus titre at which 50% of the mosquitoes get infected midguts. Most of the authors did not 
determine the transmission rate and reported mainly the infection rate only. The number of 
mosquitoes tested varied from as little as one mosquito to 800 mosquitoes. The method used 
to infect mosquitoes also varied some used live chicks while others used a glass membrane 
feeder. The glass feeder consists of an outer chamber for circulating water which is heated to 
37°C and an inner chamber into which the infectious blood is added. A membrane is stretched 
over the lower portion of the inner chamber from which mosquitoes feed on. The hanging drop 
methods allow mosquitoes to feed on hanging blood drops. Studies also used either field 
collected or colony mosquitoes for their vector competence experiments. 
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Table 4: Review of vector competence studies of Japanese encephalitis virus 
Author Species Infection 
Rate (%) 
Dissemination 
Rate (%) 
Transmission 
Rate (%) 
# tested Method Infecting titre 
(pfu/mL) 
Genotype Temp 
(°C) 
 Colony or 
 Field 
collected 
(Turell, Mores, 
Dohm, Lee, et 
al., 2006) 
Culex pipiens 
pallens 
0 0 NOT TESTED 40 Live chicks 4.3 ? 26 FIELD 
 Culex pipiens 
pallens 
6 0 NOT TESTED 32 Live chicks 5.2 ? 26 FIELD 
 Culex  
tritaeniorhynchus 
100 80 67 (6 tested) 10 Live chicks 4.3 ? 26 FIELD 
 Culex 
tritaeniorhynchus 
100 93 NOT TESTED 14 Live chicks 5.2 ? 26 FIELD 
           
(Turell, Mores, 
Dohm, 
Komilov, et 
al., 2006) 
Culex pipiens 
pipiens (f. 
molestus) 
47-56 25-26 8 (37 tested) 142 Live chicks 4.5 - 5.4 ? 26 FIELD 
           
(van den Hurk 
et al., 2003) 
Culex annulirostris 78-100 6-78 24-81 90 Glass 
membrane 
4.5 2 28 FIELD 
 Culex sitiens 83-92 6-33 7-67 90 Glass 
membrane 
4.5 2 28 FIELD 
 Culex  
quinquefasciatus 
98 28 50 51 Glass 
membrane 
4.5 2 28 FIELD 
 Ochlerotatus 
vigilax 
19-39 18-39 0 75 Glass 
membrane 
4.5 2 28 FIELD 
 Ochlerotatus 
notoscriptus 
27 8 27 48 Glass 
membrane 
4.5 2 28 FIELD 
 Aedes aegypti 27 17 NOT TESTED 60 Glass 
membrane 
4.5 2 28 FIELD 
 Ochlerotatus 
notoscriptus 
20 20 NOT TESTED 5 Glass 
membrane 
4.5 2 28 FIELD 
 Ochlerotatus 
normanensis 
0 0 NOT TESTED 1 Glass 
membrane 
4.5 2 28 FIELD 
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Author Species Infection 
Rate (%) 
Dissemination 
Rate (%) 
Transmission 
Rate (%) 
# tested Method Infecting titre 
(pfu/mL) 
Genotype Temp 
(°C) 
Colony or 
 Field 
collected 
 Ochlerotatus 
purpureus 
100 0 NOT TESTED 2 Glass 
membrane 
4.5 2 28 FIELD 
 Mansonia 
septempunctata 
67 54 NOT TESTED 24 Glass 
membrane 
4.5 2 28 FIELD 
 Mansonia 
uniformis 
100 100 NOT TESTED 1 Glass 
membrane 
4.5 2 28 FIELD 
 Verrallina funerea 0 0 NOT TESTED 2 Glass 
membrane 
4.5 2 28 FIELD 
           
(Weng et al., 
1997) 
Aedes albopictus 2.03-4.98 
MID50 
NOT TESTED NOT TESTED ? Hanging drop 5 1 28-32 COLONY 
 Culex 
tritaeniorhynchus 
1.02 MID50 NOT TESTED NOT TESTED ? Hanging drop 5 1 28-32 COLONY 
           
(Weng et al., 
2000) 
Culex 
tritaeniorhynchus 
1.02 MID50 NOT TESTED NOT TESTED ? Hanging drop 5.5 1 28-32 COLONY 
 Culex pipiens 
molestus 
2.83 MID50 NOT TESTED NOT TESTED ? Hanging drop 5.5 1 28-33 COLONY 
           
(Kramer et al., 
2011) 
Opifex fuscus 74 70 0 50 Pledgets 8.1 3 24 FIELD 
 Aedes notoscriptus 0 NOT TESTED NOT TESTED 39 Pledgets 8.1 3 24 FIELD 
 Culex 
quinquefasciatus 
17 0 NOT TESTED 36 Pledgets 8.1 3 24 FIELD 
 Culex 
quinquefasciatus 
86 0 0 50 Pledgets 8.1 3 24 COLONY 
           
(Vythilingam 
et al., 2002) 
Culex sitiens 67 NOT TESTED NOT TESTED ? Glass 
membrane 
? 3 ? COLONY 
 Aedes togoi 80 NOT TESTED NOT TESTED ? Glass 
membrane 
? 3 ? COLONY 
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Author Species Infection 
Rate (%) 
Dissemination 
Rate (%) 
Transmission 
Rate (%) 
# tested Method Infecting titre 
(pfu/mL) 
Genotype Temp 
(°C) 
Colony or 
 Field 
collected 
(Samuel et al., 
2010) 
Culex 
tritaeniorhynchus 
2-17 NOT TESTED NOT TESTED 800 Pledgets 6 3 29 FIELD 
           
(Bosco-Lauth, 
2010) 
Culex tarsalis 2 100 NOT TESTED 41 Hemotek <5.0 3 25 COLONY 
 Culex tarsalis 5 100 NOT TESTED 55 Hemotek >5.0 3 25 COLONY 
 Culex tarsalis 6 100 NOT TESTED 93 Hemotek >5.0 1 25 COLONY 
 Culex pipiens 
pipiens 
2 NOT TESTED NOT TESTED 58 Hemotek <5.0 3 25 COLONY 
 Culex pipiens 
pipiens 
0 0 NOT TESTED 1 Hemotek >5.0 3 25 COLONY 
 Culex pipiens 
pipiens 
0 0 NOT TESTED 14 Hemotek <5.0 1 25 COLONY 
 Culex pipiens 
pipiens 
4 0 NOT TESTED 22 Hemotek >5.0 1 25 COLONY 
 Aedes aegypti 0 0 NOT TESTED 38 Hemotek <5.0 3 27 COLONY 
 Aedes aegypti 9 100 NOT TESTED 42 Hemotek >5.0 1 27 COLONY 
 Aedes aegypti 26 100 NOT TESTED 46 Hemotek >5.0 3 27 COLONY 
 Aedes albopictus 0 0 NOT TESTED 82 Hemotek >5.0 1 27 COLONY 
 Aedes albopictus 0 0 NOT TESTED 62 Hemotek >5.0 3 27 COLONY 
           
(Chen et al., 
2000) 
Armigeres 
subalbatus 
Not 
reported 
Not reported 79 14 Hanging drop 7.0 3 28 COLONY 
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1.2.15.3 Vector competence studies of JEV: Virus determinants 
Few studies have evaluated differences between virus strains or genotypes.  A recent 
study evaluated the difference in infection rates between genotype 1 and genotype 3 in four 
mosquitoes: Culex tarsalis, Culex pipiens pipiens, Aedes aegypti and Aedes albopictus. No 
difference was found in the infection within each species (Bosco-Lauth, 2010).  A study using an 
attenuated strain of JEV (JEV strain 2-8) and its parent (JEV strain SA 14) found that when 
colony of Culex tritaeniorhynchus was infected intrathoracically with the attenuated strain of 
JEV, only 3% went on to transmit the virus while 100% of mosquitoes transmitted virus when 
infected with the parent (non attenuated) JEV strain.  In oral infection studies 11% of 
mosquitoes became infected when feeding on attenuated virus but none of them actually 
transmitted the virus (Chen & Beaty, 1982).  Conversely, 100% of mosquitoes became infected 
when feeding on parent virus while 75 – 78% of the mosquitoes transmitted the virus.  This 
study shows that differences in infectivity occurring at the virus level may impact transmission 
of the virus by the mosquito.  However, it is important to note that the extent to which 
mosquitoes in the field actually encounter attenuated viruses is not known. 
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1.2.16 Mosquito-borne viruses in Europe 
In Europe eleven mosquito-borne viruses have been reported into date: six of them are 
autochthonous and cause human infections (Sindbis, West Nile, Ťahyňa, snowshoe hare, Inkoo, 
and Batai viruses); three of the viruses are exotic, being occasionally imported to Europe 
(Chikungunya, dengue and yellow fever); and two of the viruses are associated with birds and 
are not pathogenic to humans (Lednice, Usutu) (Hubalek, 2008).  Figure 8 below shows the 
known distribution of mosquito-borne viruses across Europe.   Mosquito-borne virus outbreaks 
are strictly determined by the presence and/or import of particular competent vectors of the 
disease. Ecological variables affect mosquito-borne viruses considerably, the main factors are: 
presence of appropriate habitats for mosquitoes, abundance of mosquito vectors and their 
vertebrate hosts and climatic factors. Some of the important flaviviruses in Europe are 
discussed below.
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Figure 8: Distribution of mosquito-borne pathogens in Europe modified from (Hubalek, 2008). 
(The dotted line indicates countries that occur at the same latitude as Great Britain).   
BATV=Batai virus, INKV=Inkoo virus, SINV=Sindbis virus, TAHV=Tahyna virus, USUV=Usutu virus, 
WNV=West Nile virus. 
 
1.2.16.1 West Nile Virus 
 
West Nile virus (WNV) is a mosquito-borne flavivirus in the Japanese encephalitis antigenic 
group. WNV is classified within the Japanese Encephalitis serological complex on the basis of 
cross-neutralization (Calisher et al., 1989) and molecular genetic studies (Kuno et al., 1998). 
WNV has a natural transmission cycle in Culex spp. mosquitoes and wild and captive birds. In 
contrast, humans and horses are incidental dead-end hosts (Kramer et al., 2007). WNV was first 
isolated in 1937 from a febrile woman in the West Nile district of Uganda (Hubalek & J., 1999) 
and subsequently was associated with sporadic cases of disease as well as major outbreaks in 
Africa, Eurasia, Australia, and the Middle East.  
Viral pathogens
No reported autochthonous transmission
BATV    
BATV  INKV  SINV
BATV  SINV  TAHV
BATV  TAHV  
BATV  TAHV  USUV
BATV  TAHV  WNV
INKV  SINV  
INKV  SINV  TAHV
SINV    
SINV  TAHV  USUV
SINV  TAHV  WNV
TAHV    
TAHV  WNV  
USUV    
USUV  TAHV  
WNV    
 
CHIKV Dengue 
CHIKV  
 Dengue 
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Epidemics that occurred prior to 1996 generally involved hundreds to thousands of cases in 
mostly rural populations, with few cases of severe neurological disease (Hayes, 2001). However, 
beginning in the 1990s, outbreaks began to occur more frequently, especially in the 
Mediterranean Basin, and were associated with increased numbers of cases with severe disease 
including viral encephalitis and neurological symptoms (Marfin & Gubler, 2001). The largest 
human outbreaks occurred in Bucharest in 1996 (393 hospitalized cases; 17 deaths) and Russia 
in 1999 (318 human cases; 40 deaths) (Platonov et al., 2001; Zeller & Schuffenecker, 2004). This 
was the largest outbreaks of arboviral illness in Europe since Sindbis virus (Alphavirus: 
Togaviridae) caused an epidemic in northern Europe in the 1980s and also the first epidemics 
reported in large urban populations (Kramer et al., 2008).  
 
This disease was previously unrecognized in the Western Hemisphere and occurred for the first 
time in North America in 1999. Its current epizootic/epidemic in North America appeared to 
have been the result of a single point introduction into the New York City area followed by a 
dramatic range expansion that now encompasses the United states, Canada, Mexico, Central 
America and the Caribbean and South America (Hayes et al., 2005; Komar & Clark, 2006; Bosch 
et al., 2007). Since 1999 to 2013, WNV has caused 39 557 cases of West Nile disease and 1668 
deaths in the United States (CDC, 2014).  In 1999 recognition of human cases was 
foreshadowed by weeks by reports of dead exotic and domestic birds in the New York City area 
(Steele et al., 2000). 
 
In North America, the New York 1999 (NY99) strain of WNV was first isolated from a dead 
American Crow (Lanciotti et al., 1999) and subsequently from carcasses of 22 other bird species 
collected between August and November 1999 (Anderson et al., 1999; Steele et al., 2000) 
Steele et al., 2000). After the initial outbreak in 1999, WNV overwintered in New York, with 
mid-winter infections discovered in hibernating mosquitoes (Nasci et al., 2001). WNV continued 
to cause sporadic equine and human disease in the United States (Marfin et al., 2001) reaching 
Canada in 2001. In 2002, the largest outbreak of WNV encephalitis ever recorded occurred in 
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the United States, with numerous epicenters spread across the nation’s mid-section, and virus 
activity occurring coast-to-coast, breaching both the Canadian  (Pepperell et al., 2003)and 
Mexican borders (Blitvich et al., 2003). 
 
1.2.16.1.1 Mosquitoes and Birds 
Throughout its worldwide distribution, WNV is maintained in nature in an enzootic cycle 
between ornithophilic mosquitoes, predominantly Culex (Culex) species, and birds. 
Approximately 59 species of mosquitoes and 284 species of birds (48) have been found infected 
in North America (Hayes et al., 2005).  Essentially, all vertebrate hosts that were exposed, 
whether by inoculation or by infectious mosquito bite, developed viremia and/or raised 
antibodies. However, birds stand out from other vertebrates as being important WNV 
amplification hosts due to the development of viremias of sufficient duration and magnitude to 
infect vector mosquitoes.  
 
Culex spp. are important in their potential role for overwintering WNV in temperate climates, 
where they hibernate as adult mosquitoes. Field evidence of this phenomenon was observed in 
the cold months of early 2000 when three WNV-infected hibernating adult Culex. pipiens 
mosquitoes were collected in Queens, New York City, near the epicenter of the 1999 outbreak. 
In the fall, Culex pipiens mosquitoes destined for hibernation undergo a developmental arrest 
(diapause) determined by the effect on the pupal stages of shortening day-length. The 
mosquitoes entering diapause feed only on plant sugars and do not blood-feed, so presumably 
the overwintering mosquitoes acquired their infection by vertical transmission (Nasci et al., 
2001). 
 
The emergence of West Nile virus (WNV) in eastern North America in 1999 was a major event in 
modern arbovirology, not because of its disease impact or the potential threat it represented, 
but because it alerted the world that pathogens may turn up anywhere at any time. However, 
New York City, the epicenter of the 1999 outbreak, had no capacity for surveillance and control 
of arboviral diseases.  
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1.2.16.1.2 Control of WNV 
WNV infection can be prevented by avoiding exposure to infected mosquitoes. Coordinated 
mosquito control programs that eliminate mosquito breeding sites, apply larvicides to breeding 
areas, and spray pesticides targeted at adult mosquitoes can reduce their abundance, but the 
impact of such programs on human disease depends on multiple ecologic determinants of 
mosquito abundance and human exposure to mosquitoes (Gubler et al., 2000). To reduce their 
exposure to mosquito bites, people should wear insect repellent on skin and clothes and avoid 
being outdoors during hours of peak feeding by WNV mosquito vectors, usually from dusk to 
dawn. Repellents containing N,N-diethyl-m-toluamide (DEET) have excellent safety records and 
are effective (Fradin & Day, 2002). Oil of lemon eucalyptus, soybean oil, and picaridin also 
appear to provide effective protection (Barnard & Xue, 2004). Blood donations in WNV endemic 
areas should be screened for evidence of WNV infection to prevent transmission of WNV 
through blood transfusions (Custer et al., 2004). Because WNV is known to cause viremia in 
humans, blood transfusion was considered a potential risk factor for WNV infection after the 
1999 epidemic in New York City.  
 
Research toward an effective vaccine to prevent WNV disease in humans is rapidly expanding. 
Both an inactivated WNV vaccine and a recombinant vaccine based on canarypox expression of 
WNV antigens are currently licensed for use in horses (Minke et al., 2004). Vaccine candidates 
for use in humans include an inactivated WNV vaccine, an attenuated WNV vaccine, chimeric 
live virus vaccines that incorporate WNV E and preM genetic sequences into a 17-D yellow fever 
vaccine or serotype-4 dengue virus backbone, DNA vaccines that elicit WNV antigen or 
attenuated Kunjin virus antigen expression, and a recombinant vaccine that uses measles 
vaccine as a vector for WNV antigens (Tesh et al., 2002; Hall & Khromykh, 2004). Thus far, only 
the chimeric vaccine using a yellow fever 17-D vaccine backbone has been tested in clinical 
trials in humans (Hall & Khromykh, 2004). 
1.2.16.2 Dengue 
Dengue is a mosquito-borne infection that has re-emerged as a major international public 
health concern over the last four decades. It is currently regarded as the most important 
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arboviral disease internationally as over 50% of the world’s population live in areas where they 
are at risk of the disease, and approximately 50% live in dengue endemic countries (Gubler, 
2011; WHO, 2012) (WHO, 2014). Dengue fever (DF) is caused by any of four closely related yet 
antigenically distinct single-stranded RNA viruses (genus Flavivirus, family Flaviridae) or 
serotypes: The serotypes are termed DENV-1, DENV-2, DENV-3, and DENV-4. Infection with one 
serotype does not protect against the others but results in lifelong immunity to that specific 
serotype (Halstead, 1974; Wilder-Smith et al., 2010) and sequential infections put people at 
greater risk for dengue hemorraghic fever (DHF) and dengue shock syndrome (DSS). Each of the 
four serotypes has been individually found to be responsible for dengue epidemics and 
associated with more severe dengue (Gibbons & Vaughn, 2002; Asia., 2011) unlike all other 
flaviviruses, such as JEV and WNV, DENVs that cause most human disease are not zoonoses, but 
exclusively utilize humans as reservoir and amplification hosts (Weaver & Reisen, 2010). 
 
Epidemic DHF/DSS emerged 50 years ago in Southeast Asia (Hammon et al., 1960) and did not 
become hyperendemic until the 1980s and later. It was first seen in the Americas only in 1981 
(Kouri et al., 1989) and in South Asia in 1989 (Messer et al., 2002b). Since the 1950s, the 
incidence of DHF/DSS has increased over 500-fold, with more than 100 countries affected by 
outbreaks of dengue (WHO, 2000). Increases in human population, uncontrolled urbanization, 
and the increase in human air travel and perhaps commerce have undoubtedly facilitated the 
spread of DENV strains and enhanced hyperendemicity. In addition, the lack of sustained 
mosquito control programs, the increase in use of disposable containers and tyres have 
enhanced conditions for Aedes aegypti and for efficient interhuman transmission and can 
explain much of the spread and persistence of dengue (Rosen, 1977; Gubler, 1997; Weaver & 
Reisen, 2010). 
 
The arthropod vector for the dengue virus is the Aedes spp. mosquito.  Two species of the 
Aedes mosquito are known to transmit the dengue virus to humans. These are Aedes aegypti 
and Aedes albopictus.  (Pourrut et al., 2011). Humans become infected with the dengue virus 
when a female Aedes spp. mosquito takes a blood meal from an infected human host, and then 
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bites another uninfected human, thereby transmitting the virus during the second feeding 
event. Thus, humans are in fact a natural reservoir for the dengue virus and play a critical role in 
the spread of dengue virus to new geographic regions (Bain, 2011). Interhuman DENV 
transmission is highly efficient due to the relatively high viremia titers found in many infected 
persons, and the susceptibility, but more importantly, the behavior and ecology of Aedes 
aegypti. This mosquito prefers artificial water containers as its larval habitat, human habitations 
as a resting and host-seeking habitat as adults, and human blood as both a protein source for 
oogenesis (egg development) and energy for flight. In addition, adult females often feed on 
multiple human hosts during a single gonotrophic cycle (Harrington et al., 2001). 
1.2.16.2.1 Mosquitoes 
The principal vector of DENV is the Aedes aegypti mosquito, an anthropophilic (one that prefers 
to feed on humans) species that has adapted extremely well to the urban environment, which 
is found both indoors and outdoors in close proximity to human dwellings (Rodhain & Rosen, 
1997). Aedes aegypti is believed to have originated in the jungles of Africa and was most likely 
spread throughout the rest of the world via slave and trading ships during the seventeenth to 
nineteenth centuries (Romi, 1995). It was noted some time ago that epidemics of dengue 
seemed to correlate with the spread of Aedes aegypti in South and Southeast Asia, appearing 
first in port towns and moving inland over time along waterways (Romi, 1995). Now a fully 
domesticated mosquito, Aedes aegypti is an efficient vector of DENV because of its preference 
for laying its eggs in artificial containers, biting humans, and remaining indoors, where it has 
access to its favourite host (Rodhain & Rosen, 1997). 
Aedes albopictus is a secondary vector of DENV in Southeast Asia, the Western Pacific, and 
increasingly in Central and South America (Gratz, 2004), but it has also been documented as the 
sole vector during certain dengue epidemics (Ali et al., 2003). Prior to 1979, this species was 
found only in Asia and in the Western Pacific, but it has spread to much of the rest of the world 
in recent decades (Gratz, 2004). The invasion of North America by Aedes albopictus was first 
confirmed with its discovery in Houston, Texas, in 1985 (CDC, 1986) probably arriving in 
shipments of used tyres from Japan (Hawley et al., 1987). The range of Aedes albopictus 
stretches farther north than that of Aedes aegypti, and its eggs are somewhat resistant to 
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subfreezing temperatures (Hawley et al., 1987) raising the possibility that Aedes albopictus 
could mediate a re-emergence of dengue in the United States or Europe. For example, Aedes 
albopictus can survive the winters in northern Italy (Romi, 1995) and was recently implicated in 
an outbreak of Chikungunya virus in Italy (Rezza et al., 2007). 
 
Infection with JEV confers lifelong immunity to the virus. However, patients who fail to produce 
antibody are more likely to have virus isolated from their CSF and are more likely to die (Burke, 
Lorsomrudee, et al., 1985). While with Dengue infection, epidemiological studies have 
demonstrated that secondary infection with a heterologous serotype or primary infection of 
infants born to dengue immune mothers significantly increases the risk of developing severe 
disease. These clinical observations have led to the widely accepted hypothesis of antibody-
dependent enhancement (ADE) of disease (Halstead & Simasthien, 1970; Halstead & O'Rourke, 
1977). 
 
Antibody-dependent enhancement (ADE) of infection occurs when pre-existing antibodies 
present in the body from a primary (first) dengue virus (DENV) infection bind to an infecting 
DENV particle during a subsequent infection with a different dengue serotype. The antibodies 
from the primary infection cannot neutralize the virus. Instead, the Antibody-virus complex 
attaches to receptors called Fcγ receptors (FcγR) on circulating monocytes. The antibodies help 
the virus infect monocytes more efficiently. The outcome is an increase in the overall 
replication of the virus and a higher risk of severe dengue (Whitehead et al., 2007). 
 
Differences in severity associated with individual Dengue serotypes or particular sequences of 
serotypes in sequential infection have been observed. For example, DENV2 viruses have most 
commonly been associated with DHF/DSS (Thein et al., 1997; Guzman et al., 2002; Balmaseda 
et al., 2006) along with DENV1 and DENV3 viruses (Harris et al., 2000; Messer et al., 2002a); 
While DENV4 appears to be the most clinically mild, although it too can cause severe disease 
(Nisalak et al., 2003). DENV2 and DENV4 have been associated with increased disease severity 
as a secondary infection, whereas DENV1 and DENV3 seem to cause more severe disease in 
50 
 
primary infection than do the other two serotypes (Vaughn et al., 2000; Balmaseda et al., 
2006). None the less, secondary infection by any of the four DENV serotypes remains the 
greatest risk factor for severe disease (Halstead, 2007). There are no reports of difference of 
virulence of the different JEV genotypes (Solomon et al., 2003).  
 
In mosquitoes, the Asian DENV2 strains also disseminated in a larger percentage of field caught 
Aedes aegypti mosquitoes compared with American DENV2 strains (Armstrong & Rico-Hesse, 
2003), and when the mosquitoes were co-inoculated with equal titres of Asian and American 
strains, the Asian strains were consistently recovered from a larger percentage of mosquitoes 
than were the American strains (Cologna et al., 2005). Studies have also shown that the Thai 
DENV strains (Asian genotype) replicated to higher titers than American genotype DENV2 
strains in human monocyte-derived macrophages and dendritic cells (Cologna & Rico-Hesse, 
2003). Thus, it is possible that the success of the Southeast Asian DENV2 strains is due in part to 
more efficient replication in human target cells as well increased transmission by vector 
mosquitoes. 
  
1.2.16.2.2 Control of Dengue 
Mosquito control measures are important and play a central role worldwide in the control of 
Dengue due to the current lack of dengue-specific vaccines or therapeutics. Since Aedes aegypti 
facilitated the emergence of epidemic dengue in urban centres around the world and is still the 
primary vector of dengue today, most control efforts have focused on this species (Keller et al., 
2006; Hombach, 2007; Whitehead et al., 2007). 
 
A fundamental distinction in the design of a vector control program is whether it takes a 
government-led, vertical (top-down) approach or a community-led, horizontal (bottom-up) 
approach (Gubler, 1989). Two examples of successful vertical control programs were 
undertaken by the governments of Singapore and Cuba. DHF was first reported in Singapore in 
1960 (Chew et al., 1961), and beginning in 1968, the Vector Control Unit of the Ministry of 
Health established a program of entomologic surveillance, larval source reduction, public 
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education, and law enforcement targeted to control both Aedes aegypti and Aedes albopictus 
(Ooi et al., 2006). This program succeeded in bringing the house index (HI) down from almost 
50% to approximately 2% by 1973, where it has remained until the present time. In the case of 
Cuba, a devastating epidemic of DHF/DSS in 1981, the first in the Americas, resulted in over 
10,000 cases of severe illness and 158 deaths. The Cuban government initiated a vertical, 
systematic campaign aimed at eradicating the Aedes aegypti vector from the island, and Aedes 
aegypti was eliminated from 13 of Cuba’s 14 provinces (Kouri et al., 1989). Some 10,000 health 
workers remained committed to the control program, and for 15 years no dengue cases were 
reported in Cuba (Kouri et al., 1989; Kouri et al., 1998). With their past successes, Singapore 
and Cuba had long been considered to have model dengue control programs, owing in part to 
their unique political and geographical situations. These two countries implemented consistent 
programs and policies that made possible the long-term control of dengue, rather than relying 
only on emergency responses to manage epidemics. However, both locales have faced 
reintroductions of dengue in spite of low reported vector indices, likely due in large part to the 
continued influx of people from endemic regions either as tourists, migrant workers, or 
recipients of cultural exchange, combined with a highly susceptible native population that, 
ironically, resulted from the success of vector control programs in these countries (Kyle & 
Harris, 2008). 
 
1.2.17 Mosquito-borne viruses in Great Britain 
Mosquito-borne viruses belong to an ecological group of viruses characterized by their specific 
biological transmission via competent mosquitoes to vertebrates. Competent vectors are those 
that are able imbibe the virus in the course of blood-feeding on an infected donor host, to 
support the replication of the virus in their body and to biologically transmit the virus to the 
recipient host (Weaver & Reisen, 2010). Mosquito-borne viruses are important causes of 
human disease worldwide. They circulate among wild animals, and many cause disease after 
spill-over transmission to humans and agriculturally important domestic animals that are 
incidental or dead-end hosts. In the past three decades, many mosquito-borne viruses have 
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emerged, creating new challenges for public health. Some are exotic pathogens that have been 
introduced into new regions, and others are endemic species that have greatly increased in 
incidence or have started to infect local human populations for the first time. 
One such example is the current spread of Chikungunya virus in the Caribbean. Chikungunya 
virus (CHIKV) is a mosquito-transmitted alphavirus belonging to the Togaviridae family, first 
isolated in Tanzania in 1952. The main vectors are mosquitoes from the Aedes genus (Chretien 
et al., 2007). Chikungunya virus causes Chikungunya fever  an acute febrile illness associated 
with severe, often debilitating polyarthralgias and  is transmitted to humans primarily via the 
bite of an infected mosquito (Caglioti et al., 2013). CHIKV transmission is reported to have 
begun with just 10 confirmed cases of the Chikungunya virus on the French side of St. Martin in 
December 2013, has quickly spiralled into a much larger outbreak with nearly 300 confirmed 
cases in two months spanning the Caribbean from Martinique to the British Virgin Islands 
(Promed_mail, 2013).  This is the first report for the local transmission of this virus in the New 
world reminding us the very real risk of introduction of exotic pathogens in new regions. This is 
not the first time CHIKV emergence has surprised everyone. Between 2005 and 2007 CHIKV 
epidemic in the Indian Ocean area caused millions of cases and significant morbidity (Kumar et 
al., 2011). The virus was imported into the first European country in 2007 and caused an 
autochthonous-transmitted CHIKV outbreak in Italy (Rezza et al., 2007). 
Another example is the West Nile Virus (WNV) which gained notoriety during the 1999 – 2004 
US epidemic which resulted in >16,600 human cases with >650 deaths (CDC, 2008).  WNV is a 
member of the genus Flavivirus in the family Flaviviridae. The virus is closely related to other 
flaviviruses in the Japanese encephalitis virus serological complex. WNV has a natural 
transmission cycle in Culex spp. mosquitoes and wild and captive birds. Most humans infected 
with WNV remain asymptomatic. Approximately 20–40% of infected humans develop 
symptoms, the vast majority of which range from a mild flu-like syndrome, West Nile fever 
(WNF), to severe West Nile encephalitic disease (WNED) (Rossi et al., 2010). WNV has a wide 
geographic distribution, but is commonly found in Africa, Asia, and the Middle East.  During the 
past 40 years, WNV outbreaks have occurred in many European countries including the Czech 
53 
 
Republic, France, Italy, Poland, Portugal, Romania, Russia and Spain (Murgue et al., 2002; Higgs 
et al., 2004).   
The two examples given above (i.e. CHIKV and WNV) are among the best understood mosquito-
borne viruses to have emerged in the last two decades indicating just how explosive epidemics 
can be in new regions. In addition, autochthonous occurrence of dengue fever occurring in 
Madeira in 2012 were reported to start with two confirmed cases in October of 2012 which 
eventually turned to approximately 2144 probable cases in just three months (Tomasello & 
Schlagenhauf, 2013). 
1.2.18 History of mosquito-borne pathogens in the Great Britain 
1.2.18.1 Yellow fever  
Great Britain has not completely been free of mosquito-borne disease.  As early as the 16th 
century, there have been sporadic events of mosquito-borne pathogen circulation.  
In 1865, Yellow fever (YF) was introduced into Swansea when the ‘Hecla’ a wooden sailing 
vessel, docked with from Cuba with Aedes aegypti mosquitoes carrying the YF virus on board. It 
coincided with a spell of exceptionally hot weather therefore leading to an epidemic of Yellow 
fever in the town.  Twenty five days after its introduction, at least 27 inhabitants were infected 
and 15 of them died. (Meers, 1986).  Yellow fever, the original viral haemorrhagic fever, was 
one of the most feared lethal diseases before the development of an effective vaccine. Today, 
the disease still affects as many as 200,000 persons annually in tropical regions of Africa and 
South America (Monath, 2001). 
1.2.18.2 Myxomatosis  
Myxomatosis which is caused by the myxoma virus, (MYXV) a type of poxvirus that only affects 
rabbits appeared in Britain in 1953. The first case in England was confirmed at Bough Beech, 
near Edenbridge, Kent in October 1953. It is not clear how myxomatosis entered England. It 
may have been brought by rabbit fleas on birds, through wind carriage of infected insects or by 
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the deliberate introduction of diseased rabbits (Andrewes, 1954). It was first discovered in 1896 
in Uruguay and was imported to Australia in 1951 to control its large rabbit populations - 
initially having the desired devastating effect (Kerr, 2012). The disease was illegally introduced 
to France in 1952 and it quickly spread to both wild and domestic rabbit populations and within 
a few years it had spread throughout Europe (Sellers, 1987). A study by Sellers showed that the 
first outbreaks of myxomatosis in S.E. England in 1953 could have resulted from wind carriage 
of insects infected with myxoma virus from northern France.  The most likely insect was the 
mosquito Anopheles atroparvus which breeds along the coastal marshes of England and 
northern France and which has been shown experimentally and in the field to transmit myxoma 
virus mechanically (Andrewes et al., 1956).  In England it was caught in 1954 biting rabbits in a 
built-up area in Newhaven, East Sussex, indicating that flight had occurred away from its 
normal coastal marshes habitat (Muirhead-Thomson, 1956). 
1.2.18.3 Malaria 
Malaria a mosquito-borne infectious disease of humans and other animals was common in 
marsh communities in southern England between the 16th and 19th centuries (Dobson, 1997) 
where it was referred to the “ague” meaning acute and is usually used to describe fever. 
Malaria is caused by parasitic protozoa of the genus Plasmodium.  The disease is transmitted via 
a bite from an infected female Anopheles mosquito.  Malaria causes symptoms that typically 
include fever and headache, which in severe cases can progress to coma or death. The disease 
is widespread in tropical and subtropical regions in a broad band around the equator, including 
much of Sub-Saharan Africa, Asia, and the Americas (WHO, 2013).  Its introduction into England 
coincided with the arrival of many Dutch refugees who came to England's marshes to escape 
the Catholic persecution in Holland (Cracknell, 1959).  Malaria was endemic in Holland (Shute, 
1944) and it is likely that many Dutch refugees would have brought Plasmodium vivax with 
them.  More indigenous malaria cases occurred at the beginning of the 20th Century.  The 
Plasmodium vivax parasite was being transmitted by local Anopheles atroparvus whose normal 
habitat is brackish water (Newman, 1919).  In 1917 and 1918 there were around 330 cases of 
locally-transmitted vivax malaria when infected servicemen returning from overseas were 
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billeted near salt marshes on the Thames Estuary (James, 1920). Those areas most badly 
affected included the Fens, Thames Estuary, South-East Kent, the Somerset levels, the Severn 
Estuary and the Holderness of Yorkshire (Shute & Maryon, 1974).  From 1840 to 1910, a total of 
8,209 deaths were reported. The highest rates were reported from Kent, Essex, and 
Cambridgeshire consistent with historical observations of high ague mortality in coastal and 
marshy areas (Whitley, 1863) where the principal mosquito vector, Anopheles atroparvus, is 
still present (Kuhn et al., 2002).  These deaths declined steadily over time due to a number of 
factors. Marsh drainage could have eliminated many breeding sites of the main local vector, 
Anopheles atroparvus, in the brackish waters of coastal marshes, river deltas, and fens 
(MacArthur, 1951).   Anopheles atroparvus feeds mainly on livestock but will take human blood 
when available. Hence, increasing livestock densities may have diverted biting from humans 
toward cattle, pigs, or horses. Improved housing, better access to health care and medication, 
and improved nutrition, sanitation, and hygiene all may have reduced transmission and/or 
mortality rates. At present, more than one thousand imported cases of falciparum malaria are 
reported in Great Britain each year, mostly from West Africa. Many of these people live in 
London and other urban areas in the south of England, in areas where Anopheles mosquitoes 
occur (Williams et al., 2002). 
1.2.19 British Mosquitoes 
At present, there are thirty-four species of mosquitoes recorded in the British Isles comprising 
six species of Anophelinae (genus Anopheles) and 28 species of Culicinae in seven genera: 
Aedes (3), Coquillettidia (1), Culex (4), Culiseta (7), Dahliana (1), Ochlerotatus (11) and 
Orthopodomyia (1) (Medlock & Vaux, 2009; Golding et al., 2012). These mosquitoes occupy 
different habitats and differ in their feeding habits.  Some develop in permanent water bodies 
such as ditches and ponds (e.g. Anopheles claviger-human-biting, Coquillettidia richiardii bird-
biting and human biting), while others occupy temporary freshwater pools in woodlands (e.g. 
Ochlerotatus cantans-bird-biting and human biting), Ochlerotatus rustius-human biting) and 
flooded meadows (e.g. Aedes cinereus bird-biting and human biting) or saline pools in salt 
marshes (Ochlerotatus detritus bird-biting and human biting ) and grazing marsh (Culex 
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modestus bird-biting and human biting). A few species occupy tree-holes (e.g. Anopheles 
plumbeus bird-biting and human biting, Dahliana geniculata human biting); while in urban 
areas others can use containers such as rainwater butts (e.g. Culex pipiens pipiens biotype 
human biting, Culiseta annulata bird-biting and human biting). One species also favours 
underground water in flooded basements, the foundations of dwellings, drains and 
underground railway tunnels (Culex pipiens molestus biotype human biting) (Service, 1969; 
Service, 1971; Snow et al., 1998; Medlock et al., 2005). Mosquitoes that feed on both birds and 
mammals can spread viruses from birds to humans such as WNV and JEV which are maintained 
in birds and are infectious to humans. These mosquitoes are called bridge vectors as they 
bridge the gap between birds and mammals. These bridge vectors are of great public health 
importance. Table 5 gives a list of British mosquitoes that are considered bridge vectors due to 
their feeding habits. It also shows their distribution, habitat and mosquito-borne viruses they 
have been implicated to transmit elsewhere. 
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Table 5: Important British mosquitoes considered bridge vectors 
Mosquito species Distribution Habitat Implicated for mosquito-borne 
virus transmission elsewhere† 
Aedes cinereus  Widespread ,patchy Flooded habitat WNV, SINV, TAHV 
Anopheles plumbeus  widespread Tree holes  
Coquillettidia richiardii  widespread Permanent 
waters 
WNV, TAHV, BATV 
Culex modestus* Widespread Fresh and 
brackish waters 
WNV, TAHV, UUKV 
Culex pipiens sensu lato Widespread 
abundant 
Permanent 
waters 
WNV, SINV, TAHV, USUV RNA, 
LEDV 
Culex pipiens biotype 
molestus 
Locally sporadic Underground WNV 
Culex  europaeus*  Widespread, few 
records 
 Small permanent 
collections of 
ground water 
WNV 
Culiseta annulata widespread Permanent 
waters 
TAHV, USUV RNA 
Culiseta litorea  Widespread in 
south 
Coastal waters  
Culiseta morsitans Wide spread Permanent 
waters 
WNV, SINV, TAHV 
Ochlerotatus cantans widespread Woods and 
scrublands 
WNV, SINV 
Ochlerotatus detritus Widespread, patchy Coastal waters WNV, TAHV 
Ochlerotatus punctor Widespread Woodland pools BATV, UUKV 
*These mosquitoes are very rare in Great Britain hence do not pose threat to public health. 
†Based on virus isolation or autochthonous disease. 
 WNV=West Nile virus, SINV=Sindbis virus, TAHV=Tahyna virus, USUV=Usutu virus, LEDV=Lednice 
virus, BATV=Batai virus, UUKV=Uukuniemi (Romi et al., 2004; Medlock et al., 2005, 2007; Li et al., 
2010) 
 
1.2.20 Invasive mosquitoes 
In addition to the 34 species of mosquitoes, there is threat from invasion of new mosquito 
species. Culex modestus, a mosquito vector suspected of WNV transmission to animals and 
humans in France and other European countries, was identified in Kent, Essex and 
Cambridgeshire (Golding et al., 2012). Six exotic species (Ochlerotatus atropalpus, Aedes 
aegypti, Ochlerotatus japonicas, Aedes albopictus, Aedes triseriatus, and Aedes koreicus and 
have also recently been found in Europe hence raising the prospect that they might also be 
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introduced to the British Isles. Two main mosquitoes that have a great impact on public health, 
Aedes aegypti and Aedes albopictus are discussed in detail below. 
1.2.20.1 Aedes albopictus 
This mosquito is considered the most invasive mosquito in the world and presents a major 
threat to public health (Paupy et al., 2009).  The eggs of Aedes albopictus have successfully 
been transported globally via the used tyre trade and the importation of lucky bamboo and its 
success in colonizing new geographic locations is due to its ability to adapt to different climates 
through the production of cold-resistant eggs (Scholte et al., 2007).  Aedes albopictus is an 
important known vector of Chikungunya virus (CHIKV). It was the primary vector involved in 
outbreaks of CHIKV on La Reunion Island (Pialoux et al., 2007), Italy (Rezza et al., 2007), and 
France (Grandadam et al., 2011). It has also been implicated as a vector for dengue virus 
causing outbreaks in Hawaii (Effler et al., 2005), Le Reunion Island (Pierre et al., 2005) Mauritius 
(Ramchurn et al., 2009), Croatia (Gjenero-Margan et al., 2011) and France (La Ruche et al., 
2010).   So far Aedes albopictus has been detected in 20 European countries including 
Netherlands, Albania, Belgium, Bosnia, Germany, Greece, Italy and France with Italy being the 
most infested (Medlock, Hansford, Schaffner, et al., 2012). 
1.2.20.2 Aedes aegypti 
This species was previously established in Brest and Odessa in Europe up to the beginning of 
the 20th century (Reiter, 2010) and has recently re-established in Europe in Madeira (Almeida 
et al., 2007) and around the Black Sea in southern Russia, Abkhazia, and Georgia (Yunicheva et 
al., 2008). It was reported for the first time in the Netherlands in 2010, associated with 
imported used tyres (Scholte et al., 2010). Aedes aegypti can utilize sheltered sites in a 
domestic setting, which provides protection against environmental conditions and numerous 
aquatic habitats suitable for oviposition (Reiter, 2010). It is also a highly effective vector of YFV, 
a disease found in west, central, and east Africa and in South America. The historical, YF 
outbreak that occurred in Swansea in the 19th century was caused by importation of Aedes 
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aegypti (Buchanan, 1865).  This mosquito has a major impact on public health as it  causes 
dengue fever epidemics in the Americas, Southeast Asia, and the western Pacific, with an 
estimated 50 million infections every year (Wilder-Smith et al., 2010). 
1.2.21 Risk of arbovirus introduction into the Great Britain 
There is currently no transmission of mosquito-borne arboviruses to humans in Great Britain, 
However some evidence pointed to the serological detection of antibodies to West Nile virus 
(WNV), Usutu virus and Sindbis virus in both migrant and non-migrant wild bird species 
(Buckley et al., 2003) and to WNV in sentinel chickens raised on a farm (Buckley et al., 2006). 
Prior to this, the only previous record of a mosquito-borne arbovirus in Great Britain was 
serological evidence of Tahyna virus in small mammals in Devon (Chastel, 1985). 
With a number of mosquito-borne arboviruses being endemic in other parts of Europe where 
they cause human disease and the continuing invasion of exotic mosquito species, it is likely 
that some of these diseases and mosquitoes could appear in Great Britain.  This may occur 
through movement of infected humans, animals and insects leading to subsequent 
transmission.  For example Chikungunya virus was introduced into Italy by a viraemic traveller 
(Rezza et al., 2007) and so was the dengue outbreak in France (La Ruche et al., 2010). The 
growth in air travel not only enables global transit of pathogens but also accelerates their 
introduction by allowing infectious host to reach other continents in a few days. Transportation 
also could aid in the introduction of exotic mosquito species that could in turn lead to 
epidemics of disease as was the case with CHIKV in France (Grandadam et al., 2011).  This could 
be through importation in used tyres. Climatic factor could also influence the introduction of 
arboviruses.  
Arthropods are an important part of the transmission cycle and are dependent on specific 
climatic conditions for their development and maintenance. Warmer summers and milder 
winters could favour the abundance of disease causing mosquitoes. Global warming also has 
the potential to increase the distribution of vectors and to enhance transmission potential in 
temperate climates by elongating transmission seasons, increasing host-vector contact  and 
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shortening extrinsic incubation times (Weaver & Reisen, 2010). Wind has also been shown to 
play a part for example several epidemics of bluetongue are thought to have been as a result of 
windborne infected Culicoides from affected areas across seas (Gibbs & Greiner, 1988). Another 
potential way that arboviruses could be introduced into Great Britain is through migratory 
birds. Several studies have implicated migratory birds in the spread of arboviruses (Johnston & 
Conly, 2000; Farfan-Ale et al., 2004; Lvov et al., 2004).  There is one study that has shown 
migratory birds testing positive for WNV and Usutu antibodies in Great Britain (Buckley et al., 
2003). However, follow up studies have not shown evidence (Phipps et al., 2008).  Nonetheless, 
bird migrations likely only offer a partial explanation to the emergence of a pathogen in an 
area.   
Great Britain had recently seen the emergence of Culicoides biting midge-borne viruses, 
bluetongue (2007) (Baylis, 2002; Landeg, 2007) and Schmallenberg viruses (2012) (Beer et al., 
2013). Both viruses affect ruminants e.g. sheep and cattle.  While these are not mosquito-borne 
viruses and do not cause disease in humans it still suggest that there is potential for 
transmission of arboviruses in the UK. 
One of the major mosquito-borne viruses considered a threat to Europe is Japanese 
encephalitis virus (JEV). Unlike WNV which causes relatively mild disease in humans, JEV is 
known to cause severe illness in humans mainly children between the ages of 1 through 15 
years (Ghosh & Basu, 2009). JEV has also been reported to have a high potential to expand to 
new areas and indeed one possible introduction was reported in Italy in 2010 when JEV RNA 
was detected in a pool of Culex pipiens mosquitoes collected in north-eastern Italy (Ravanini et 
al., 2012).  It is thought that this virus may have been introduced into Italy through migratory 
waterfowl or wild water-birds (Ravanini et al., 2012).  However, it is important to note that 
autochthonous cases of Japanese encephalitis (JE) have never been reported in Europe 
(Erlanger et al., 2009). 
It is thought that significant levels of immunity in avian species, and the  low temperatures that 
in turn lead to low densities of mosquitoes in Great Britain may provide a barrier for the 
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introduction of arboviruses (Gould & Higgs, 2009). However there has been transmission of 
mosquito-borne viruses in countries occurring at the same latitude as Great Britain or even 
higher as indicated by the map in figure 6 above. 
With all the factors of introduction of mosquito-borne pathogens considered one very crucial 
aspect is the availability of competent vectors to actually sustain the circulation of these 
pathogens. Some of the mosquito species in Great Britain have been implicated for 
transmission of mosquito-borne viruses elsewhere (see Table 3). However one important factor 
lacking is the evaluation of the fitness of these local species to transmit viruses. 
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1.3 Aims and hypothesis: 
1.3.1 Aim 1:  
Sequence the previously uncharacterised Tengah isolate of JEV, and determine the evolutionary 
rate of JEV, determined using complete genomes, including three complete sequences of 
genotype V that have not been used in evolutionary studies before. 
1.3.1.1 Hypothesis 1 
A. Evolutionary trees that use all the available information on complete genome sequences 
of JEV will reveal different evolutionary rates than those based on partial genome only. 
B. The rate of evolution for genotype V will be slower than that of the other  genotypes 
 
1.3.2 Aim 2:  
Assess the infectivity of Muar (genotype V) stain of JEV in Culex quinquefaciatus mosquitoes 
and compare its infection, dissemination and transmission rates to Nakayama (genotype III). 
1.3.2.1 Hypothesis 2 
A. Muar will infect and will be transmissible in Culex quinquefaciatus mosquitoes 
B. The infectivity efficiency of Muar GV will be lower when compared to that of Nakayama 
genotype III. 
 
1.3.3 Aim 3:   
Investigate for the first time, the vector competence of a British mosquito species Ochlerotatus 
detritus for JEV at different temperature and compare the vector competence to Culex 
quinquefasciatus. 
1.3.3.1 Hypothesis 3 
A. Ochlerotatus detritus will be susceptible to infection with JEV 
B. If Ochlerotatus detritus is capable of transmitting JEV, it will be more competent at the 
higher temperature of  28°C than at the lower temperature of 23°C 
C. The transmission efficiency of Ochlerotatus detritus will be lower than that of the known 
JEV vector Culex quinquefaciatus. 
  
63 
 
1.4 Thesis outline 
The results chapters of this thesis are organized as follows: Chapter 3 characterizes the full 
genome sequence of the Tengah isolate of JEV using molecular biology methods of RNA 
extractions, polymerase chain reaction, sequencing analysis and phylogenetic methods. The 
Tengah sequence provides additional sequence information which is then included in 
evolutionary studies using all published full genome sequences of JEV. Of the published 
sequences, three from genotype II and one from genotype V were recently published hence 
they have not being used in evolutionary studies before.  The evolutionary analysis aims to 
provide a more comprehensive evolutionary rate of JEV together with the evolutionary rate of 
genotype V which has not been provided before due to lack of adequate sequence information.  
Chapter 4 continues to explore genotype V isolate Tengah (now referred to as Muar due to the 
fact that its sequence is virtually identical to Muar as revealed in chapter 3) to understand the 
factors that may have led its limited distribution and isolation. Isolates in genotype V have 
never been used in vector competence studies before hence the rate of infectivity is not 
known. The infectivity of Muar in Culex quinquefaciatus mosquitoes (a known vector for JEV) is 
assessed for the first time. The ability of Muar to infect Culex quinquefaciatus mosquitoes is 
also compared to that of Nakayama, an isolate belonging to genotype III which is the most 
frequently isolated genotype of JEV. 
With the possibility of JEV emerging in places it has never been seen before, there is a concern 
of such an arbovirus emerging in Great Britain which is has yet to see any autochthonous 
transmission of mosquito-borne viruses. Increased global trade and transportation together 
with climatic factors may enable the emergence of arboviruses in Great Britain. However it is 
not known whether the local British mosquitoes can maintain and support the circulation of 
these viruses. Hence in chapter 5 I determine the competence of a local British mosquito 
Ochlerotatus detritus to JEV at two different temperatures. The work in this chapter has been 
accepted for publication in the Medical and Veterinary Entomology journal (manuscript 
attached). 
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2 Chapter 2: General materials and methods  
2.1 Cell culture 
2.1.1 Cells 
The cell line used in this study was the Vero cell line. Vero cells are a mammalian continuous 
cell line derived from the Kidney epithelial cells of an African green monkey in the 1960s (Simizu 
& Terasima, 1988). African green kidney epithelial cells (Vero) were maintained in Dulbecco 
Modified Eagle’s Minimal Essential Medium (DMEM) (Sigma-Aldrich, Dorset, UK) media 
containing 10% heat-inactivated Fetal bovine serum (FBS), 2 mM L-glutamine and 50 µg/ml 
Penicillin/Streptomycin in 75 cm2 flasks with vented cap (Corning® New York, USA). The cells 
were incubated in a humidified 37°C incubator in the presence of 5% CO2. The cells were sub-
cultured once they reached 80-90% confluence. This was done by pipetting out medium and 
washing the monolayer. The media was aspirated and the monolayer was washed with 10 ml of 
1 × Potassium phosphate buffer (PBS) twice. The cells were then incubated with 1 × trypsin- 
Ethylenediaminetetraacetic acid (EDTA) (0.05% trypsin, 0.53 mM EDTA, 1 ml/25 cm2) for 5 
minutes at 37°C until cells start to streak as they detach from the flask. To help detach the cells, 
the flask was tapped gently from side to side, then 10 mls of fresh DMEM with 10% FBS was 
added to inactivate trypsin. The cells were aspirated several times to ensure single cell 
suspension and dispensed into new flasks. The cells were diluted 1:20 and passed every 7 days 
until virus inoculation.  
2.1.2 Long-term storage of cells 
Cells were grown until they attained 80-90% confluence. Growth medium was removed and the 
monolayer washed with 10 ml of 1× Phosphate buffered Solution (PBS) twice. The cells were 
then incubated with 1 × trypsin-EDTA for 5 minutes at 37°C. Five mls of fresh DMEM with 20% 
FBS was added to inactivate trypsin. The cell suspension was transferred to a sterile 15 ml 
conical tube and centrifuged for 10 minutes at 1000 × g to pellet the cells. The supernatant was 
removed and replaced with cell freezing medium  containing 10% dimethyl sulphoxide (DMSO) 
(Sigma-Aldrich, Dorset, UK)  and DMEM with heat-inactivated 20% FBS. The DMSO is added to 
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prevent the formation of ice crystals during the freezing process and hence to preserve the cells 
during the freezing and thawing process respectively. Re-suspended cells are added to cryo 
vials 1 ml each and slowly frozen to -80°C in a Cryo 1°C freezing container (Mr. Frosty, Nalgene, 
UK) which provides the recommended -1°C/minute cooling for successful cell cryopreservation 
for 24 hours,  then transferred to liquid nitrogen. 
2.1.3 Cell counting 
To assess cell viability and to determine cell density, cell culture suspensions were analysed 
using a hemacytometer Improved Neubauer (Hausser Scientific USA).  Cell viability was 
determined using trypan blue exclusion. Only dead cells were stained with the trypan blue dye 
while the viable cells remained clear. Cultured cells were pelleted by centrifugation and re-
suspended in 2-5ml of growth medium. Equal amounts of cell suspension and 0.4% v/v trypan 
blue solution (Gibco) were mixed and allowed to stand for 5-10 minutes and loaded on to an 
assembled hemacytometer.  The number of clear (viable) cells and the number of blue (non-
viable) cells were counted within 4 random 1 mm21mm2 squares.  The percentage of viable cell 
density (cells/ml) was calculated as below and only cell suspensions containing >90% viable 
cells were used. 
Cell count (cells/mL) = Average cell count per 1mm2square × dilution factor 104  
Cell viability (%) = Cell count (viable)/Total cell count × 100  
2.2 Virus 
Two strains of Japanese encephalitis virus (JEV) were used in this study Tengah and Nakayama. 
2.2.1 Tengah 
Tengah strain of JEV was originally obtained from the brain of a nine year old Malay girl in 
Singapore in 1952 (Hale et al., 1952; Okuno et al., 1968) and was kindly donated to us by 
Professor Ichiro Kurane from the Department of Virology, National Institute of Infectious 
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Diseases, Tokyo, Japan. The virus has been passaged 5 times in Vero cells before use in this 
study. This strain has been fully sequenced and characterized as a JEV genotype V strain in 
Chapter 3 of this thesis.  
2.2.2 Nakayama 
Nakayama is a genotype III strain of JEV and was originally isolated in Japan in 1935 from 
human cerebellum (Lewis, Taylor, & et al., 1947). It was kindly donated by Dr. David Beasley 
and Dr. Alan Barrett from University of Texas Medical Branch, Texas, USA. 
2.2.3 Virus culture and harvest 
All procedures using ‘live’ virus were carried out in Advisory Committee on Dangerous 
Pathogens containment level 3 facilities (ACPD CL3) at the University of Liverpool. All viruses 
were propagated in Vero cells. Vero cells were grown till 60-80% confluence was reached. 
Growth media was removed and 0.5- 2ml of virus growth media (DMEM supplemented with 5% 
FBS and penicillin/Streptomycin) was added to the flask (in T25 tissue culture flask). 100 µl of 
seed virus was added into the flask and rocked gently to ensure that the monolayer was evenly 
covered. The flask was incubated at room temperature for 30 -60 minutes with gentle rocking 
every 5-10 minutes. After incubation, 7-8 ml of virus growth medium was added to the flask 
and incubated in a humidified incubator at 37°C with 5% CO2.  
Cells were monitored daily for development of cytopathic-effect (CPE) and the virus was 
harvested when 50-70% CPE was observed. Supernatant from the infected cells was transferred 
to a 15 ml centrifuge tube and centrifuged at 2000 rpm for 15 minutes in sealed centrifuge 
buckets to remove cellular debris. The clarified medium was transferred to a sterile 15 ml tube 
then aliquoted in screw-top cryovials (Nalgene®, UK) and stored at -80°C freezer. 
2.2.4 Virus titration 
Plaque assays were performed to determine virus titre (plaque forming units/ml) in Vero cells. 
Cells were grown until they were 100% confluent, and then counted using the method stated 
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above. The cells were diluted to a 7.5 x 105 cells/ml density with growth medium. One milliliter 
of the cells was added to each well in a 6 well tissue culture plate then topped with 2-3 ml of 
growth medium and incubated overnight in a 37°C incubator with 5% CO2. A 2% agarose 
overlay was prepared by dissolving 2 g of SeaPlaque® agarose-(Lonza, Basel, Switzerland) in 
sterile distilled water and then autoclaved. This medium was allowed to cool in a 56°C water 
bath before 2 x nutrient medium was added. The composition of 2 x nutrient medium is 5 x 
Minimum Essential Media (MEM) (Sigma-Aldrich Dorset, UK) 4% FBS, Gentamicin (50 mg/ml 
10000x) (Thermo Fisher Scientific, UK), Amphotericin B (Fungizone) (250ug/ml, 1000x) (Thermo 
Fisher Scientific, UK), 7.5% Sodium hydro carbonate NaHCO3 and sterile distilled water. Equal 
volumes of 2% agarose and 2x nutrient medium were mixed to obtain a 1% agarose and 1x 
nutrient medium. The overlay medium was held at 42°C until required. Virus was diluted ten-
fold from 10-1 to 10-6, medium was removed from all wells on the plate and 500 µl of virus 
dilution was inoculated into each well on the plate (one dilution per plate). The plates were 
then incubated at 37°C for 1 hour with rocking every 10 minutes; after incubation 4ml of 
agarose overlay were added to each well. Once the overlay had set the plates were incubated 
at 37°C in the presence of 5% CO2 for 5- 7 days. 
2.2.5 Assay development 
After incubation 2 ml of 10% neutral buffered formalin solution was added to each well and 
incubated at room temperature for 3 hrs or overnight. The formalin solution inactivates any 
virus present and fixes the cells to the plate. The fixative and agarose plugs were removed from 
the wells and 0.5 ml of crystal violet solution was added to each well and left to stain for 5 
minutes. The stain was washed off using water and the plates were dried on tissue paper. The 
plates were placed on a light box and plaques were counted in each well.  
To calculate the plaque forming units per ml: 
Plaque forming units per ml (pfu/ml) = Number of plaques/dilution factor × volume of diluted 
virus added to the well. 
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2.3 Molecular biology 
2.3.1 Viral RNA extraction  
RNA extraction was undertaken using the QIAamp Viral RNA Mini Kit (Qiagen®, Valencia, CA, 
USA.) according to manufacturer’s instructions. Briefly, 140 μl of cell culture supernatant was 
added to 560 μl of AVL buffer containing carrier RNA and vortexed for 15 seconds. The sample 
was incubated for 10 minutes to inactivate the virus at room temperature. After a brief 
centrifugation, 560 μl of 100% ethanol was added and mixed by vortexing for 15 seconds. The 
solution was then applied to a QIAamp mini spin column and centrifuged at 8000 rpm for 1 
minute and the filtrate discarded. AW1 buffer (500 μl) was then added to the spin column and 
centrifuged for 1 minute at 8000 rpm. After discarding the filtrate, 500 μl of AW2 buffer was 
added and centrifuged for another 3 minutes at 14,000 rpm. To make sure that there is no 
residue of the AW2 buffer the spin column was then transferred to a clean collection tube and 
centrifuged again for 1 minute at 14000 rpm. To elute viral RNA the spin column was 
transferred to a clean collection tube and 60 μl of AVE buffer (RNase-free water with 0.04% 
Sodium azide) was added. The sample was incubated at room temperature for 3 minutes then 
centrifuged at 8,000 rpm for 1 minute. The obtained RNA was then stored at -70°C for further 
analysis. The extracted RNA was used as a template for the amplification of cDNA by reverse 
transcriptase-PCR (RT-PCR). 
2.3.2 Agarose gel electrophoresis 
A 1% agarose gel was prepared in 1 × Tris-Acetate (TAE) buffer (40 mM Tris-Acetate, 1mM 
EDTA, pH 8.3, Fisher products Loughborough, UK). The suspension was heated in a convectional 
microwave oven until the agarose had completely dissolved. A gel-casting try was prepared by 
sealing both ends with tape and inserting small combs to produce wells. After the agarose had 
cooled to 50-60°C, ethidium bromide was added to a final concentration of 0.5 µg/ml and the 
solution was transferred to a casting tray. Once set, the tape and combs were removed and the 
tray transferred to an electrophoresis tank containing TAE buffer. The samples were mixed with 
10 × loading buffer (50% v/v glycerol, 10 mM Tris-HCL pH 7.5, 1 mM EDTA, 0.2% (w/v) 
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Bromothymol blue to a final concentration of 2 × loading buffer and loaded on to the gel. A 1 
kilo base DNA ladder (New England Biolabs Ontario, Canada) was included in each gel (0.5 
µg/well) to allow approximation of band size and concentration during visualization. The DNA 
fragments were separated by electrophoresis using 100-120 volts for the appropriate amount 
of time. PCR products were analyzed visually by electrophoresis through ethidium bromide-
stained 1% agarose gels under UV light. Bands were visualized and photographed using a 
Syngene gel documentation system. Products were purified by using a QIAquick Spin PCR 
Purification kit (Qiagen®). Amplicons were sequenced on both strands via an automated ABI 
3730XL sequencer by the Eurofins MWG Operon® Company Ebersberg, Germany. 
2.3.3 Cloning of PCR products 
Sections of the Tengah sequence which had double peaks were later cloned to verify the 
nucleotides in these positions. These were 5500 to 6000, 7000 to 7500 and 8900 to 9100 
regions. Cloning was done using the TA Cloning® Kit with pCR™2.1 Vector and One Shot® TOP10 
chemically competent E. coli (Invitrogen Corporation Carlsbad, California) following the 
manufacturer’s instructions. Briefly, PCR products were obtained using primers specific for 
these regions (A table of primers is provided in chapter 3). These products were ligated into the 
cloning  vector, pCR®2.1 by pipetting 2 μl of the PCR product, 1 μl of the ligation buffer, 2 μl of 
the vector, 1 μl of T4 DNA ligase and 4 μl of water to a final volume of 10 μl. The reaction was 
incubated at 14°C overnight. After ligating the insert into the pCR®2.1 vector, the construct was 
transformed into One shot® E. coli competent cells (TOP10). The vials containing the ligation 
mix were centrifuged briefly and placed on ice. 2 μl of the reaction was added to a vial with 
50μl of thawed competent cells and incubated on ice for 30 minutes. The cells were then heat 
shocked without shaking for 30 seconds in a 42°C water bath, then immediately transferred to 
ice. After 30 seconds, 250 μl of S.O.C (Super Optimal Broth) medium equilibrated to room 
temperature was added to the vial. The vials were incubated in a shaking incubator at 225 rpm 
for 1 hour at 37°C. The transformation was spread on Luria broth (LB) agar plates containing 50 
μg/ml Kanamycin after they had been equilibrated at 37°C for 30 minutes. The LB plates were 
then incubated overnight at 37°C. Screening of colonies: Ten colonies for each reaction were 
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picked and screened by PCR using the Qiagen HotStarTaq Master Mix kit, according to the 
manufacturer’s instructions. Primers specific for these regions were used and the following PCR 
conditions: An initial activation of 95°C for 15 minutes followed by 25 cycles of denaturation at 
94°C for 1 minute, annealing at 68°C for 1 minute, extension at 72°C for 1 minute and a final 
extension at 72°C for 10 minutes. The positive colonies were then incubated overnight in LB 
medium containing 50 μg/ml of Kanamycin for plasmid extraction. Incubation was at 37°C with 
vigorous shaking at 250 rpm. 
2.3.4 Plasmid extraction 
Plasmids were extracted using the QIAprep Spin Miniprep kit as described in the protocol. 
Briefly, bacterial cells were centrifuged at 8000 rpm in a conventional tabletop centrifuge for 3 
minutes at room temperature. The supernatant was carefully removed and the pelleted 
bacterial cells were re-suspended in 250 μl of buffer P1 and transferred to a 1.5 ml micro-
centrifuge tube. A volume of 250 μl of buffer P2 was added and mixed thoroughly by inverting 
the tube 4-5 times. This was done to lyse the cells. Buffer N3 was added at a volume of 350 μl 
and tubes mixed immediately. The tubes were then centrifuged at 13,000 rpm for 10 minutes 
and the supernatant obtained was pipetted on to a QIAprep spin column. After another 
centrifugation for 1 minute at 13,000 rpm, the spin column was washed by adding 500 μl of 
buffer PB and centrifuged for 1 minute at 13,000 rpm. An additional wash was followed using 
750 μl of buffer PE and centrifuged at 13,000 rpm for 1 minute. The flow through was discarded 
and the tubes centrifuged again for 1 minute at 13,000 rpm to ensure complete removal of 
buffer PE. To elute DNA, 50 μl of buffer EB was added to the center of the QIAprep spin column, 
incubated for 2 minutes, then centrifuged for 1 minute at 13,000 rpm. The obtained plasmid 
DNA was sequenced on both strands using an automated ABI 3730XL sequencer by the Eurofins 
MWG Operon ® Company Ebersberg, Germany. 
2.3.5  Sequence analysis 
Obtained sequences were compiled together to form the complete genome using the Contig 
assembly application of Vector NTI Advance ™11. The complete sequence was compared to 
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sequences in the public database using NCBI-Blast program. ClustalW2 Cambridge, UK (Chenna 
et al., 2003) was also used to align the Tengah genome with other complete genome sequences 
of different JEV genotypes. 
2.4 Vector competence methods 
2.4.1 Mosquito acquisition and maintenance 
2.4.1.1 Mosquitoes 
Mosquitoes used in this study were derived from wild-caught larvae of Ochlerotatus detritus 
sourced locally and Culex quinquefasciatus, Say (Recife strain), a colonized mosquito from 
Brazil.  Culex quinquefasciatus was used for validation since JEV has been isolated from this 
mosquito previously (Weng, Lien, Wang, Lin, Lin, & C., 1999; Halstead & Tsai, 2004; 
Nitatpattana et al., 2005; Changbunjong et al., 2013) and it has also been shown to be 
competent for JEV in infection studies (Mourya et al., 2002; van den Hurk et al., 2003; Liu et al., 
2012).  All mosquitoes were reared and maintained at the Liverpool School of Tropical Medicine 
(LSTM) insectaries. 
2.4.1.2 Ochlerotatus detritus 
Ochlerotatus detritus immatures (larvae and pupae) were collected from pools on a saline 
marsh in northwest England (GPS coordinates 53.277073N, -3.067728W) (Figure 9A). This was 
undertaken using the standard dipping technique (Service, 1993) or the net method (Robert et 
al., 2002) using a fish net (Figure 9B).  The collected samples were labelled with the date and 
site of collection and kept in separate containers for identification. They were transported to 
the LSTM insectary where they were reared in 15 × 30 × 5 cm trays, in the same saline water 
they were collected from at the marsh, and fed on brewer’s yeast tablets (Holland & Barrett, 
Nuneaton, Warwickshire, UK) as needed. Identification was carried out using the fourth instar 
larvae following the identification keys for British mosquitoes (Cranston et al., 1987). Pupae 
were collected daily once the field collected larvae started pupating and transferred to a 
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BugDorm cages® (BioQuip, Rancho Dominguez, CA) (30 × 30 × 30 cm) where they would emerge 
as adults. A colony was not established as eggs laid in the laboratory failed to hatch. 
 
                            
 
 
 
2.4.1.3 Culex quinquefaciatus 
The Culex quinquefaciatus (Recife strain) mosquitoes were obtained from a colony maintained 
in the LSTM insectary that was originally established in Brazil. Adult female mosquitoes were 
provided with a bloodmeal using a Hemotek feeding system (Discovery Workshops, UK). Two 
days later they were provide with cups filled with water to lay their eggs. Larvae hatched a day 
after and were divided into 15 × 30 × 5 cm trays (Figure 10A) with approximately 1 litre of de-
chlorinated water and fed on brewer’s yeast tablets (Holland & Barrett, Nuneaton, 
Warwickshire, UK) as needed. The amount of food provided was variable depending on the 
average size of the larvae. 
2.4.2 Maintenance 
Once the larvae started pupating, the pupae for both species of mosquito were collected daily 
and transferred to separate 30 × 30 × 30cm BugDorm® cages (BioQuip, Rancho Dominguez, CA) 
(Figure 10B) where they would emerge as adults. The larval stages pupated after 7 days and the 
adults emerged after 2 to 3 days at an optimal temperature of 27°C. All mosquitoes were 
Figure 9: (A) Mosquito sampling site at the saline Marsh in Cheshire – 
GPS coordinates: 53.277073N –3.067728W and (B) mosquito sampling 
method using a fish sweep net.  
A B 
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reared under standard insectary conditions with a relative humidity of 70-90% and 12: 12 light: 
dark cycle at 27°C.  The adults were maintained with cotton wool soaked in 10% sucrose 
solution placed on top of the cage as a carbohydrate source, and water ad libitum. The sugar 
was then removed twenty four hours before the infection experiments. 
 
                                           
Figure 10: Larval trays (A) and cages used to rear mosquitoes (B) 
 
2.4.3 Vector competence studies 
2.4.3.1 Infection of mosquitoes by artificial bloodmeal 
Five to seven day old adult female mosquitoes were mechanically aspirated from their cages 
into small plastic cups.  They were deprived of sugar and maintained on water for 24 hours 
before they were used for vector competence studies.  About 100 mosquitoes were allowed to 
feed to try and achieve a minimum of 50 mosquitoes for each experiment. 
All work with infectious blood meals was undertaken in an Advisory Committee on Dangerous 
Pathogens Arthropod containment level 3 (ACDP ArCl3) facilities at the Liverpool School of 
Tropical Medicine (LSTM), Liverpool, UK.  Infectious blood meal containing virus from frozen 
stock was prepared by combining 1 ml of defibrinated horse blood (Thermo Oxoid Remel) with 
the appropriate amount of virus stock and 100 µl of adenosine 5’-triphosphate (ATP 0.02 µm) 
as a phagostimulant to a final concentration of 6 logs pfu/ml. 
B A 
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Peroral infection was achieved by exposing mosquitoes to the infectious bloodmeal artificially 
using a Hemotek feeding system (Discovery Workshops, UK) (Figure 11B) enclosed in a glove 
box (Figure 11A) for 1-hour in the dark, at room temperature. This is done by using an artificial 
membrane (Parafilm®).  The membrane is stretched on to the Hemotek reservoir connected to 
the feeding apparatus which warms the blood to 37°C. The reservoir is then placed on the top 
of the cage with the membrane towards the mosquitoes and mosquitoes allowed to engorge.  
In all cases a 0.5 ml aliquot of the infectious blood meal was taken both before and after the 
mosquitoes were fed, and was stored at -80° C for subsequent plaque assay analysis. 
Mosquitoes were chilled and sorted on ice and placed in 0.5 litre plastic cups with lids.  Only the 
fully engorged mosquitoes were used for the study. Fed females were maintained with 10% 
sucrose, under a 70-90% relative humidity and a photoperiod of 12: 12 light: dark cycle. 
Experiments for the different temperatures were set on different days and so mosquitoes were 
either held at 23° C or 28° C. 
 
                       
 
 
 
A 
Figure 11: Glove Box (A) Oral infection of mosquitoes on JEV infectious 
bloodmeal (B) Hemotek feeding system containing infectious bloodmeal with 
Parafilm as membrane is placed on top of container holding female 
mosquitoes to allow mosquitoes to feed. Feeding was carried out in a glove 
box in the ACDP ArCL3 facility. 
B 
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2.4.3.2 Determination of infection, dissemination and transmission 
Mosquitoes were sampled at 0, 1, 3, 7, 14, 21 and 28 days post infection (dpi) at both 23°C and 
28°C. All mosquitoes collected at 0, 1, and 3 dpi were frozen individually in 1.5ml tubes 
containing virus diluents media. All mosquitoes collected at 7, 14, 21 and 28 dpi had their saliva 
collected before they were then separated into bodies and legs. This was achieved by 
anesthetizing using Triethylamine (TEA) (Sigma, St. Louis, MO). Studies have shown that low-
level exposures to TEA anesthetize mosquitoes for several hours and do not affect heart 
physiology or reduce mosquito survival thus making it suitable for mosquito anaesthesia and 
ideal for experiments where mosquitoes must be restrained for prolonged periods of time 
(O'Guinn & Turell, 2002). 
The corner of a 10 × 10 cm cotton gauze pad was dipped into TEA and placed on the screen of a 
0.5 litre cardboard container and the container was placed in a plastic bag for 4-5 minutes. 
Mosquitoes remained alive but were incapacitated for several hours. 
Salivary secretions were collected using a modified in vitro capillary transmission assay (Aitken, 
1977). Mosquito mouth parts were inserted into a capillary tube containing approximately 10 µl 
of a mixture of virus diluent (Minimum essential medium (MEM), containing 1% Bovine serum 
albumin (BSA), 50 µg/ml penicillin/streptomycin, 0.3% Sodium hydrogen carbonate and 2.5 
µg/ml Fungizone), sucrose and adenosine 5’-triphosphate (ATP, 0.02 µM) for 45 minutes (Figure 
12).  One µL of 1% pilocarpine, an analogue of the acetylcholine, prepared in phosphate 
buffered solution (PBS) and 0.1% Tween 80, was applied on the thorax to stimulate salivation. 
Active movements of the maxillary palpi and the stylets observed under a stereoscopic 
microscope were interpreted as a sign of salivation. After 45 minutes, medium containing the 
saliva was expelled under pressure into 1.5 ml tubes containing 0.5 ml of virus diluent and 
frozen at -80° C for subsequent determination of transmission rates.  
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Legs were removed and placed in 1.5 ml tubes containing 0.5 ml of virus diluent and frozen at -
80° C for subsequent determination of dissemination rates.  Bodies were placed in separate 
tubes containing 0.5 ml virus diluent and frozen at -80° C for subsequent determination of 
infection rates. 
Infection was determined by recovery of virus from the mosquito tissue suspension by plaque 
assay. If virus was recovered from its body and but not its legs, the mosquito was considered to 
have a non-disseminated infection. If virus was recovered from both the legs and the body 
suspension the mosquito was considered to have a disseminated infection (Turell et al., 1984) 
and if virus was recovered from its saliva the mosquito was considered to have a transmissible 
infection.  Infection, dissemination and transmission rates were defined as the percentage of 
mosquitoes tested that contained virus in their bodies, legs and saliva respectively. In all cases 
0.5 ml aliquots of the infectious blood meal were collected both before and after the 
mosquitoes were fed and stored at -80°C for subsequent virus isolation. This was done to 
confirm that the virus was viable before and after the blood feed.  
 
                                   
 
 
 
 
 
Figure 12: Mosquito saliva collection 
 Mosquito proboscis was inserted into a capillary tube containing 
medium. Mosquitoes were anesthetized using Triethylamine and 1 µl of 
pilocarpine in PBS was applied on the thorax to stimulate salivation. 
Saliva collection was carried out under a dissecting microscope in a glove 
box in the ArCL3 facility. 
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2.4.3.3 Mosquito sample plaque assay 
Body and leg samples were prepared for virus titration by homogenizing using a Disruptor 
Genie® for 5 minutes. Plaque assays were performed by inoculating 100 µl of the salivary 
secretions or the supernatant of the homogenized bodies or legs onto a confluent monolayer of 
Vero cells on a 6-well plate (Costar®, Corning Life Sciences). The plates were then incubated at 
37°C at an atmosphere of 5% CO2 for 30 -60 minutes with rocking every 10 minutes to allow the 
virus to enter the cells. A 4 ml overlay of Minimum essential medium (MEM), 4% Fetal bovine 
serum (FBS), 50 µg/ml gentamycine, 0.5% Sodium hydrogen carbonate and 2.5 µg/ml Fungizone 
(amphotecerine B) to limit contamination and 1% SeaPlaque® low melting point agarose was 
then added to the wells and the plates were incubated at 37°C in 5% CO2. After 5 days of 
incubation, 2 ml of 10% neutral buffered formalin solution was added to each well and the 
plates left for at least 3 hours with the fixative to ensure complete inactivation of the virus. In 
order to visualize the plaques the wells were stained with 0.5 ml of crystal violet solution. 
Samples were scored as virus-positive or virus-negative based on the presence or absence of 
plaques. Infection, dissemination and transmission rates were determined by Fisher exact test 
at the 95% confidence level. 
2.4.4 Statistical analysis 
Fisher Exact Test was used to determine if there were significant differences (p < 0.05) in rates 
of infection, dissemination and transmission between temperatures and species.  SISA, an open 
access online statistics calculator (http://www.quantitativeskills.com/sisa/) was used to 
conduct Fisher Exact Test (sum of small p’s).  Confidence intervals of proportions were 
calculated using VassarStats (http://vassarstats.net/prop1.html).  VassarStats uses the Wilson 
Score Interval method which is more robust when dealing with small number of trials and/or an 
extreme probability (Newcombe, 1998). Sample size in each group was dictated by the feeding 
success and the survival rates through the days post infection (dpi).   
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3 Chapter 3: Molecular characterization of Tengah isolate of 
Japanese encephalitis virus 
3.1 Abstract 
Molecular studies have suggested that flaviviruses are rapidly evolving and may have originated 
from a common ancestor about 10,000 to 20,000 years ago. There are five genotypes of JEV 
(genotype I, II, III, IV and V), each associated with different geographical distributions and 
epidemiology.  The Muar strain of JEV, the fifth genotype, is believed to represent the oldest 
lineage from which genotype I – IV evolved. This single characterized isolate (Muar) was last 
seen in 1952 and considered the only representative of genotype V.  However, two recent 
isolates belonging to genotype V were reported in 2009 and 2010 in China and Korea, 
respectively.  At the same time as Muar was isolated (1952) another virus (Tengah strain) was 
also isolated in Singapore from a nine year old child but this strain has never been fully 
characterized. In this chapter I characterise the full genome of Tengah and utilize the Bayesian 
evolutionary analysis of sampling trees (BEAST) program to examine the evolutionary rate of 
JEV using published complete genome sequences.  Molecular characterization of Tengah strain 
showed that it is another isolate of genotype V, with 99% sequence similarity to Muar.  
Evolutionary analysis performed using BEAST program estimated that JEV is evolving at a rate of 
3.53 x104 nucleotide substitution per site per year. Tengah represents a variant of the Muar 
strain due to its close similarity. Evolutionary analysis revealed the time to the most recent 
common ancestor of genotype II strains and genotype V strains. Genotype II isolates appear to 
have evolved from a common ancestor around 1910 while genotype V evolved from a common 
ancestor in 1814.  
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3.2 Introduction 
Japanese encephalitis virus is divided into five genotypes. Genotype I, II, III, IV and V. These 
genotypes are distributed throughout Southeast Asia and the Indian subcontinent, through the 
Indonesian archipelago, and into the Australasian geographical region (van den Hurk et al., 
2009). Genotype V which is believed to be the oldest had initially only been isolated in one 
instance in Singapore at the Singapore general hospital from a patient in 1952 (Hasegawa et al., 
1994; Mohammed et al., 2011). In the same hospital in the same year, three other virus 
isolations from three patients were also reported to be Japanese encephalitis virus (Hale et al., 
1952). Tengah, one of the three isolates was thought to be genotype V but has never been fully 
characterised (Okuno et al., 1968). More recently, this genotype has been isolated from Culex 
tritaeniorhynchus mosquitoes collected in China, after 57 years (Li, Fu, et al., 2011). Another 
isolation of Genotype V has also been reported from Republic of Korea (Takhampunya et al., 
2011).This shows that this virus is not limited to Southeast Asia as previously thought. 
Japanese encephalitis (JE) virus belongs to the family Flaviviridae and is endemic in several 
regions of Asia and the pacific (Lindenbach et al., 2007).  JE virus (JEV) shares many virological, 
epidemiological and clinical features with other encephalitis-causing viruses such as  the 
flaviviruses, St. Louis encephalitis virus (SLEV) in North America, West Nile virus (WNV) in Africa 
and the Middle East, Murray Valley encephalitis virus (MVEV) in Australia, Rocio virus in South 
America and the Tick-borne encephalitis virus (TBEV) in Russia (Solomon, 2004). In addition 
there are similarities to mosquito-borne alphaviruses, such as Eastern equine encephalitis virus 
(EEEV). 
Molecular studies have suggested that flaviviruses are rapidly evolving and may have originated 
from a common ancestor about 10,000 to 20,000 years ago (Solomon et al., 2003).  JEV has a 
genome comprising a positive sense single-stranded RNA molecule of approximately 11 kilo 
bases (Kb) in length, comprising a single open reading frame (ORF) flanked by 5’ and 3’ 
untranslated regions (UTR). The ORF encodes a large polyprotein which is post-translationally 
processed into three structural proteins (capsid (C), the precursor of the membrane (prM), and 
envelope (E) and seven non-structural proteins (NS1 NS2A, NS2B, NS3, NS4A NS4B and NS5) 
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(Chambers et al., 1990; Lindenbach et al., 2007).  They have been isolated from many 
vertebrate and invertebrate vectors and hosts (Johansen et al., 2000),  such as bats (Wang, Pan, 
Zhang, Fu, & Wang, 2009), a variety of mosquito species (van den Hurk et al., 2009) humans 
(Wang et al., 2010; Zhang et al., 2011), horses (Gulati et al., 2012), pigs (van-den-Hurk et al., 
2008) and birds (Yang et al., 2011). A genetic distance of 12% at the amino acid level is used to 
classify different genotypes while the maximum genetic distance within a genotype is 6% at the 
amino acid level (Chen et al., 1990; Chen et al., 1992; Tsarev et al., 2000). 
Genotype I is distributed widely in Asia, including Japan, Korea, China, India, Vietnam, 
Cambodia, Malaysia, Thailand, Taiwan, northern Australia and Philippines. Genotype II includes 
isolates from southern Thailand, Malaysia, Indonesia and northern Australia and Papua New 
Guinea. Genotype III includes isolates from Southeast Asia, China, Japan, Korea, Taiwan and 
Central Asia sub-continent. Genotype IV has been isolated only in Indonesian archipelago 
(Solomon et al., 2003).  
In order to understand how these viruses spread to new areas, it is important to sequence their 
full genomes to assess their genetic diversity which in turn could be used to evaluate how they 
evolve.  However, with JEV some genotypes lack enough sequence information to make this 
possible.  To date, there are several complete genome sequences available for genotype I and 
genotype III, while there are only four for genotype II, only one complete genome sequence of 
genotype IV and only two complete genome sequences of genotype V. There is therefore a 
need to determine more complete genome sequences of JEV viruses in order to provide more 
accurate evolutionary rate for JEV. 
3.2.1 Evolutionary analysis 
JEV is a single stranded RNA virus whose transmission cycle involves, mosquito vectors, 
vertebrate host (birds and pigs) and humans as incidental dead-end host. RNA viruses are 
thought to evolve faster than DNA viruses because of a combination of highly error-prone 
replication with RNA polymerase or reverse transcriptase, large population sizes, and rapid 
replication rates (Domingo & Holland, 1997; Moya et al., 2004). These high mutation rates 
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facilitate their ability to replicate alternately in disparate vertebrate and invertebrate 
hosts(Holland & Domingo, 1998). The study of rates of nucleotide substitution in RNA viruses is 
central to our understanding of their evolution which can provide information for development 
of an evolutionary model of viral emergence (Holmes & Drummond, 2007).  In a study that 
utilized 50 RNA viruses to determine the rates of evolution in RNA viruses a significant 
relationship between genetic divergence and isolation time was reported for majority of the 
viruses indicating a molecular clock (Jenkins et al., 2002). The molecular clock hypothesis states 
that DNA and protein sequences evolve at a rate that is relatively constant over time and 
among different organisms (Ho, 2008). However in RNA viruses, a higher rate variation exists 
among lineages than would be expected under the constraints of a molecular clock. This high 
variation may be as a result of mutation rates, replication rates, or undefined selective 
constraints, which might be expected if RNA viruses infect a variety of host species. The general 
lack of a molecular clock or clock-likeness clearly reduces the power of gene sequences to 
estimate divergence times for RNA viruses accurately. The study by Jenkins and others showed 
that fluctuations in clock-like behavior increased the error in rate estimates. They however 
concluded that, since the error is random, multiple random deviations from rate constancy 
would be expected to have no net effect on the overall rate estimate. Therefore, substitution 
rates estimated from large data sets should still be reliable indicators of the average speed of 
evolution, even if rate heterogeneity is present (Jenkins et al., 2002). 
3.2.1.1 Evolutionary analysis using Bayesian Evolutionary Analysis Sampling 
Trees (BEAST) 
BEAST is a program for evolutionary inference of molecular sequences orientated toward 
rooted, time-measured phylogenies inferred using molecular clock models. Molecular clock is a 
technique in molecular evolution that uses fossil constraints and rates of molecular change to 
deduce the time in geologic history when two species diverged. It is used to estimate the time 
of occurrence of events where strict molecular clock means that the rate of evolutionary 
change of any specified protein is approximately constant over time and over different lineages 
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and relaxed molecular clock means that the rate of evolution can vary over time and over 
different lineages.  
BEAST analysis generates a set of trees which are often condensed into a single tree 
representing the whole set. BEAST uses Bayesian MCMC analysis to average over tree space, so 
that each tree is weighted proportional to its posterior probability (Drummond et al., 2002). In 
BEAST, divergence time estimation has also been extended to include relaxed phylogenetics 
models, in which the rate of evolution is allowed to vary among the branches of the tree. 
(Drummond et al., 2006). Dates of sequence isolations can be incorporated into the model 
providing a source of information about the overall rate of evolutionary change, (Rambaut, 
2000) hence estimating the time to the most recent common ancestor (TMRCA) (Drummond & 
Rambaut, 2007). 
Some of the advantages of Bayesian analysis are it provides a natural and principled way of 
combining prior information with data and it also provides interpretable answers, such as “the 
true parameter  has a probability of 0.95 of falling in a 95% credible interval”(Berger, 1985). 
However with Bayesian analysis, there is no correct way to choose a prior. Bayesian inferences 
require skills to translate subjective prior beliefs into a mathematically formulated prior. If 
priors are not chosen with caution, they can generate misleading results. In addition, the 
computational cost can be high especially in models with a large number of parameters and 
simulations provide slightly different answers unless the same random seed is used 
(Wasserman, 2004). 
3.2.2 Sequence analysis 
Sequence analysis uses sequence alignment methods to compare a new sequence to those with 
known functions as a way of understanding the biology of an organism from which the new 
sequence comes from. This information can be used to assign function to genes and proteins by 
the study of the similarities between the compared sequences (Durbin et al., 1998). Results can 
reveal sequences that are 100% similar or show variations in the sequences referred to 
mutations. Some mutations can either be silent mutations or missense mutations. In silent 
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mutations the changed nucleotide does not result in a change in the amino acid sequence and 
are also known as synonymous mutations. Missense mutations also known as non-synonymous 
mutations the changed nucleotide results in a different amino acid which can code for a 
different protein (Loewe, 2008). Sequence analysis can also reveal quasispecies. 
3.2.2.1 Quasispecies 
The term ‘quasispecies’ was first introduced in 1977 by Eigen and Schuster. They used this term 
to describe the cluster of closely related molecular species produced by errors in the self 
replication of nucleic acids (Eigen & Schuster, 1977).  Hence selection and mutation form a 
distribution of mutants that are called quasispecies. The target selection is not an individual 
mutant but the whole quasispecies. Therefore fitness is a property of the quasispecies and not 
of individual mutants (Nowak, 1992).Quasispecies are a cluster of variant viruses that arise from 
mutations over time within a viral isolate. They arise following error-prone replication 
associated with the viral RNA polymerase, which is less accurate at copying template molecules 
than those of DNA viruses. The quasispecies generated by mutation are acted on by complex 
and powerful selective pressures in the host, with some viruses having a survival or fitness 
advantage over others (Lauring & Andino, 2010). 
Four viral encephalitis cases were reported in Malaya (n= 1) and Singapore (n= 3) in the 
summer of 1952. All patients exhibited high fever, vomiting, headache, disturbance of 
consciousness, stiff neck and deep coma with rapid progression to death by respiratory failure 
(Hale et al., 1952). Four virus isolates were isolated from brain tissue specimens and identified 
as JEV by neutralization tests using the Japanese Nakayama strain of JEV (Okuno et al., 1968). 
Of these, the Muar strain, isolated from a 19-year-old male patient in Singapore in 1952, was 
classified as a genotype V (Okuno et al., 1968; Hasegawa et al., 1994; Uchil & Satchidanandam, 
2001; Mohammed et al., 2011). The Tengah isolate of JEV is one of the three viral isolates 
originally isolated in Singapore in 1952 from a nine year old Malaysian patient (Hale et al., 
1952).  Using an antibody-absorption test, it was characterised as JaGAr01 immunotype. 
However slight quantitative differences between Tengah and JaGAr01 were noted. They also 
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reported very close similarity between the Tengah and the Muar strain based on antibody 
absorption test (Okuno et al., 1968). To this date, this strain remains to be fully characterised.  
This study was undertaken in order to: 
 Determine the complete nucleotide and predicted amino acid sequence of the Tengah 
strain of JEV. 
 Compare the nucleotide and predicted amino acid sequence of Tengah to other 
published JEV strains. 
 Determine a more comprehensive rate of evolution of JEV by including three complete 
sequences of genotype V which have not been used in evolutionary analysis before. 
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3.3 Materials and methods 
Refer to chapter 2 (general materials and methods) for detailed source of the virus, viral RNA 
extraction, reverse transcription and genome sequencing analysis. Chapter specific protocols 
and alterations are detailed below.  
3.3.1 Virus propagation and amplification 
The Tengah strain of JEV was originally obtained from a nine year old patient in Singapore in 
1952 and was kindly donated by Prof. Ichiro Kurane from the Department of Virology, National 
Institute of Infectious Diseases, Tokyo, Japan. All procedures using live virus were carried out in 
a containment level-3 facility. The virus was propagated in Vero cells and cells were monitored 
daily for development of cytopathic-effect (CPE). The virus was harvested when 50-70% CPE 
was observed. RNA extraction was done using the QIAamp Viral RNA Mini Kit (Qiagen®, 
Valencia, CA, USA.) according to manufacturer’s instructions. Reverse transcription and PCR 
amplification were achieved in one reaction using the Titan-One tube reaction kit (Roche 
Applied Science, Indianapolis, IN, USA) according to manufacturer’s instructions. Primers used 
were synthesized based on the published sequence of a JEV strain, JKT6468 (Solomon et al., 
2003) and later on from the Tengah sequence already derived. The amplified products were 
then run on a 1% agarose gel for visualization to allow approximation of band size and 
concentration by comparing them to a 1 kb DNA ladder (New England Biolabs) with fragments 
of similar size and known concentration. Products were then purified using a QIAquick Spin PCR 
Purification kit (Qiagen® Valancia, CA, USA.) before sequencing to get rid of residual PCR 
primers and unincorporated nucleotides. If multiple products were amplified, the correct band 
based on the size of the amplicon was excised and gel eluted using QIAquick® Gel Extraction Kit 
(Qiagen® Valencia, CA, USA).  Amplicons were sequenced on both strands using the same 
primers that were used for amplification via an automated ABI 3730XL sequencer by the 
Eurofins MWG Operon® Company.  Table 6 below shows a list of all primers used to amplify the 
open reading frame (ORF) of the Tengah complete genome. 
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Table 6: Primers used to amplify and sequence the ORF of the Tengah JEV 
strain. 
No. Primer Name  Sequence (5’-3’) 
1 4 S AGTTTATCTGTGTGAACTTCTTGG 
1265A AARCCTTGYTTGCACACRTA 
2 1202S CCACGACTGGAGAAGCYCACAA 
1720A GTGGCGTGCGCCTCTTCAAA 
3 1202S CCACGACTGGAGAAGCYCACAA 
2518A CCACACCTCATCTCTTTTCTTG 
4 1202S CCACGACTGGAGAAGCYCACAA 
2598A TCTGGGCGTYTCTGGCARRT 
5 2534 S CTTCGTACACAACGATGTGGAAGCTTGGG 
3200A AAGATCACTTTCCTCAACGCCATCTCCC 
6 3172S GGGGAGATGGCGTTGAGGAAAGTGATC 
3866A TGCCCCTAGGACCAAAACCATGTTTTCT 
7 3172S GGGGAGATGGCGTTGAGGAAAGTGATC 
5122A TCTTGACGGTCACCTTGCACAATAGCG 
8 5005S GGAACATCCGGCTCACCCAT 
6378A CTTYCTCTCACCCATYCGGG 
9 5500S GCTGCAAGAGGATACATATCTACC 
6000A GGGCTAGGTTGGTGTCATCC 
10 6331S GARGAYAACACYGAGGTRGA 
7653A GTTCTTRATGAGAGTCCAGG 
11 6652S TGACAGGAGGATTCTTCCTGCTCATGATG 
7376A AACCATTCCGTCTACGACGGCATTCTT 
12 7000S GGAAGACATAAGGAGCATCCTTGG 
7500A CCTCTCGTACTGTTGTGACATTAG 
13 7601S TGCGAGGYAGCTACCTRGCT 
8842A GTGACAAGTGGGCCCACAGC 
14 7601S TGCGAGGYAGCTACCTRGCT 
9011A AGGTGGTTTTCCCTCTCCAC 
15 8600S GGACATACCATGGAAGTTACGAAG 
9100A GCTCCAAGCCACATGAACCAGAT 
16 10131S GAACAGRGTVTGGATTGAAG 
10965A AGATCCTGTGTTCTTCCTCA 
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3.3.2 Sequencing of the 5’ UTR and 3’ UTR 
Sequencing of the 5’ and 3’ UTR were determined using Invitrogen’s Rapid Amplification of 
cDNA Ends  (RACE) system – 5’ RACE and 3’ RACE.  5’ RACE was performed according to 
standard protocols (Invitrogen 5’RACE kit).  3’ RACE was performed by first adding a poly A tail 
polymerase (New England Biolabs) to the RNA template, then conducting RT-PCR with gene 
specific primers and an oligo-dT-adapter primer (details in Chapter 2). A list of the primers used 
to amplify the 5’ and 3’ region are listed below in Table 7. 
Table 7: Primers used for the amplification and sequencing of the 5, and 3, untranslated regions (UTR) 
Application Name Oligonucleotide sequence(5’-3’) 
5’ RACE Abridged anchor primer GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG 
5’RACE Abridged Universal 
Amplification Primer (AUAP) 
GGCCACGCGTCGACTAGTAC 
5’RACE Universal Amplification 
Primer (UAP) 
CUACUACUACUAGGCCACGCGTCGACTAGTAC 
PCR GSP1/5’RACE 1720aJE GTGGCGTGCGCCTCTTCAAA 
PCR GSP2/5’RACE 1265aJE AARCCTTGYTTGCACACRTA 
3’RACE Adapter Primer (AP) GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT 
PCR GSP1/3’RACE 10131S GAACAGRGTVTGGATTGAAG 
PCR GSP2/3’RACE 10944a CCACCAGCTACATGTTTCGGCGCTC 
 
3.3.2.1 Cloning of PCR products 
To investigate quasispecies of the Tengah strain of JEV, sections of the Tengah consensus 
sequence which had double peaks were reamplified, cloned, and multiple clones sequenced to 
verify the nucleotides in these positions. These were regions 5500 to 6000, 7000 to 7500 and 
8900 to 9100. Cloning was done using the TA Cloning® Kit with pCR™2.1 Vector and One Shot® 
TOP10 chemically competent E. coli (Invitrogen Corporation) following the manufacturer’s 
instructions.  Colonies for each reaction were picked and screened by PCR using primers specific 
for these regions. PCR was done using the Qiagen HotStarTaq Master Mix kit, according to the 
manufacturer’s instructions. (Detailed protocol in Chapter 2) 
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3.3.2.2 Plasmid extraction 
Plasmids were extracted using the QIAprep Spin Miniprep kit as described in the protocol. The 
obtained plasmid DNA was sequenced on both strands using the same primers used for 
amplification as listed in Table 4 above using an automated ABI 3730XL sequencer by the 
Eurofins MWG Operon ® Company (detailed protocol in Chapter 2). 
3.3.3 Sequence analysis 
Consensus sequences were compiled together to form the complete genome using the Contig 
assembly application of Vector NTI Advance ™11 (Invitrogen). The complete sequence was 
compared to sequences in the public database using NCBI-Blast program. ClustalW2 (Chenna et 
al., 2003) was also used to align Tengah with other complete genome sequences of different 
JEV genotypes. 
3.3.4 Phylogenetic analysis  
The genetic relationship to other JEV genotypes was determined by phylogenetic analysis using 
the MEGA 5.1 (Tamura et al., 2011). Analysis was performed using published sequences of 
various JEV strains obtained from the Genbank database. A list of these sequences, their year of 
isolation, geographic origin, accession numbers and genotype are listed in Table 8 below.  
Sequences were aligned and phylogenetic trees were generated by Neighbour joining and 
confidence levels for internal nodes estimated by 1000 bootstrap replicates. 
3.3.5 Evolutionary analysis 
Bayesian analysis was performed using the BEAST (Bayesian evolutionary analysis of sampling 
trees ) software package v1.7.4 (Drummond & Rambaut, 2007). The maximum clade credibility 
(MCC) phylogenetic tree was inferred using the Bayesian Markov Chain Monte Carlo (MCMC) 
method to estimate the rate of nucleotide substitution and the Time to the Most Common 
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Recent Ancestor (TMRCA). This was done by incorporating the date of sample collection as the 
age of the virus. Path-O-Gen Version 1.2 software (by A. Rambaut; 
http://tree.bio.ed.ac.uk/software/pathogen) was used to investigate the temporal signal and 
‘clocklikeness’ of the sequence data. In BEAUti v1.7.4, the analysis utilised the general time 
reversible (GTR) model for substitution with combination of gamma distribution and proportion 
of invariant sites (GTR + G + I) to describe rate heterogeneity among sites. This model was 
selected after the sequence datasets were subjected to TOPALi v2 (Milne. I et al., 2004) to 
determine the most suitable nucleotide substitution model. Uncorrelated lognormal relaxed 
clock model was chosen in order to accommodate for variation in substitution rate among 
branches (Drummond et al., 2006). MCMC chains were 100 000 000 generations with 10% 
burn-in to make an effective sample size (ESS) for parameter estimates >200. BEAST output was 
viewed with TRACER v1.5 for convergence. Trees from multiple runs were combined using the 
LogCombiner v1.7.4 program and the evolutionary tree was generated in the FigTree program 
v1.3.1. To reveal uncertainty in the estimations 95% high probability density (HPD) intervals in 
each case was also determined. Posterior probability values were provided as an assessment of 
the degree of support for each node on the tree. Sequences used for the evolutionary analysis 
are listed in table 6 below.  
Since the XZ0938 isolate in genotype V was isolated 57 years after Muar and Tengah, BEAST 
analysis were performed with and without this isolate in order to examine the effect this isolate 
would have on the estimation of JEV evolutionary rate. 
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Table 8: Details of the Japanese encephalitis virus isolates sequences retrieved from GenBank for 
use in this study. 
No. Genotype Strain Year Origin Host GenBank accession no. 
1 I HEN0701 2007 China Pig FJ495189 
2 I Ishikawa 1998 Japan Mosquito AB051292 
3 I JEV/sw/Mie/40/2004 2004 Japan Pig AB241118 
4 I JEV/sw/Mie/41/2002 2002 Japan Pig AB241119 
5 I JX61 2008 China Pig GU556217 
6 I K94P05 1994 Korea Mosquito AF045551 
7 I SC04-17 2009 China Mosquito GU187972 
8 I SH17M-07 2007 China Mosquito EU429297 
9 I XJ69 2007 China Mosquito EU880214 
10 I XJP613 2007 China Mosquito EU693899 
11 II Bennett 1951 Korea Human FJ515927/872376 
12 II FU 1994 Australia Human AF217620 
13 II JKT654 1978 Indonesia Mosquito HQ223287 
14 II WTP-70-22 1970 Malaysia Mosquito HQ223286 
15 III 14178 2001 India Human EF623987 
16 III 57434 2005 India Human EF623988 
17 III 04940-4 2002 India Mosquito EF623989 
18 III B58 1986 China Bat FJ185036 
19 III Beijing-1 1949 China Human L48961 
20 III CH1392 1990 Taiwan Mosquito AF254452 
21 III CH2195LA 1994 Taiwan Mosquito AF221499 
22 III GB30 1997 China Bat FJ185037 
23 III GP78 1978 India Human AF075723 
24 III HVI 1967 Taiwan Human AF098735 
25 III JaGAr01 1959 Japan Mosquito AF069076 
26 III JaOArS982 1982 Japan Mosquito M18370 
27 III JaOH0566 1966 Japan Human AY508813 
28 III K87P39 1987 Korea Mosquito AY585242 
29 III Ling 1965 Taiwan Human L78128 
30 III Nakayama 1935 Japan Human EF571853 
31 III NJ2008 2008 IU IU GQ918133 
32 III P3 1950 China Human U47032 
33 III RP-9 1985 Taiwan Mosquito AF014161 
34 III SA14 1954 China Mosquito U14163 
35 III T1P1 1997 Taiwan Mosquito AF254453 
36 III Vellore-P20778 1958 India Human AF080251 
37 IV  JKT6468 1981 Indonesia Mosquito AY184212 
38 V Tengah 1952 Singapore Human This study 
39 V Muar 1952 Malaysia Human HM596272 
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40 V XZ0938 2009 China Mosquito HQ652538 
3.4 Results 
3.4.1 Sequencing of complete genome of Tengah 
The full-length Tengah strain genome was compiled, edited and analysed using the Vector NTI 
software (Invitrogen).  The complete genome was 10,988 nucleotides long, and encoded a 
predicted polyprotein of 3433 amino acids. Nucleotide and amino acid sequence for the 
complete Tengah sequence can be found in appendix I and II. Nucleotide sequence homology to 
sequences in the public database using NCBI-Blast program revealed 99% nucleotide and amino 
acid sequence similarity to JEV isolate Muar (Mohammed et al., 2011) which belongs to 
genotype V (Table 9). 
Table 9: Percentage nucleotide and amino acid sequence similarity with other JEV genotypes. 
Strain Genotype K94P05 FU JaOAr982 JKT6468 Muar Tengah 
  I II III IV V  
K94P05 I 100 96 97 93 90 90 
FU II 89 100 97 94 91 91 
JaOAr982 III 89 89 100 95 91 91 
JKT6468 IV 83 83 84 100 90 90 
Muar V 78 78 79 78 100 99 
Tengah  78 78 79 78 99 100 
Nucleotide similarity in lightface type; amino acid in bold-face type  
3.4.2 Quasispecies 
ClustalW2 (Chenna et al., 2003) was used to align Tengah with other complete genome 
sequences of JEV and revealed three nucleotide differences when compared to Muar sequence. 
Two were synonymous substitutions while one was non-synonymous. The non-synonymous 
mutation occurred in position 7173 of the nucleotide sequence and 2391 of the predicted 
amino acid sequence, and resulted in a cytosine (C)-guanine (G) substitution, in the NS4B 
region.  
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3.4.3 Phylogenetic analysis  
 The results of the nucleotide and amino acid sequence similarity in Table 9 above which shows 
a 99% sequence similarity between Muar and Tengah isolates of JEV are further supported by 
the phylogenetic tree which shows that Tengah clusters in the same branch as Muar which 
belongs to the fifth genotype of JEV. Both Muar and Tengah are significantly divergent from the 
other four JEV genotypes as shown on the phylogenetic tree in Figure 13. This suggests that 
Tengah is a fourth isolate belonging to the fifth genotype along with the JEV isolate Muar, 
XZ0934 and 10-8027 (Hasegawa et al., 1994; Li, Fu, et al., 2011; Mohammed et al., 2011; 
Takhampunya et al., 2011).  
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Figure 12: Maximum likelihood tree based on complete nucleotide genome sequences for 40 
Japanese encephalitis virus isolates. 
 Phylogenetic analysis was performed using MEGA 5 based on the Tamura-Nei model. Genotype 
(GI-GV) is represented to the right of the tree. Bootstrap percentages are based on 1000 
GI
GII
GIV
GIII
GV
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replicates and are shown next to the branches. Scale bar represents the number of nucleotide 
substitutions per site per year. 
3.4.4 Evolutionary analysis 
3.4.4.1 Path-O-Gen 
3.4.4.1.1 Evaluation of the temporal signal and ‘clock-likeness’ of the data 
A strict molecular clock states that the rate of evolutionary change of any specified protein is 
approximately constant over time and over different lineages. Hence any mutations will 
accumulate in a clock-like rate (Zuckerkandl & Pauling, 1962).  Therefore, the lack of clock-
likeness indicates that the evolutionary rate of one sequence cannot predict the evolutionary 
rate of another.    
Regression of root-to tip distances (the root being the oldest sequence and the tip being the 
youngest sequence) against date of sampling of 40 sequences to investigate the ‘clock-likeness’ 
of its molecular phylogeny using Path-O-Gen revealed an R squared value of 0.3 as shown in 
figure 14 below. Based on these results there is some but limited clocklike data.  
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Figure 13: Extract of the output from the Path-O-Gen programme, where 40 JEV sequences 
(listed in Table 6) have been analysed. 
 Parameter values were set as: date range = 74 years which is the range from the youngest to 
the oldest sequence. The line of best fit through the points is shown. The line explains about 
30% of the variance in the data.  The y-axis represents the amount of sequence variation from oldest 
sequence (root) to the youngest sequence (tip).    
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3.4.4.2 Bayesian evolutionary analysis of sampling trees 
The maximum clade credibility (MCC) tree for 39 whole genomes of JEV in Figure 15 contains 
five distinct clades corresponding to genotypes V, IV, III, II, and I. The most common recent 
ancestor for all genotypes is estimated to have occurred 778 years ago (95% highest posterior 
density -212 to -1602 years). The branching of the genotypes was predicted to have occurred in 
the following order: Genotype III at -142 years, (95% HPD -93 to -206 years), Genotype II at -98 
years (95% HPD -60 to -151 years), and Genotype I at -64 years (95% HPD -26 to -114 years). 
Genotype IV and genotype V in figure 15 are ignored since genotype IV has only one sequence 
and the two sequences for genotype V Muar and Tengah are very similar hence the results are 
not reliable 
Based on the Bayesian MCMC approach assuming a relaxed uncorrelated log-normal molecular 
clock, the mean nucleotide substitution rate for the entire 39 sequence set was estimated at 
4.39 × 10-4 substitutions per site per year (95% HPD, 1.86 × 10-4 to 7.19 × 10-4). Genotype I and II 
had a high evolutionary rate of 6.11 × 10-4 substitutions per site per year (95% HPD, 1.43 × 10-4 
to 1.64 × 10-3) for genotype I and 6.14 × 10-4 substitutions per site per year (95%HPD, 9.34 × 10-
5 to 2.45 × 10-3) for genotype II. Genotype III had the slowest rate with 3.29 × 10-4 substitutions 
per site per year (95%HPD, 3.98 × 10-5 to 1.12 × 10-3) (Table 10). 
Table 10: Rates of evolution for GI to GV for the MCC tree with 39 whole genome sequences 
(Figure 15) 
Genotype TMRCA year 95%HPD 
(height) 
Rate-
median 
95% HPD (rate) 
G I (n=10) 64 1944 26-114 6.11 × 10-4 1.43 × 10-4 to 1.64 × 10-3 
G II (n=4) 98 1910 60-151 6.14 × 10-4 9.34 × 10-5  to 2.45 × 10-3 
G III (n=22) 142 1866 93-206 3.29 × 10-4 3.98 × 10-5 to 1.12 × 10-3 
G V (n=2) 57 1951 57-60 9.75 × 10-4 2.20× 10-6 to 3.35 × 10-3 
WHOLE TREE 
(n=39) 
778 1230 212-1602 4.39 × 10-4 1.86 × 10-4 to 7.19 × 10-4 
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Figure 14: Maximum clade credibility (MCC) tree for 39 whole-genome sequences of JEV.  
The analysis was undertaken using GTR + Gamma + invariant sites substitution model, relaxed 
molecular clock. The high posterior probability values and the Time to the Most Recent 
Common Ancestor (TMRCA) of these lineages are shown beside the nodes.  Overall, a rate of 
nucleotide substitution of 4.39 x10-4 (95% HDP: 1.86 -7.19 × 10-4) per site per year was 
estimated. 
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¶=New sequences used in this study compared to previous studies (Mohammed et al., 2011; 
Pan et al., 2011b; Takhampunya et al., 2011).*= Sample sequenced in this study. 
Similarly the maximum clade credibility (MCC) tree for 40 whole genomes of JEV in Figure 16 
contains five distinct clades corresponding to genotypes V, IV, III, II, and I. The most common 
recent ancestor for all genotypes is estimated to have occurred 888 years ago (95% highest 
posterior density -249 to -2065 years). The branching of the lineages occurred in the following 
order: Genotype V at -194 years (95% HPD, -66 to -466 years), Genotype III at -143 years, (95% 
HPD -95 to -224 years), Genotype II at 98 years (95% HPD -60 to -170 years), and Genotype I at 
63 years (95% HPD -28 to -126 years). 
The mean nucleotide substitution rate for the entire 40 sequence set was estimated at 3.53 × 
10-4 substitutions per site per year (95% HPD, 1.40× 10-4 to 5.80 × 10-4). For genotype I, 5.17 × 
10-4 substitutions per site per year (95% HPD, 1.26 × 10-4 to 1.25 × 10-3), genotype II, 4.86 × 10-4 
substitutions per site per year (95%HPD, 8.56 × 10-5 to 1.67 × 10-3) genotype III, 2.65 × 10-4 
substitutions per site per year (95%HPD, 4.56 × 10-5 to 8.99 × 10-4) and genotype V, 5.60 × 10-4 
substitutions per site per year (95% HPD, 9.00 × 10-6 to 2.67 × 10-3) (Table 11). 
 
Table 11: Rates of evolution for GI to GV for the MCC tree with 40 whole genome sequences 
(Figure 16) 
Genotype TMRCA year 95%HPD 
(height) 
Rate-
median 
95% HPD  (rate) 
G I (n=10) 63 1945 28-126 5.17 × 10-4 1.26 × 10-4 to 1.25 × 10-3 
G II (n=4) 98 1910 60-170 4.86 × 10-4 8.56 × 10-5  to 1.67 × 10-3 
G III (n=22 143 1865 95-224 2.65 × 10-4 4.56 × 10-5 to 8.99 × 10-4 
G V (n=3) 194 1814 66-466 5.60 × 10-4 9.00 × 10-6  to 2.67 × 10-3 
W Tree n=40 888 1120 249-2065 3.53 × 10-4 1.40 × 10-4  to 5.80 × 10-4 
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Figure 15: Maximum clade credibility tree (MCC) for 40 whole-genome sequences of JEV.  
The analysis was undertaken using GTR + Gamma + invariant sites substitution model, relaxed molecular 
clock. The high posterior probability values and the TMRCA of these lineages are shown besides the 
nodes.  Overall, a rate of nucleotide substitution of 3.53 × 10-4 (95% HDP: 1.40 -5.80 × 10-4) per site per 
year was estimated.¶=New sequences used in this study compared to previous studies (Mohammed et 
al., 2011; Pan et al., 2011b; Takhampunya et al., 2011).*= Sample sequenced in this study. 
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The two MCC trees show a similar pattern for the age of the genotypes with genotype I being 
the youngest followed by genotype II then genotype III. Genotype V has the highest 
evolutionary rate in both MCC trees with 9.75 × 10-4 substitutions per site per year in figure 15 
and 5.60 × 10-4 substitutions per site per year in figure 16, while genotype III had the lowest 
evolutionary rate with 3.29 × 10-4 substitutions per site per year in figure 15 and 2.65 × 10-4 
substitutions per site per year in figure 16. The broad 95% HPD value especially for genotype II 
and genotype V in both trees is a result of insufficient sequence information with two to three 
complete sequences for genotype V available and only four for genotype II. This is further 
supported by the results on the temporal signal and ‘clock-likeness’ showing the sequences are 
not evolving at a constant rate. 
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3.5 Discussion 
The complete sequence genome of Tengah contains 10,988 nucleotides and codes for 3433 
amino acids. Phylogenetic analysis showed that the Tengah isolate belongs to genotype V of 
JEV. Sequence homology analysis revealed that Tengah  had a 99% nucleotide sequence 
similarity and a 99% deduced amino acid sequence similarity to Muar isolate (GenBank 
accession number HM596272) isolated from a patient in Malaysia in 1952. The sequences of 
both isolates are almost identical, with a difference of only one nucleotide in the non-structural 
protein NS4B region. This suggests that Tengah is a fourth isolate belonging to the fifth 
genotype along with the JEV strains Muar, XZ0934 and 10-8027. 
In order to understand how viruses evolve and spread to new areas, it is helpful to characterize 
their full genomes. To date, there are several complete genome sequences available for GI 
(n=10) and GIII (n=22). On the other hand, there are only four genotype II sequences, one 
genotype IV and three genotype V sequences. Therefore the objective of this study was to 
determine the complete nucleotide sequence and deduced amino acid sequence of JEV Tengah 
strain and to perform evolutionary analysis using BEAST for a more comprehensive evolutionary 
rate of JEV by including the Tengah strain, the new XZ0934 genotype V isolate and three new 
genotype II isolates (Bennett, JKY654 and WTP-70-22).  
Based on the sequence comparison and phylogenetic results, there is only one non-
synonymous nucleotide difference between Tengah and Muar. This non-synonymous mutation 
occurred in NS4B in position 7173 of the nucleotide sequence and position 2391 of the amino 
acid sequence and may be at the quasispecies level. Other genotype V isolates i.e. Muar, 
XZ0934, and 10-8027 have a cytosine (C) nucleotide in this position while the cloned isolates in 
this region in Tengah varied, with 50% showing C nucleotide and the other 50% showing a 
guanine (G) nucleotide. The nucleotide sequence in appendix 1 is reported using guanine (G) in 
this position. The NS4 protein has been shown to be hydrophobic hence supporting the fact 
that it plays a role as a membrane component. The poor nucleotide sequence conservation of 
this region among JEV strains suggests that it might be important to adapt each virus to 
different viral growth environments (Chambers et al., 1990; Sahoo et al., 2008).   
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In an effort to provide a more inclusive evolutionary rate of JEV, evolutionary analysis using 
BEAST was undertaken. Previous studies on the evolutionary rate of JEV using complete 
genomes have only used one sequence representing genotype V and two genotype II 
sequences (Solomon et al., 2003; Mohammed et al., 2011; Pan et al., 2011b; Takhampunya et 
al., 2011). This study utilized three GII sequences and two genotype V sequences that have not 
been used before. Since the gap between the isolation of the Indo-Malaysian strains of 
genotype V (Muar and Tengah) and that of the Chinese isolate (XZ0934) was 57 years, analysis 
was performed with and without this virus isolate. During the course of this study another 
genotype V strain 10-1827 was isolated from a pool of Culex bitaeniorhynchus collected in 
South Korea in 2010 (Takhampunya et al., 2011); this strain was not included in this study since 
only the partial envelope gene sequence was available. 
My results from both MCC trees (Figure 15 and 16) estimate the Time to the Most Recent 
Common Ancestor (TMRCA) for genotype I to have occurred around the mid-1900s which is 
similar to previous studies (Mohammed et al., 2011; Schuh et al., 2013). This genotype also 
shows a higher evolutionary rate than genotype III (Table 10 and 11) which is in agreement with 
a study by Pan et al 2011 that reports the rapid expansion of genotype I from the 1970s and a 
drop in the genetic diversity of genotype III hence making genotype I the dominant genotype in 
Asia (Pan et al., 2011b). 
From the BEAST analysis results we can now estimate for the first time the TMRCA for GII based 
on the full genome sequences which have not been reported before. Both MCC trees (Figure 15 
and 16) predict the TMRCA for genotype II to have occurred approximately in the early 1900s 
These results are similar to those reported using the E gene sequence only by Schuh et al 2013 
in which they utilized 28 isolates. 
Our results predict genotype III to have the lowest evolutionary rate when compared to the 
other genotypes. This is in agreement with a study by Pan et al 2011 that reports a drop in the 
genetic diversity and also in the number of isolates collected from this group. Their study using 
skyline plot analysis also demonstrated that the genetic diversity of genotype III had already 
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reached a plateau by the time the first isolate (JEV prototype Nakayama) was collected in 1935. 
TMRCA of genotype III is predicted to have occurred in the 1860s in both trees. Results in figure 
15 show genotype III to be the oldest when only two GV sequences are included. However, 
when an additional sequence of genotype V is included in the analysis (Figure 16), the results 
show genotype V to be the oldest lineage.   
The TMRCA of genotype V is predicted to be in 1814 (figure 16 and table 11). This is the first 
time the TMRCA of genotype V is reported using complete genome sequences. This is however 
represented by a broad 95%HPD as a result of small number of sequences (n=3). The results 
utilizing three genotype V sequences (figure 16) are supported by a decrease in width of the 
95% HPD (table 11) for rate of evolution making them more reliable for the prediction of 
evolutionary rate of JEV. They predict the overall TMRCA of JEV to have occurred in 1120 with a 
mean evolutionary rate of 3.53 x 10-4 and in agreement with other studies (Uchil & 
Satchidanandam, 2001; Solomon et al., 2003; Mohammed et al., 2011). These results are 
consistent with the hypothesis that genotype V to is the ancestral lineage of JEV.  They also give 
an estimate that is consistent with that inferred for JEV when using the envelope gene which 
estimated the evolutionary rate of JEV to be 3.50 × 10-4 (Jenkins et al., 2002).These findings 
support the need for isolation and characterization of more JEV isolates to aid in understanding 
the actual distribution of JEV and its significance in terms of risk of emergence in new areas and 
vaccine strategies. 
Overall, the evolutionary rates for both MCC trees fall within the same range as that reported 
for other RNA viruses which is between 1 x 10-3 to 1 x 10-6 nucleotides substitutions per site per 
year (Steinhauer & Holland, 1987; Jenkins et al., 2002). However we have to bear in mind that 
these results are based on sequences that show only moderate clocklikeness, therefore 
lowering the likely accuracy of these estimates. 
Additionally, since genotypes I, II and III are more widely distributed while genotypes IV and V 
had only been reported in the Indonesian and Malaysian region prior to 1952 (Solomon et al 
2003), further study of the Muar, Tengah and XZ0934 strains of genotype V at a molecular level 
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may help in identifying those properties of the virus that may have evolved and aided in the 
expansion of JEV distribution into new global habitats. However, the gap of 57 years between 
isolation of these viruses shows a vast amount of unsampled diversity missing for this 
genotype. Still, the three available complete sequences for genotype V provide data to 
investigate the phenotypic variations within genotype V and between genotype V and other 
genotypes. Nonetheless, in order for this to be more accurate the gap within genotype V itself 
would need to be filled by the isolation and characterization of more sequences.  
Lack of diversity in genotype V challenges the fact that it is the ancestral lineage. For unknown 
reasons no viruses from this genotype were isolated for 57 years. However, it has now been 
isolated in China which is thousands of kilometres from the original Muar isolation location of 
Singapore.  Some factors that may have aided in its spread would include wind-blown 
mosquitoes or migratory birds as suggested for the introduction of JEV into Australia (Hanna et 
al., 1996) and also from mainland China into Taiwan and Japan (Nabeshima et al., 2009; Huang 
et al., 2010), change in agricultural practices that may provide new breeding sites and change in 
climatic factors that may now be favourable. Evolution of this genotype could have also played 
a major part. This is supported by the predicted high evolutionary rate within this genotype as 
shown on the MCC trees. 
The re-emergence of genotype V after nearly 60 years raises questions on its once thought 
limited distribution, isolation and circulation. It is uncertain whether this is related to its 
virulence, host susceptibility, reduced transmission/ amplification or lack of surveillance.  Hence 
future studies can now start to unravel the mysterious disappearance of this genotype by 
carrying out studies comparing the old and the new isolates in different mosquitoes and hosts 
and also under different environmental conditions. 
My results based on sequence analysis and BEAST analysis showed that the Tengah strain of JEV 
belongs to genotype V. Muar and Tengah are very similar, suggesting Tengah represents a 
second isolate of Muar. This is further supported by the fact that both viruses were isolated in 
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the same region in the same year and for that reason Tengah is referred to Muar in the next 
chapters. 
The lack of isolation or distribution of the Muar strain may be attributed to infectivity in 
mosquitoes hence  studies to assess its infectivity in mosquitoes and also to compare its 
mosquito infection, dissemination and transmission rates with that of the most frequently 
isolated JEV genotype may provide valuable information.  The next chapter addresses this 
question 
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4 Chapter 4: Comparative infectivity of the Nakayama 
(Genotype III) and Muar strains (Genotype V) of Japanese 
encephalitis virus in Culex quinquefasciatus 
 
4.1 Abstract 
In the previous chapter sequencing results showed that Tengah is a variant of the Muar strain 
of genotype V.  Hence, in this chapter it is now referred to as Muar.  Prior to 2009, Muar had 
been the only strain described belonging to genotype V.  Nearly 60 years later, the report of 
two other genotype V isolates from China and Korea in 2009 and 2010 respectively, raised 
questions on the factors that may have led to the limited distribution of the original genotype V 
isolate Muar.  In order to address this question, I undertook vector competence studies to 
determine the infectivity of Muar in Culex quinquefasciatus mosquitoes. Muar was then 
compared to Nakayama strain of genotype III which is the most frequently isolated genotype. 
Two hundred and fifty Culex quinquefasciatus mosquitoes were offered an infectious blood 
meal containing Muar and 130 Culex quinquefasciatus mosquitoes were offered an infectious 
blood meal containing Nakayama strain. All mosquitoes were incubated separately at 28°C for 
21 days and the infection, dissemination and transmission rates were recorded at 7, 14 and 21 
days post infection. Muar was able to infect Culex quinquefasciatus mosquitoes with a 
transmission rate of 23% at 21 days post infection. There was a significant difference in the 
infection and dissemination rates at 14 days post infection but no significant difference in 
infection and dissemination at 7 and 21 dpi.  These findings argue against poor infectivity of 
mosquitoes being the key determinant which might explain why genotype V strains of JEV are 
apparently in limited circulation. 
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4.2 Introduction 
Japanese encephalitis virus is divided into five genotypes (genotype I, II, III, IV and V) based on 
nucleotide sequencing and phylogenetic studies utilizing the capsid, pre-membrane and 
envelope genes (Chen et al., 1990). These genotypes have spread widely in South East and 
South-eastern Asia and Australasia (Solomon et al., 2003). Nakayama and Muar strains of JEV 
belong to Genotype III and Genotype V respectively.  
Nakayama is the prototype strain of JEV and was isolated from the brain of a male that died of 
summer encephalitis in Tokyo, Japan in 1935 (Lewis, Taylor, Sorem, et al., 1947). Genotype III 
has been the source of annually occurring epidemics of encephalitis and includes isolates 
collected in China, India, Indonesia, Japan, Korea, Malaysia, Myanmar, Nepal, Philippines, Sri 
Lanka, the former Soviet Union, Taiwan, Thailand and Vietnam between 1935 and present 
(Schuh et al., 2013). The isolates have been derived from bats (Wang, Pan, Zhang, Fu, & Wang, 
2009), birds (Hasegawa et al., 1975; Yang et al., 2011), horses (Singha et al., 2013), humans (Xu 
et al., 2013), mosquitoes (Van Den Hurk et al., 2006) , and pigs (Deng et al., 2011). This virus has 
been used extensively from vaccine development to vector competence studies. 
Muar strain represents the first isolate of genotype V, having been isolated in 1952 from the 
brain of a fatal case in Singapore (Hale et al., 1952) and had not been isolated since.  However, 
after 57 years of undetected virus circulation, this genotype has recently been isolated from a 
pool of Culex tritaeniorhynchus in China in 2009 and in Culex bitaeniorhynchus in 2010 in the 
Republic of Korea (Li, Fu, et al., 2011; Takhampunya et al., 2011). Evolutionary studies have 
shown genotypes IV and V form the oldest JEV lineage that originated from an ancestral virus in 
the Indonesian-Malaysian region.  Hence it is thought that JEV probably originally spread from 
this region (Solomon et al., 2003; Mackenzie et al., 2004). The underlying factors that have 
contributed to the once thought limited distribution of the genotype V of JEV (Solomon et al., 
2003) and the recent discovery in China and Korea are not clear.  Several factors may have 
contributed to the re-emergence of this genotype ranging from climate and environmental 
changes, improved pathogen detection or mosquito-pathogen transmission factors. 
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JEV is maintained in ardeid wading birds, mosquito and pig cycle with humans and other non-
avian vertebrates considered to be dead-end hosts. The principal vector for JEV is considered to 
be Culex tritaeniorhynchus mainly because the peak seasonal abundance of Culex 
tritaeniorhynchus coincided well with the seasonal occurrence of epidemic encephalitis, this 
lead to the subsequent recovery of the virus from this rice-paddy breeding mosquito in 1938 
(Mitamura, Kitaoka, K., et al., 1938).  This mosquito is also distributed widely across the JEV-
endemic regions (Impoinvil et al., 2011; van den Hurk et al., 2011). 
Several other mosquitoes have been incriminated as JEV vectors and subsequently tested to 
assess their competence.  These mosquitoes have been shown to vary in competence ranging 
from high level of efficiency to be infected with, disseminate and transmit the virus, to 
complete refractoriness to infection. The majority of these studies have used genotype III 
strains of JEV. These mosquitoes are listed in table 12 below. 
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Table 12: Comparison of different species of mosquitoes assessed for competence of JEV 
Mosquito species Level of 
Competence* 
Country JEV 
Genotype 
Reference 
Culex tritaeniorhynchus  High Japan Genotype III 
(JaGAr01) 
(Takahashi, 
1982a) Culex tritaeniorhynchus  Moderate Taiwan 
Culex tritaeniorhynchus  Low Pakistan 
Opifex fuscus Refractory New Zealand Genotype III 
(Nakayama) 
(Kramer et al., 
2011) Aedes notoscriptus Refractory 
Culex quinquefasciatus  Refractory 
Culex quinquefasciatus  Refractory USA 
Culex pipiens  Refractory 
Culex annulirostris   High Australia 
(Southeast 
Queensland) 
Genotype II 
(TS3306) 
(van den Hurk 
et al., 2003) Culex sitiens Moderate 
Culex quinquefasciatus   Moderate 
Culex gelidus Moderate Australia 
(North 
Queensland) 
 
Culex annulirostris  High 
Ochlerotatus vigilax Low 
Culex quinquefasciatus   Refractory 
Aedes aegypti  Refractory 
Ochlerotatus kochi  Refractory 
Verrallina funerea   Refractory 
Aedes aegypti Low  ??? Likely 
Genotype III  
 
Aedes japonicas Moderate ??? Likely 
Genotype III 
(Takashima & 
Rosen, 1989) 
Aedes notoscriptus,  Moderate Taiwan Genotype III 
(CH1392) 
(Chen et al., 
2000)  Armigeres subalbatus High 
Culex tritaeniorhynchus Moderate 
*Refractory refers to lack of transmission or inability detected virus in the mosquito saliva 
Vector competence refers to the ability of arthropods to acquire, maintain, and transmit 
microbial agents (Kramer & Ebel, 2003). It is usually a measure of the rate at which mosquito 
vectors are able to become infected, disseminate and transmit these agents. Vector 
competence looks at two aspects between the vector and pathogen: 1) the vector’s innate 
ability to support transmission and 2) the pathogen’s ability to infect the host. 
Vector competence studies with JEV have been paramount in improving our understanding of 
transmission dynamics in mosquitoes. Many of the early vector competence transmission 
studies have used Culex tritaeniorhynchus (Hale et al., 1957; Gresser, Hardy, Hu, et al., 1958; 
110 
 
Gresser, Hardy, & Scherer, 1958; Buescher, Scherer, Rosenberg, et al., 1959; Takahashi, 1976, 
1980b).  These studies revealed that 1) JEV could be transmitted as early as 5 days post 
infection depending on prevailing temperatures; 2) highly competent vectors, such as Culex 
tritaeniorhynchus are able to become infected with low doses of virus; ranging from 101.0 - 3.5 
suckling mouse intracerebral (SMIC) LD50 (lethal dose 50 %)/0.03 mL of blood; and 3) 
concentration of virus in the mosquito saliva can be as high as 104.2 SMIC-LD50/1 mL of saliva 
and virus diluents (Takahashi, 1976). 
The brown medium-sized southern house mosquito, Culex quinquefasciatus is a tropical to sub-
tropical mosquito species usually found within the latitudes 36° N and 36° S.  This mosquito is a 
nocturnal, opportunistic blood feeder that is a vector of many of pathogens, several of which 
affect humans and both domestic and wild animals (i.e. birds or other mammals).  Some of the 
pathogens well-established to be vectored by this mosquito include the filarial nematode, 
Wuchereria bancrofti  (Nelson et al., 1946; Janousek & Lowrie, 1989; Pothikasikorn et al., 2008) 
and several arboviruses which include West Nile virus (Jansen et al., 2008), St. Louis 
encephalitis virus (Meyer et al., 1983). Western equine encephalitis virus (Wang et al., 2012) 
and Rift Valley fever virus (RVF) (Turell et al., 2007) (Table 13). These mosquitoes tend to have a 
ubiquitous distribution due to their ability to develop in diverse habitats ranging from nutrient-
rich and sometimes organically polluted standing water such as stagnant drainage canals, water 
troughs and septic tanks (Weaver & Barrett, 2004), to relatively pristine water sources such as 
water tanks or rain-water filled tyres.  Culex quinquefasciatus infected with JEV has been 
isolated in the field (Weng, Lien, Wang, Lin, Lin, & C., 1999; Nitatpattana et al., 2005) suggesting 
a role in JEV transmission.  
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Table 13: Competence levels of Culex quinquefaciatus mosquitoes to various arboviruses 
isolated from different regions. 
 Source  virus Level of 
competence* 
Reference 
Australian WNV High (Jansen et al., 2008) 
Australian (southeast Queensland 
strains) 
JEV Moderate (van den Hurk et al., 
2003) 
Australian (north Queensland) JEV Refractory 
Australian MVEV, KUNV, 
RRV 
Low  (Kay et al., 1982) 
American WNV Moderate (Sardelis et al., 2001) 
American JEV Refractory (Kramer et al., 2011) 
Southern California WNV Low  (Goddard et al., 2002) 
California SLEV Moderate (Meyer et al., 1983) 
New Zealand BFV,  Low (Kramer et al., 2011) 
RRV Low 
SINV Refractory 
WNV Moderate 
MVEV Low 
JEV Refractory 
Argentine WNV Moderate (Micieli et al., 2013) 
China WEEV High (Wang et al., 2012) 
North American RVFV Refractory (Turell et al., 2010) 
China WNV Moderate (Jiang et al., 2010) 
African RVFV Refractory (Turell et al., 2008) 
Kenyan RVFV Low (Turell et al., 2007) 
Mexican and Honduran VEEV Refractory (Turell et al., 2003) 
WNV-West Nile Virus, JEV-Japanese encephalitis virus, MVE-Murray valley encephalitis virus, BFV-
Barmah Forest virus, RRV-Rose River virus, SLEV-Saint Louis encephalitis virus, KUNV-Kunjin virus, 
SINV-Sindbis virus, WEEV-Western equine encephalitis virus, VEEV-Venezuela equine encephalitis 
virus. 
*Refractory refers to lack of transmission or inability detected virus in the mosquito saliva 
Susceptibility and competence has been shown to vary among and within mosquito species 
from different geographical regions. A study comparing the transmission efficiency among 
colonized strains of Culex tritaeniorhynchus showed that two strains from Japan had high 
transmission efficiency while three strains from Pakistan had low efficiency (Takahashi, 1982b) 
(see table 10). More important is the comparison of the vector competence and transmissibility 
of the different JEV genotypes by various mosquito species to determine whether there are any 
variations between the genotypes. These studies have not been done before using JEV and may 
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provide some answers as to why some genotypes emerge in places they were not found before.  
A route to disease emergence can be caused by the competitive displacement of a less virulent 
pathogen strain by a more virulent strain. One example is the displacement of the American 
genotype of dengue serotype 2 which causes dengue fever by the Southeast Asian genotype 
which causes a more severe dengue haemorrhagic fever that occurred in the Western 
Hemisphere and the South Pacific Islands (Rico-Hesse et al., 1997). Previous studies have also 
shown variation in competence and susceptibility within mosquito species when infected with 
different strains of Chikungunya virus (CHIKV).  An isolate of CHIKV with a mutation in the 
envelope protein gene, led to a significant increase in CHIKV infectivity in Aedes albopictus 
when compared to an isolate without the mutation (Tsetsarkin et al., 2007).  In another study 
the four dengue serotypes were shown to differ in the oral infection threshold with a 
significantly higher proportion of Aedes aegypti mosquitoes becoming infected with dengue 2 
and 3 compared to the serotype 1 and 4 (Gubler et al., 1979).  
It is possible that the lack of detection or circulation of the Muar strain of JEV relates to the 
replication efficiency of the virus in mosquitoes.  To date few studies have compared JEV 
genotypes to determine if there are differential infection rates in mosquitoes. In addition no 
studies have been done to determine the competence of Muar in mosquitoes.  Therefore, the 
objective of this study is: 
I. Assess the infectivity of Muar (genotype V) stain of JEV in Culex quinquefasciatus 
mosquitoes. 
II. Compare infection, dissemination and transmission of the Nakayama (genotype III) and 
Muar (genotype V) strains of JEV in Culex quinquefasciatus mosquitoes. 
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4.3 Materials and methods 
For detailed acquisition and maintenance of mosquitoes, cell and virus source and 
maintenance, vector competence studies and plaque assay methodology please refer to 
chapter 2 (general materials and methods) Chapter specific protocols and alterations are 
detailed below.  
4.3.1 Mosquito acquisition and maintenance 
Culex quinquefaciatus (Recife strain) mosquitoes were obtained from a colony maintained in 
the Liverpool School of Tropical Medicine insectary. The colony was originally established in 
Brazil. This mosquito was selected because JEV has been isolated from it previously  
(Nitatpattana et al., 2005). Details of its maintenance can be found in chapter 2. 
4.3.2 Cells and viruses 
Vero cells were maintained in Dulbecco Modified Eagle’s Minimal Essential Medium (DMEM) 
Sigma-Aldrich) media containing 10% heat-inactivated Fetal Calf Serum (FCS), 2 mM L-
glutamine and 50 µg/ml Penicillin/Streptomycin. Viruses used for this study were Muar 
(genotype V) strain of JEV and Nakayama (genotype III) strain of JEV.  
4.3.2.1 Muar 
Muar was originally obtained from the brain of a patient in Singapore 1952(Hale et al., 1952; 
Okuno et al., 1968) and was kindly donated by Prof. Ichiro Kurane from the Department of 
Virology, National Institute of Infectious Diseases, Tokyo, Japan. 
4.3.2.2 Nakayama  
Nakayama strain was originally isolated in Japan in 1935 from human cerebellum (Lewis, Taylor, 
& et al., 1947) and was kindly donated by Dr. David Beasley and Dr. Alan Barrett from University 
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of Texas Medical branch. All procedures using virus were carried out in a containment level-3 
facility. 
4.3.3 Vector competence  
Culex quinquefasciatus colony mosquitoes were tested for JEV vector competence using either 
Muar or Nakayama at 28°C which is the optimum temperature for maintenance of this tropical 
mosquito. Mosquitoes were sampled at 0, 1 3, 7, 14 and 21 days post infection (dpi; i.e. after 
offering an infectious blood-meal). Time point 0 represent mosquitoes collected 1-hour after 
offering an infectious blood meal. 
4.3.3.1 Per oral infections 
Details on per oral infections and plaque assay methodology can be found in Chapter 2 
(Materials and Methods). Briefly, infectious blood meal containing virus from frozen stock was 
prepared by combining defibrinated horse blood (Thermo Oxoid Remel), with the appropriate 
volume of JEV Muar strain stock or Nakayama strain stock and 100 µl of adenosine 5’-
triphospahte (ATP 0.02 µm) as a phagostimulant to a final concentration of 6 logs pfu/ml. 
Seven day old females were selected and offered an infectious bloodmeal containing either 
Muar or Nakayama strain of JEV artificially using the Hemotek feeding system (Discovery 
workshops, UK) for 1 hour. A sample of 0.5 ml of the infectious bloodmeal was collected before 
and after the mosquitoes fed and stored at -80°C for subsequent plaque assay analysis. 
Engorged mosquitoes were selected and incubated at 28°C and maintained on 10% sucrose 
solution at 70-90% relative humidity and a photoperiod of 12: 12 light: dark cycle. Experiments 
for each virus strain were carried out on different days. 
4.3.3.2 Determination of infection dissemination and transmission 
 Mosquitoes were sampled at 0, 1, 3, 7, 14 and 21 days post infection (dpi). All mosquitoes 
collected at 0, 1, and 3 dpi were frozen at -80°C individually in 1.5ml tubes containing virus 
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diluents media. All mosquitoes collected at 7, 14 and 21 dpi had their saliva collected before 
they were then separated into bodies and legs and frozen individually at -80°C. 
Infection was determined by recovery of virus from the mosquito tissue suspension by plaque 
assay. If virus was recovered from its body and but not in its legs, the mosquito was considered 
to have a non-disseminated infection. If virus was recovered from both the legs and the body 
suspension the mosquito was considered to have a disseminated infection (Turell, Gargan et al. 
1984) and if virus was recovered from its saliva the mosquito was considered to have a 
transmissible infection. Infection, dissemination and transmission rates were defined as the 
percentage of mosquitoes tested that contained virus in their bodies, legs and saliva 
respectively. 
All samples were processed by plaque assay and scored as virus-positive or virus-negative 
based on the presence or absence of plaques. 
4.3.4 Statistical analysis 
Fisher Exact Test was used to determine if there were significant differences (p < 0.05) in rates 
of infection, dissemination and transmission between temperatures and species.  SISA, an open 
access online statistics calculator (http://www.quantitativeskills.com/sisa/) was used to 
conduct Fisher Exact Test.  Confidence intervals of proportions were calculated using 
VassarStats (http://vassarstats.net/prop1.html). VassarStats uses the Wilson Score Interval 
method which is more robust when dealing with a small number of trials and/or an extreme 
probability (Newcombe, 1998). The sample size in each group was dictated by the feeding 
success and the survival rates through the days post infection (dpi).  
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4.4 Results 
One hundred and twenty eight mosquitoes offered an infectious bloodmeal containing Muar 
(genotype V) were sampled and 67 offered an infectious bloodmeal containing Nakayama 
(genotype III) were sampled making a total of 195 mosquitoes. Sixty five percent of 130 
mosquitoes offered an infectious blood meal containing Nakayama successfully engorged, while 
72% engorged when offered an infectious blood meal containing Muar strain. Of those that 
acquired the Nakayama strain infectious blood meal 21% of them died while 29% died out of 
those offered the Muar strain infectious blood meal (Table 14). The rates of engorgement and 
mortality in Culex quinquefasciatus mosquitoes that were fed either Muar or Nakayama strain 
infectious bloodmeal were very similar. 
Table 14: Rate of engorgement and mortality of mosquitoes offered either Nakayama or 
Muar strain infectious bloodmeal 
Virus strain Initial no. 
of  
Mosquitoes 
Bloodfed 
 (%)a 
Sampled 
 (%)b 
Dead 
 (%)c 
Nakayama 130 85 (65%) 67 (79%) 18 (21%) 
Muar 250 181 (72%) 128 (71%) 53 (29%) 
aPercentage Bloodfed = (no. of bloodfed mosquitoes/Initial no. offered bloodmeal) * 100 
bPercentage sampled = (no. of mosquitoes sampled/total no. of bloodfed mosquitoes) * 100 
cPercentage dead = (no. of mosquitoes that died /total no. of bloodfed mosquitoes) * 100 
 
Early time points starting at day 0 to day 3 were sampled to ensure that virus detected in later 
time points was a result of new virus production rather than that of input virus. A typical eclipse 
phase was observed for Muar in which the virus titre decreased from 0 to 3 dpi followed by an 
increase after 7 dpi. This is attributable to the reduction in virus titre after day 0 as ingested 
virus either infects cells or gets digested; virus successful in infecting cells replicates to 
detectable levels several days later. Nakayama showed a similar pattern with a decrease in 
virus titre from 0 to 3 dpi and increase at 7 and 21 dpi. However no virus was detected at 14 dpi 
(figure 17). 
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Figure 16: Graph showing the virus eclipse phase for Nakayama and Muar in Culex 
quinquefaciatus mosquitoes at 28°C 
 
Muar strain of JEV replicated successfully in Culex quinquefasciatus as evident by presence of 
virus in the saliva at 14 and 21 dpi samples. The number of mosquitoes that tested positive for 
virus decreased from 0 to 1 dpi then increased from 7 to 21dpi. The infection rate for Culex 
quinquefasciatus when infected with Muar strain was 23% at 7dpi with no dissemination and 
transmission. Infection, dissemination and transmission rates were 41%, 30% and 7% at 14dpi 
respectively and 35%infection, 35% dissemination and 23% transmission rates at 21dpi (Table 
15). 
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Table 15: Infection, dissemination and transmission rates of Culex quinquefasciatus mosquitoes 
exposed to 6 logs PFU of Muar strain of JEV. 
Virus strain DPI No. tested I D T Infection ratea 
(95% CI) 
Dissemination  
rateb (95% CI) 
Transmission  
ratec (95% CI) 
Nakayama (III) 0 11 11 nt nt 100 (74-100) nt nt 
 1 5 2 nt nt 40 (11-77) nt nt 
 3 6 3 nt nt 50 (18-81) nt nt 
 7 13 1 0 0 8(1.4-33) 0 (0-23) 0 (0-23) 
 14 13 0 0 0 0 0 0 
 21 19 8 8 5 42 (23-64) 42 (23-64) 26 (11-49) 
Muar (V) 0 18 18 nt nt 100 (82-100) nt nt 
 1 15 11 nt nt 73 (48-89) nt nt 
 3 15 0 nt nt 0 nt nt 
 7 22 5 0 0 23 (10-43) 0 (0-15) 0 (0-15) 
 14 27 11 8 2 41 (25-59) 30 (16-48) 7 (2-23) 
 21 31 11 11 7 35 (21-53) 35 (21-53) 23 (11-40) 
DPI=Days post infection; I=number infected; D=number disseminated; T= number transmitting; 
nt=not tested 
a Percentage of mosquitoes containing virus in their bodies out of no. tested (95% confidence 
interval). 
b Percentage of mosquitoes containing virus in their legs out of no. tested (95% confidence 
interval). 
c Percentage of mosquitoes containing virus in their saliva out of no. tested (95% confidence 
interval). 
Nakayama strain of JEV replicated successfully in Culex quinquefasciatus as evident by presence 
of virus in the saliva at 21 dpi. The number of mosquitoes that tested positive for virus 
decreased from 0 to 3 dpi then increased by 21 dpi. The infection rate was 8% at 7 dpi and none 
at 14dpi. There was no dissemination and transmission at both 7 and 14 dpi. At 21 dpi, the 
infection and dissemination rate were at 42% and transmission rate was 26% (Table 15 above). 
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Table 16: Dissemination and transmission transition efficiency of Culex quinquefasciatus 
mosquitoes exposed to Nakayama and Muar strain of JEV 
Virus strain DPI Dissemination/  
% of no. infected 
 (95% CI) 
Transmission,  
% of no. disseminated 
 (95% CI) 
Transmission,  
% of no. infected 
 (95% CI) 
Nakayama (III) 7 0  (0-79) 0 0 
 14 0 0 0 
 21 100 (67-100) 63 (31-86) 63 (31-86) 
Muar (V) 7 0 0 0 
 14 72 (43-90) 25 (7-59) 18 (5-47) 
 21 100 (74-100) 64 (35-84) 64 (35-84) 
DPI= days post infection; CI= Confidence intervals 
a Percentage of mosquitoes containing virus in their bodies out of no. infected 
b Percentage of mosquitoes containing virus in their saliva out of no. disseminated 
c Percentage of mosquitoes containing virus in their saliva out of no. infected 
To describe the transition efficiency of the virus after overcoming the midgut barrier in the 
mosquito, the number of mosquitoes with a disseminated infection out of the number infected 
(dissemination efficiency) was examined (Table 16 above). The number of mosquitoes able to 
transmit out of those with disseminated infection (transmission efficiency) was also examined 
at 7, 14 and 21 dpi. Dissemination efficiency reached 100% at 21 dpi when the mosquitoes 
were infected with Nakayama strain and the transmission efficiency was 63%.   
When infected with Muar strain, the dissemination efficiency was 72% at 14 dpi and the 
transmission efficiency was 25%. Out of the total numbers that were infected at 14 dpi, 18% of 
them developed a transmissible infection. There was 100% dissemination efficiency at 21 dpi 
and 64% transmission efficiency.  Of the total number of mosquitoes that were infected at 21 
dpi, 64% of them developed a transmissible infection (Table 16). 
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Table 17: Comparison of the rates of infection, dissemination and transmission at the different 
time points for the two strains of virus Muar and Nakayama. 
dpi  Virus strain No positive/ 
no testeda 
Percent  
positive 
df Chi-
square 
P values 
7 Infected Muar 
Nakayama 
5/22 
1/13 
23 
8 
1 0.780 0.377 
Disseminated Muar 
Nakayama 
0/22 
0/13 
0 
0 
1 0 1 
Transmission Muar 
Nakayama 
0/22 
0/13 
0 
0 
1 0 1 
14 Infected Muar 
Nakayama 
11/27 
0/13 
41 
0 
1 7.273 0.007 
Disseminated Muar 
Nakayama 
8/27 
0/13 
30 
0 
1 4.350 0.037 
Transmission Muar 
Nakayama 
2/27 
0/13 
7 
0 
1 0 1 
21 Infected Muar 
Nakayama 
11/31 
8/19 
35 
42 
1 0.089 0.766 
Disseminated Muar 
Nakayama 
11/31 
8/19 
35 
42 
1 0.089 0.766 
Transmission Muar 
Nakayama 
7/31 
5/19 
23 
26 
1 0 1 
df= degrees of freedom 
a Total number of mosquitoes positive for virus out of the total number tested at 7, 14 and 21 
dpi. 
 
When the infection, dissemination and transmission rates were compared for the two virus 
strains at 7, 14 and 21 dpi there was a significant difference in the infection and dissemination 
rate at 14 dpi (Table 17). There was no significant difference between the two viruses in their 
infection and dissemination rates at 7 or 21 dpi, nor in transmission rates at any of the dpi.  
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Table 18: Chi square values for rates of infection, dissemination and transmission when 
the two virus strains are compared from 7 to 21 dpi combined at α=0.05 
 Species No 
positive/ 
no testeda 
Percent 
positive 
df Chi Square P values 
Infected Muar 
Nakayama 
27/80 
9/45 
34 
20 
1 2.082 0.149 
disseminated Muar 
Nakayama 
19/80 
8/45 
24 
17 
1 0.451 0.502 
Transmission Muar 
Nakayama 
9/80 
5/45 
11 
11 
1 0 1 
df= degrees of freedom 
aTotal number of mosquitoes positive out for virus out of the total number tested at 7, 
14 and 21 dpi combined. 
 
When 7 to 21 days post infections (dpi) are combined due to small sample sizes at individual 
time points, the overall infection rate when Culex quinquefaciatus mosquitoes are infected with 
the Muar strain was 34%, the dissemination rate was 24% and the transmission rate was 11%. 
The equivalent rates for Nakayama strain were 20%, 17% and 11% respectively. There was no 
significant difference in infection, dissemination and transmission rates between the two 
strains of virus in Culex quinquefasciatus mosquitoes (Table 18 above). 
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4.5 Discussion 
One of the questions surrounding the lack of detection or circulation of the Muar strain of JEV is 
the replication efficiency of the virus in mosquitoes.  Therefore, the objective of this study was 
to determine the rate of infection of the Muar strain of JEV (genotype-V) in Culex 
quinquefasciatus and compare these infection rates with Nakayama, the prototype genotype-3 
strain.  This is the first time a genotype-V virus has been used in mosquito infection studies.  
The results of this study have shown that Muar strain of JEV is indeed capable of infecting and 
disseminating in Culex quinquefasciatus mosquitoes, which can subsequently lead to 
transmission by bite.  However the rates were low as compared to other studies with different 
mosquitoes and different virus strains.   Of the mosquitoes tested at 14 dpi, 7% were able to 
transmit the Muar strain of JEV and by 21 days post infection, 23% of the mosquitoes had virus 
detected in their saliva (Table 15).  The dissemination efficiency at 21 dpi was 100% (Table 16) 
indicating that in all mosquitoes the virus was not confined to the midgut but was able to infect 
various tissues throughout the mosquito body.  Still, not all mosquitoes with a disseminated 
infection were shown to be able to transmit the virus. The transmission efficiency (i.e. the 
number of mosquitoes able to transmit after infection) was 64% (Table 16).    
Another reason that may have contributed to the limited distribution of the Muar strain may 
have been competition from other genotypes.  Hence the fitness of Muar infectivity was 
compared to a genotype III strain Nakayama under laboratory conditions at 28°C.  This is also 
the first study to compare a JEV genotype V strain (Muar) to a genotype III strain (Nakayama).  
When Culex quinquefasciatus were infected with Nakayama (genotype III) strain, there was no 
dissemination and transmission at 7 dpi which was similar to the results obtained using the 
Muar strain.  However, while Muar strain was detected at 14 dpi with a transmission rate of 7%, 
there was no infection, dissemination or transmission at this time point when the mosquitoes 
were infected with Nakayama strain.  Infection, dissemination and transmission rates were 
42%, 42% and 26%, respectively at 21 dpi for Nakayama (Table 15).  These results did not differ 
from the rates at 21 days post infection when mosquitoes were infected with Muar (genotype 
V). The dissemination efficiency at 21 dpi was 100% for both Nakayama and Muar.  The 
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transmission efficiency was 63% for Nakayama and 64% for Muar strain (Table 16).  Therefore 
these two virus strains have similar transmission characteristics in Culex quinquefasciatus.  
Culex quinquefasciatus was used mainly because it was readily available in the laboratory.  It is 
important to note that Culex quinquefasciatus is not the main vector for JEV and its role as a 
secondary vector is likely to be variable in different locations.  For example, vector competence 
of this vector to JEV has ranged from refractory to moderate (see Table 12).  Vector 
competence studies using Culex quinquefasciatus and genotype II strains of JEV showed high 
infection rates of 98% at  >17 days post infection, with 28% dissemination and 50% 
transmission (van den Hurk, Nisbet et al. 2003).  However, a similar study using a genotype III 
strain of JEV reported no transmission at >14 dpi (Kramer, Chin et al. 2011).  This suggests that 
is significant variation in the competence of Culex quinquefasciatus to JEV.  In this study I would 
rank competence of this mosquito strain as low.  Nonetheless, the results reveal that Muar is 
capable of infecting a mosquito and this did not vary greatly from Nakayama.    
The results obtained here do not explain the underlying factors that have contributed to the 
once thought limited distribution, isolation and circulation of the Muar strain of JEV (genotype 
5) (Solomon et al., 2003) and the more recent the discovery of the genotype in China and Korea 
after a 57 year hiatus (Li, Fu, et al., 2011; Takhampunya et al., 2011) are not clear.   
Several factors may have contributed to the manifestation of this genotype ranging from 
climate and environmental changes, improved pathogen detection or mosquito-pathogen 
transmission factors.  This virus has been isolated from Culex tritaeniorhynchus and Culex 
bitaeniorhynchus hence it shows it has the ability to infect mosquitoes.  Future studies should 
compare the different genotypes in Culex tritaeniorhynchus, the main vector for JEV or other 
mosquito species that are highly susceptible to JEV such as Culex vishnui or Culex annulirostris, 
to determine growth characteristics of Muar/genotype V relative to the other genotypes in 
permissive mosquitoes.  Furthermore, studies using the different genotypes at different 
environmental conditions would also provide valuable information since studies have shown 
genotype distribution are associated with climatic conditions (Schuh et al., 2013). 
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The results provided here show that the infection rate of Muar (genotype V) in Culex 
quinquefaciatus did not differ from that of Nakayama (genotype III). This observation, together 
with the recent emergence of viruses belonging to the genotype V in China and Korea, provide 
evidence of the potential of JEV and its genotype to appear in places they were never found 
before .Consequently it is important to assess the vector competence of mosquitoes in such 
areas to determine which mosquito species are likely to support the maintenance and 
circulation JEV should it emerge. The next chapter thus goes on to evaluate the vector 
competence of a local British mosquito Ochlerotatus detritus to JEV. 
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5 Chapter 5: Evaluation of a temperate climate mosquito, 
Ochlerotatus (Aedes) detritus, as a potential vector for 
Japanese encephalitis virus 
 
5.1 Abstract 
Great Britain has not yet experienced a confirmed outbreak of mosquito-borne virus 
transmission to people or livestock despite numerous autochthonous epizootic and human 
outbreaks of mosquito-borne diseases in the European mainland.  Indeed, it has not been 
established if British mosquitoes are competent to transmit arboviruses.  Therefore, in this 
chapter I assessed the competence of a local (temperate) British mosquito species, 
Ochlerotatus (Aedes) detritus, for a member of the Flavivirus genus, Japanese encephalitis virus 
(JEV) as a model for mosquito-borne virus transmission.  I also evaluated JEV competence in a 
laboratory strain of Culex quinquefasciatus, an incriminated JEV vector, as a positive control.  
Ochlerotatus detritus adults were reared from field-collected juvenile stages.  In oral infection 
bioassays, adult females developed disseminated infections and were able to transmit virus as 
determined by isolation of virus in saliva secretions.  When pooled from 7 to 21 days post 
infection, 13 and 25% of Ochlerotatus detritus were able to transmit JEV when held at 23 and 
28°C, respectively.  Similar results were obtained for Culex quinquefasciatus.  To my knowledge, 
this study is the first to demonstrate that a British mosquito species, Ochlerotatus detritus, is a 
potential vector of an exotic flavivirus. 
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5.2 Introduction 
The emergence of mosquito-borne viruses in subtropical and temperate regions of Europe 
(Phipps et al., 2008) in recent years has raised concerns about the risk of an outbreak occurring 
in Great Britain.  However, the risk to Great Britain from mosquito-borne arboviruses is 
unknown. A major knowledge gap is the vector competence of Great Britain’s indigenous 
mosquitoes for arboviruses. While there have been no reports of outbreaks of disease caused 
by mosquito-borne viruses, studies in Great Britain have reported the serological detection of 
antibodies to West Nile virus (WNV), Usutu virus and Sindbis virus in both migrant and non-
migrant wild bird species (Buckley et al., 2003), and to WNV in sentinel chickens raised on a 
farm (Buckley et al., 2006), suggesting that some transmission of arboviruses may occur. 
Vector competence is a measure of the ability of a mosquito to become infected with, allow 
replication of, and transmit virus to a susceptible host (Kramer & Ebel, 2003).  At present, there 
are thirty-four species of mosquitoes recorded in the British Isles comprising six species of 
Anophelinae (genus Anopheles) and 28 species of Culicinae in seven genera: Aedes (3), 
Coquillettidia (1), Culex (4), Culiseta (7), Dahliana (1), Ochlerotatus (11) and Orthopodomyia (1) 
(Medlock & Vaux, 2009).  With the exception of the recently (re)discovered Culex modestus 
(Marshall, 1945; Golding et al., 2012; Medlock & Vaux, 2012), all of these mosquitoes are 
thought to be native species.  However, to my knowledge there is no information on the vector 
competence of these resident British populations to any arbovirus.  
Ochlerotatus detritus Haliday 1833 (Diptera: Culicidea) was selected in this study as a model to 
determine the vector competence of a temperate mosquito originating from Great Britain.  
Because of its relative abundance in the sampling site (Cheshire county, Great Britain), 
accessibility and biting behaviour, it was found to be ideal for vector competence evaluation at 
the time this study was implemented.  It is one out of thirteen British species of mosquito that 
can be considered a potential bridge vector should any mosquito-borne virus emerge in the UK 
(Medlock et al., 2005).  Ochlerotatus detritus has been shown to feed on both birds and 
humans (Service, 1971) and therefore can potentially transmit flaviviruses from their natural 
cycle in birds over to humans.  It is a salt marsh mosquito found in the low-lying coastal and 
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some inland saline waters (Rees & Snow, 1996).  Though Ochlerotatus detritus has a 
widespread but patchy distribution in Great Britain  (Figure 18) (Snow et al., 1998; Medlock et 
al., 2005), in coastal areas where it is found, this mosquito causes the greatest human biting 
nuisance of any British mosquito (Clarkson & Setzkorn, 2011). 
   
Figure 17: Distribution of Ochlerotatus detritus within Great Britain (Snow et al., 1998) 
Ochlerotatus detritus oviposits in salty ground prone to periodic flooding and usually a 
generation follows each immersion (Snow, 1990), hence it is multi-voltine.  Ochlerotatus 
detritus bites humans persistently with adults appearing from March to November and 
overwinters as 4th instar larvae.  Biting occurs mainly outdoors (Service, 1971).  Ochlerotatus 
detritus is distributed throughout European coastal districts from the Baltic to the Aegean, 
Mediterranean and Red sea, and in inland saline areas in Europe and North Africa (Cranston et 
al., 1987)  Some of the countries where this mosquito have been identified  include: China, 
Croatia, Cyprus, Egypt, France, Greece, Iran, Mongolia, Morocco, Poland, Portugal, Romania, 
Russia, Slovakia, Spain, Tajikistan, Turkey, Italy, Sweden and United Kingdom (Figure 19). 
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Figure 18: Worldwide distribution of Ochlerotatus detritus.  
Japanese encephalitis (JE) virus was used as the model virus to evaluate vector competence in 
Ochlerotatus detritus because it was readily available and used in the laboratory.  JE virus (JEV) 
is one of seven mosquito-borne zoonotic viruses considered a threat to Northern Europe 
(Johnson et al., 2012); indeed, its genome was recently detected in Culex pipiens mosquitoes in 
Italy (Ravanini et al., 2012).  JEV is also the prototype of a sero-complex of closely related 
flaviviruses, which includes WNV and Usutu virus (USUV).  JEV is an arbovirus that is maintained 
in a zoonotic cycle, which can be both enzootic and epizootic.  This cycle involves pigs as the 
major reservoir/amplifying host, water birds as carriers and mosquitoes (in particular Culex 
tritaeniorhynchus) as vectors.  Humans are considered dead-end hosts because they produce 
low viraemia levels over a limited time-frame that is insufficient to infect feeding mosquitoes 
(Scherer, Kitaoka, et al., 1959; Chan & Loh, 1966; Impoinvil et al., 2013).  The disease caused by 
Ochlerotatus detritus distribution
Countries
Algeria
Belarus
Belgium
Bulgaria
China
Croatia
Denmark
Egypt
France
Germany
Greece
Hungary
Iran
Ireland
Italy
Malta
Mongolia
Montenegro
Norway
Poland
Portugal
Republic of Serbia
Romania
Russia
Slovakia
Spain
Sweden
Tajikistan
Tunisia
Ukraine
United Kingdom
No reports of Oc. detritus occurence
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JEV has an estimated worldwide annual incidence of 70,000 human cases with approximately 
three quarters occurring in children aged 0 to 14 years (Campbell et al., 2011).  Roughly, one 
quarter of encephalitis patients will die while about one half of the survivors will develop 
permanent neurologic and/or psychiatric impairment (Unni et al., 2011).  Although commercial 
inactivated vaccines are available against JEV, it still remains the most important member of the 
JEV sero—complex and the most widespread of a group of antigenically related mosquito-
borne viruses that cause encephalitis in man.   
Given the possible threat posed by mosquito-borne flaviruses to Great Britain, I have 
investigated, for the first time, the vector competence of a resident British mosquito species for 
JEV.  The aim of this study was to investigate JEV dissemination in a temperate mosquito 
species and its potential to transmit virus through detection of viable JEV in its saliva. 
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5.3 Materials and methods 
5.3.1 Mosquitoes 
Mosquitoes used in this study were derived from wild-caught larvae of Ochlerotatus detritus 
sourced locally and Culex quinquefasciatus, Say (Recife strain), a colonized mosquito from 
Brazil.  Culex quinquefasciatus was used for validation since JEV has been isolated from this 
mosquito previously (Weng, Lien, Wang, Lin, Lin, & Chin, 1999; Halstead & Tsai, 2004; 
Nitatpattana et al., 2005; Changbunjong et al., 2013) and found to be competent for JEV in 
infection studies (Mourya et al., 2002; van den Hurk et al., 2003; Liu et al., 2012). 
Ochlerotatus detritus immatures (larvae and pupae) were collected from pools on Quayside 
saline marsh in northwest England (GPS coordinates: 53.277073N, -3.067728W) and 
transported to the Liverpool School of Tropical Medicine (LSTM) insectary.  They were reared in 
trays (15 × 30 × 5 cm) in the same water from which they were collected.  Identification of 
fourth instar larvae was carried out using the identification keys for British mosquitoes 
(Cranston et al., 1987).  A colony for this mosquito was not established because laid eggs failed 
to hatch; hence immatures were collected fresh for every experiment.  Culex quinquefaciatus 
were obtained from a colony maintained in the LSTM insectary.  Larvae were hatched, then 
divided among 15 × 30 × 5 cm trays with approximately one litre of de-chlorinated water and 
fed on brewer’s yeast tablets (Holland & Barrett, Nuneaton, Warwickshire, UK) as needed.  
Once the larvae started pupating, pupae for both mosquito species were harvested daily and 
transferred to separate BugDorm cages® (BioQuip, Rancho Dominguez, CA) (30 × 30 × 30 cm) 
where they would emerge as adults.  All adults and larvae were maintained at 27°C with a 
relative humidity of 80% and 12:12 light: dark cycle. The adults were provided with 10% sucrose 
and water ad libitum. 
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5.3.2 Cells and viruses  
The Muar strain of JEV was used in all infection experiments. Vero cells were maintained in 
Dulbecco Modified Eagle’s Minimal Essential Medium (DMEM) Sigma-Aldrich) media containing 
10% heat-inactivated Fetal Calf Serum (FCS), 2 mM L-glutamine and 50 µg/ml 
Penicillin/Streptomycin. 
5.3.3 Vector competence 
Field populations of Ochlerotatus detritus F0 mosquitoes and Culex quinquefasciatus colony 
mosquitoes were tested for JEV vector competence at two temperatures (23°C or 28°C) and at 
time points 0, 1, 3, 7, 14, and 21 days post-infection (dpi; i.e. after offering an infectious blood-
meal). Time point 0 represent mosquitoes collected 1-hour after offering an infectious blood 
meal. Two temperatures were used to provide preliminary evidence for any important effects 
of temperature on the level of vector competence of Ochlerotatus detritus. 
5.3.4 Per oral infection and transmission assay 
 All work with infectious blood meals was undertaken in the ACDP Ar-CL3 facilities at LSTM.  
Viral stocks were diluted prior to infecting mosquitoes to ensure the final titre was correct.  
Infectious blood meal containing virus from frozen stock was prepared by combining 
defibrinated horse blood (Thermo Oxoid Remel), with the appropriate volume of virus stock 
and 100 µl of adenosine 5’-triphosphate (ATP 0.02 µm) as a phagostimulant to a final 
concentration of 6 logs pfu/ml. 
Seven day-old adult female mosquitoes were aspirated from their cages into round 0.5 litre 
polypropylene plastic containers.  Fine nylon netting was placed over the mouth of the 
container to provide ventilation and prevent the escape of the mosquitoes.  The netting was 
secured by rubber bands and the hollowed-out lid of the container.  A small slit was made in 
the net in order to fit the mouth aspirator.  The slit was closed with cotton wool.  The 
mosquitoes were deprived of sucrose solution and maintained on water soaked cotton balls for 
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24 hours prior to blood feeding.  Approximately one hundred mosquitoes for each experiment 
were offered an infectious bloodmeal in order to achieve a minimum of 50 mosquitoes for 
assessment of infection. 
Peroral infection was achieved by exposing mosquitoes to a suspension of defibrinated horse 
blood and the Muar strain of JEV, using a Hemotek membrane feeding system (Hemotek limited 
Accrington, Lancashire, UK) for 1 hr at ~23°C (50 – 70% humidity) in the dark.  Parafilm® M was 
used as the membrane.  In all cases 0.5 ml aliquots of the infectious blood meal were collected 
both before and after the mosquitoes were fed and stored at -80°C for subsequent virus 
isolation.  This was done to confirm that the virus was viable before and after the blood feed, 
and determine if there was any change in the virus concentration.  
Engorged mosquitoes were chilled and sorted on ice and placed in fresh round 0.5 litre 
polypropylene plastic containers with fine nylon netting.  Fed females were maintained on 
cotton balls soaked with 10% sucrose solution.  Excess sugar solution was squeezed out from 
the cotton ball to prevent it from dripping into the plastic cups.  Cotton balls were changed 
daily.  Mosquitoes were held at 23°C or 28°C in a Sanyo incubator model MIR-153 with a 
photoperiod of 12:12 light: dark cycle.  A pan of water was kept in the incubator to maintain a 
relative humidity range of 70 – 90% relative humidity. 
Mosquitoes were sampled at 0, 1, 3, 7, 14, and 21 dpi at both 23°C and 28°C.  All mosquito 
samples were frozen individually at -80°C in 1.5 ml skirted conical microcentrifuge tubes with 
external thread O-ring screw-cap containing virus diluent media (Minimum essential medium 
(MEM), containing 1% Bovine serum albumin (BSA), 50 µg/ml penicillin/streptomycin, 0.3% 
Sodium hydrogen carbonate and 2.5 µg/ml Fungizone).  For mosquitoes sampled at 0, 1 and 3 
dpi, the whole mosquito body was placed in 1.5 ml tubes individually with virus diluent and 
then frozen.  Early time points (0 to 3 dpi), representing the eclipse phase of virus production in 
a mosquito, were sampled to ensure that virus detection reported for later time points (7 to 21 
dpi) was the result of new virus production rather than carry over from input virus.  The eclipse 
phase is the period after the ingestion of an infectious bloodmeal by a mosquito where the 
133 
 
virus titre decreases to minimal or non-detectable levels which are reached at about 3 to 4 days 
depending on temperature, virus or vector.  After multiplying in the midgut cells and spreading 
to other organs including the salivary glands, the virus can then be detected usually from about 
7 days after feeding. 
For mosquitoes sampled at 7, 14 and 21 dpi, saliva was collected before the mosquito legs were 
dissected from the remaining mosquito carcass.  Each of these samples (saliva, dissected legs 
and the remaining mosquito carcass) were individually placed in a 1.5 ml tube with virus diluent 
and then frozen at -80°C.  Manipulation of the mosquitoes was achieved by anesthetizing them 
using Triethylamine (TEA) FlyNap® (Blades Biological Limited, UK).  
Salivary secretions were collected using a modified in vitro capillary transmission assay (Aitken, 
1977).  Mosquito mouth parts were inserted into a plastic Micro-Hematocrit capillary tube, 
(Drummond ®, Cole-Parmer, UK) containing approximately 10 µl of a mixture of virus diluent, 
50% sucrose and adenosine 5’-triphosphate (ATP, 0.02 µM) for 30 to 45 minutes.  One μl of 1% 
pilocarpine (Alfa Aesar, Ward Hill, MA, USA) solution in phosphate buffered saline (PBS) and 
0.1% Tween 80 was applied to the thorax to stimulate salivation (Boorman, 1987; Dubrulle et 
al., 2009).  Active movement of the maxillary palpi and the stylets observed under a 
stereoscopic microscope, bubble formation in the media and engorgement of the mosquito 
were interpreted as a sign of salivation.  The contents were then released under pressure into a 
tube containing 0.5 ml of virus diluent. 
Infection was determined by recovery of virus from the mosquito tissue suspension.  If virus 
was recovered from its body but not in its legs, the mosquito was considered to have a non-
disseminated infection.  If virus was recovered from both the legs and the body suspension the 
mosquito was considered to have a disseminated infection  and if virus was recovered from its 
saliva the mosquito was considered to have a transmissible infection (Turell et al., 1984). 
The infection, dissemination and transmission rates percentage are defined as the number of 
mosquitoes testing positive for virus in their bodies, legs and saliva, respectively divided by the 
total number of mosquitoes tested, times 100.  Transition efficiency – the proportion of 
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infected mosquitoes that have a disseminated or transmissible infection, or the proportion with 
disseminated infections that have a transmissible infection was also determined.  
5.3.5 Plaque assay 
Body and leg samples were prepared for virus titration by homogenizing using a Disruptor 
genie® cell disruptor (Scientific Industries, USA) for 5 minutes in a 1.5 ml tube containing 0.5 ml 
virus diluent and two 6mm glass beads (Merck KGaA, Germany).  Plaque assays were performed 
by inoculating 100 µl of the salivary secretions or the supernatant of the homogenized bodies 
and legs onto a confluent monolayer of Vero cells on a 6-well plate (Costar®, Corning Life 
Sciences).  The plates were then incubated at 37°C at an atmosphere of 5% CO2 for 30 - 60 
minutes with rocking every 10 minutes to allow the virus to enter the cells. A 4 ml overlay of 
MEM, 4% FBS, 50 µg/ml gentamycine, 0.5% Sodium hydrogen carbonate and 2.5 µg/ml 
Fungizone (amphotecerine B) to limit contamination and 1% SeaPlaque low melting point 
agarose was then added to the wells and the plates were incubated at 37°C in 5% CO2.  After 5 
days of incubation, 2 ml of 10% neutral buffered formalin solution was added to each well and 
the plates left for at least 3 hours with the fixative to ensure complete inactivation of the virus.  
In order to visualize the plaques the wells were stained with 0.5 ml of crystal violet solution.  
Samples were scored as virus-positive or virus negative based on the presence or absence of 
plaques.  Viraemia of mosquito carcases was determined for a small subset of mosquitoes (i.e. 
~3 mosquitoes per each species and temperature for 0, 1, 3, 7, 14 and 21 days).  Viraemia was 
also determined for a subset of saliva samples. 
5.3.6 Statistical analysis 
Fisher Exact Test was used to determine if there were significant differences (p < 0.05) in rates 
of infection, dissemination and transmission between temperatures.  This was done both at 
each time point (dpi) and also in pooled analysis (7 to 21 dpi) to overcome issues of small 
sample size.  SISA, an open access online statistics calculator 
(http://www.quantitativeskills.com/sisa/) was used to conduct Fisher Exact Test.  Confidence 
intervals of proportions were calculated using VassarStats (http://vassarstats.net/prop1.html).  
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VassarStats uses the Wilson Score Interval method which is more robust when dealing with 
small number of trials and/or an extreme probability (Newcombe, 1998).  Sample size in each 
group was dictated by the feeding success and the survival rates through the days post 
infection (dpi).   
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5.4 Results  
There was a constant attrition of mosquitoes during the course of the study.  A total of 873 
field-collected Ochlerotatus detritus were offered an infectious bloodmeal and only 397 (45%) 
of them engorged, while 506 out of 695 (73%) of the colony mosquito Culex quinquefasciatus 
acquired a bloodmeal.  Of those that acquired an infectious bloodmeal, more than half of the 
Ochlerotatus detritus died (224 of 397), while about a quarter (150 of 506) of the Culex 
quinquefasciatus died during the course of the experiment (Table 19).  Mortality of 
Ochlerotatus detritus was especially high (65%) at 28°C. The rate of engorgement in Culex 
quinquefasciatus was higher than Ochlerotatus detritus. 
Table 19: Rate of engorgement and mortality of Ochlerotatus detritus and Culex quinquefasciatus 
at 23 °C and 28 °C incubation temperatures. 
Mosquito 
species 
Temperature Initial no. of  
mosquitoes 
Bloodfed/ 
Initial (%) 
Sampled/ 
Bloodfed (%) 
Dead/ 
Bloodfed (%) 
Ochlerotatus 
detritus 
23 °C 430 198 (46)  103 (52)  95 (48) 
 28 °C 443 199(45) 70 (35) 129 (65) 
Culex 
quinquefasciatus 
23 °C 385 277(72) 216( 78) 61 (22) 
 28 °C 310 229 (74)  140 (61) 89 (39) 
Though freshly harvested viral stocks, prior to being frozen, were originally estimated to be ~6 
logs PFU per ml, assessment of the infectious bloodmeal before and after being placed in the 
Hemotek artificial feeding system always yielded ~4 logs PFU/ml.   
Both mosquito species displayed a typical eclipse phase following oral infection in which the 
virus titre and detection decreased from 0 to 3 dpi followed by an increase in virus titre and 
detection from 7 to 21 dpi (figure 20 and table 20).  This is attributable to the reduction in virus 
titre after day 0 as ingested virus either infects cells or gets digested; virus successful in 
infecting cells replicates to detectable levels several days later.  Viraemia of saliva samples 
ranged from ~1 log to ~ 3 logs PFU/ml for both mosquitoes at both temperatures.  
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Figure 19: Graph showing the virus eclipse phase for JEV in both Ochlerotatus detritus (A) and Culex 
quinquefasciatus (B) at 23°C and 28°C.  
This is represented by the steady decline in the virus titre from day 0 then a steady increase from day 7 
onwards. 
A 
B 
138 
 
Both mosquito species were susceptible to JEV infection with infection rates from 7 days post 
infection ranging from 32 to 100% for Ochlerotatus detritus and 25 to 100% for Culex 
quinquefasciatus (table 20 and figure 20).  In general, higher infection, dissemination and 
transmission rates were reached at later time points although there was some variation.  
Dissemination rates of both species tended to be similar to the infection rates.  Transmission 
rates tended to be lower than dissemination rates.  Nevertheless, 33 – 67% of Ochlerotatus 
detritus, and 50 – 70% of Culex quinquefasciatus, had developed transmissible infections by 21 
dpi (table 20). 
Figure 20: Sample plaque assay plate showing virus plaques obtained from Ochlerotatus (Aedes) detritus 
mosquito sampled at 7 days post infection serial diluted from neat (N) 10-1 and 10-2. 
A) Plaques from whole body indicate that the mosquito is infected (carcass). 
B) Plaques from legs indicate that the virus has disseminated to other organs in the body of the mosquito. 
C) Plaques from saliva sample shows mosquito is able to transmit virus by bite. 
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Table 20: Infection, dissemination and transmission rates of mosquitoes exposed to 4 logs PFU/ml of the 
Muar strain of JEV. 
Mosquito 
species  
Temp dpi * 
(days) 
No. 
tested 
I D T Infection 
rate a 
(95% CI) 
Dissemination 
rate b 
(95% CI) 
Transmission rate c 
(95% CI) 
O. d  23 °C 0 16 16 nt nt 100 (81-100) nt nt 
1 11 4 nt nt 36 (15-65) nt nt 
3 9 3 nt nt 33 (12-65) nt nt 
7 25 8 5 3 32 (17-51) 20 (8-39) 12 (4-30) 
  14 32 25 23 1 78 (61-89) 72 (54-84) 3 (0-15) 
  21 6 6 6 4 100 (60-100) 100 (60-100) 67 (30-90) 
  Total† 63 39 34 8 62 (50-73) 54 (42-66) 13 (7-23) 
 28 °C 0 12 6 nt nt 50 (25-75) nt nt 
 1 7 1 nt nt 14 (3-51) nt nt 
 3 3 0 nt nt 0  nt nt 
 7 15 9 9 4 60 (35-80) 60 (35-80) 27 (10-51) 
  14 6 3 2 1 50 (18-81) 33 (9-70) 17 (3-56) 
  21 3 3 3 1 100 (43-100) 100 (43-100) 33 (6-79) 
  Total† 24 15 14 6 62 (42-79) 58 (39-76) 25 (12-45) 
C. q  23 °C 0 17 17 nt nt 100 (82-100) nt nt 
1 11 6 nt nt 55 (28-55) nt nt 
3 11 3 nt nt 27 (10-57) nt nt 
7 24 6 5 4 25 (12-44) 21 (10-40) 17 (7-36) 
  14 32 20 11 1 62 (45-77) 34 (20-51) 3 (0-15) 
  21 10 7 7 5 70 (39-89) 70 (39-89) 50 (24-76) 
  Total† 66 33 23 10 50 (38-62) 35 (25-47)  15 (8-26) 
 28°C 0 7 7 nt nt 100 (65-100) nt nt 
 1 10 3 nt nt 30 (11-60) nt nt 
 3 3 0 nt nt 0  nt nt 
 7 9 4 0 0 44 (19-73) 0 0 
  14 12 8 7 2 66 (39-86) 58 (31-80) 17 (4-45) 
  21 10 7 7 7 70 (40-89) 70 (40-89) 70 (40-89) 
  Total† 31 19 14 9 61 (44-76)  45 (29-62)  29 (16-47)  
O. d= Ochlerotatus detritus ; C. q= Culex quinquefasciatus; dpi=days post infection; I=number infected; 
D= number disseminated; T= number transmitting; nt = not tested; CI=confidence interval 
* Days 0, 1, and 3 post infection represents input virus and is not true infection; † Totals include days 7 – 
21 dpi only 
a Percentage of mosquitoes containing virus in their bodies out of no. tested (95% confidence interval). 
b Percentage of mosquitoes containing virus in their legs out of no. tested (95% confidence interval). 
c Percentage of mosquitoes containing virus in their saliva out of no. tested (95% confidence interval). 
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Overall, when 7 to 21 dpi are combined, the field populations of Ochlerotatus detritus were 
competent for JEV with 62% infection, 54% dissemination and 13% transmission rate at 23°C 
and 62% infection, 58% dissemination and 25% transmission rate at 28°C.  The rate of infection, 
dissemination and transmission in Ochlerotatus detritus did not differ significantly at the two 
temperatures in individual or pooled analysis.  For Culex quinquefasciatus, when 7 to 21 dpi are 
combined, JEV competence rates were 50% infection, 35% dissemination and 15% transmission 
rate at 23°C and 61% infection, 45% dissemination and 29% transmission rate at 28°C.  In 
addition, for Culex quinquefasciatus, when the analysis was done individually for each day post 
infection (7, 14, and 21dpi) or pooled, there was either marginal (0.05 < p <0.1) or not a 
significant effect of temperature on the rate of infection, dissemination and transmission.  
However, sample sizes for individual time points are small. When the data for later time points 
(7 to 21 dpi) are pooled, the effect of temperature on the transmission rate was significant (χ2 = 
7.199, df = 1, p = 0.014).  
To describe the transition efficiency of the virus after overcoming the midgut barrier in the 
mosquito, the number of mosquitoes with a disseminated infection out of the number infected 
(dissemination efficiency) was examined and the number of mosquitoes able to transmit out of 
those disseminated (transmission efficiency) was also examined at day 7, 14, and 21  dpi (Table 
21).  Both mosquitoes attained 100% dissemination efficiency by 21 dpi.   
  
141 
 
Table 21:  Dissemination and transmission transition efficiency of mosquitoes exposed to 4 
logs PFU/ml of Muar strain of JEV. 
Mosquito  
Species  
Temp dpi 
(days) 
Dissemination, 
% of no. 
infected a 
(95% CI) 
Transmission, % 
of no. 
disseminated b 
(95% CI) 
Transmission, % 
of no. infected c 
(95% CI) 
O. d  23 °C 7 62 (30-86) 60 (23-88) 37 (14-69) 
14 92 (75-98) 4 (0-21) 4 (0-19) 
21 100 (60-100) 67 (30-90) 67 (30-90) 
28 °C 7 100 (70-100) 44 (19-73) 44 (19-73) 
14 66 (20-94) 50 (9-90) 33 (6-79) 
21 100 (43-100) 33 (6-79) 33 (6-79) 
C. q   23 °C 7 83 (44-97) 80 (38-96) 67 (30-90) 
14 55 (34-74) 9 (2-38) 5 (1-24) 
21 100 (65-100) 71 (36-92) 71 (36-92) 
28 °C 7 0  0  0  
14 87 (53-98) 28 (8-64) 25 (7-59) 
21 100 (65-100) 100 (65-100) 100 (65-100) 
O. d = Ochlerotatus detritus ; C. q = Culex quinquefasciatus; dpi= days post infection; 
CI=confidence interval 
a Percentage of mosquitoes containing virus in their legs out of no. infected 
b Percentage of mosquitoes containing virus in their saliva out of no. disseminated 
c Percentage of mosquitoes containing virus in their saliva out of no. infected. 
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5.5 Discussion 
This is the first study to investigate the biological competence of a mosquito of British origin 
(Ochlerotatus detritus) to an arthropod-borne virus.  Ochlerotatus detritus was susceptible to 
laboratory infection with JEV at 23°C and 28°C, with virus detectable in the saliva of some 
individuals as early as 7 dpi, and it therefore appears to be a competent vector for this 
flavivirus.   
Since the Ochlerotatus detritus mosquito population used in this study is a temperate variety, it 
showed poor survival when incubated at 28 °C, and there was high mortality during the 
experiments; hence, no mosquitoes survived greater than 21 dpi.  This mosquito was also not 
adapted to acquiring a blood meal from an artificial feeder and that may have led to lower 
numbers of mosquitoes acquiring an infectious blood meal. 
In this study, the transmission rate for Ochlerotatus detritus was only 19% when averaged for 
the two temperatures at the different days post infection.  However, it is important to note that 
the medium used to collect the saliva can affect the amount of virus detected; because an 
aqueous solution was used in the capillary tube assay , this may have underestimated the 
amount of virus being secreted by the mosquito (Colton et al., 2005; Turell, Mores, Dohm, Lee, 
et al., 2006).  While animal infections with the mosquito would have been a better model to 
confirm transmissibility, the facilities to do this were not available.  In this study, salivary 
viraemia ranging from 1 log to 3 logs PFU/ml were produced.  The viraemia produced in the 
saliva secretion of both mosquito species is likely to cause infections in susceptible birds, 
humans or other mammals. 
The decrease in detectable titres of JEV in Ochlerotatus detritus and Culex quinquefasciatus 
during the first 3-days after an infectious blood meal indicated an eclipse phase in virus 
replication.  At 23°C, for both species, the infection rates are very similar at 3 and 7 days (33 vs. 
32%; 27 vs. 25%).  The detection of viral dissemination and transmission by 7 dpi is likely an 
indication that viral replication has occurred by then and this is not “carry-over” input virus; the 
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increase in viral titre between 3 and 7 dpi suggests the same.  Early in the eclipse phase, the 
rate of reduction in virus titre and detection appears to have been sharper at 28 compared to 
23°C.   
It remains to be seen whether Ochlerotatus detritus is competent at normal Great Britain 
temperatures.  The extrinsic incubation period (EIP) is the duration required for a pathogen to 
complete its development within a vector from its initial acquisition via an infected blood meal 
to the point at which it can be transmitted to another host via another blood meal.  EIP is 
heavily influenced by prevailing temperatures and is an essential piece of information when 
developing vectorial capacity models.  There was no significant difference in the infection, 
dissemination and transmission rates in Ochlerotatus detritus at 23°C and 28°C.  This was 
unexpected as studies have shown that increases in temperature often reduce the EIP, 
therefore increasing infection, dissemination and transmission rates (Davis, 1932; Takahashi, 
1976; Kay et al., 1989).  In Ochlerotatus detritus, because a total of only 24 mosquitoes were 
assessed at 28°C while a total of 63 mosquitoes were assessed at 23°C, It is possible that my 
results may have been affected by small sample sizes, limiting the power of the study to detect 
a difference.  It should also be noted that an increase in temperature could also reduce the 
adult lifespan of mosquitoes and this may interrupt transmission (See Table 19).  In contrast, 
the pooled results for Culex quinquefasciatus at the two temperatures were significantly 
different. 
JEV disseminated well in the bodies of both mosquito species, as demonstrated by high 
dissemination rates (i.e. virus found in the legs).  However, transmission rates were 
considerably lower than dissemination rates.  While these results may suggest the existence of 
barriers to the development of a transmissible infection in the mosquito, it is still premature to 
make this conclusion given the low sample size.   
Some of the limitations of the study include the following:  Firstly, relatively high temperatures 
(i.e. 23 and 28°C) where used which were beyond the average summer range temperature 
experienced in Cheshire where the Ochlerotatus detritus were sourced.  For example, July is the 
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warmest month, with mean daily maximum temperatures approaching 21°C in Cheshire 
(http://www.metoffice.gov.uk/climate/uk/nw/print.html).   The higher temperature certainly 
impacted mosquito survival; still it is not clear to what extent it played a role on the overall JEV 
susceptibility.  There were no significant differences between Ochlerotatus detritus kept at 23 
and 28°C but this may be due to sample size.  Other studies have demonstrated transmission of 
JEV in mosquitoes held at 20°C (Takahashi, 1976).  Secondly, though the initial number of 
mosquitoes used was relatively large, sample size was relatively low at the later time points (i.e. 
14 and 21 dpi).  The difficulty of consistently getting mosquitoes from the field and keeping 
them alive long enough in the laboratory for assessment was a challenge.  Future study should 
focus on holding mosquitoes at more optimum survival conditions and doing more replicates to 
get larger sample sizes at later time points.  Thirdly, freshly harvested virus was not used for 
infections.  Rather frozen stocks were used out of convenience and convention.  This may have 
affected the infection efficiency as suggested in other studies (Richards et al., 2007).  
Nonetheless, the mosquitoes certainly received at least 4 logs pfu/ml of virus as determined by 
plaque assays conducted before and after offering mosquito an infectious blood meal.  
Fourthly, other physiological parameters such as mosquito size or daily mosquito survival were 
not recorded.  While these parameters are important they were beyond the scope of the 
original aim of the study, which was to assess competence of Ochlerotatus detritus.  Finally, 
only one mosquito species was used in this study, despite there being several potential 
arboviral vectors in Great Britain.  Nevertheless, this study is one of the early contributions to 
the knowledgebase of vector competence of native British mosquitoes.    
The result of 19% transmission rate by Ochlerotatus detritus must be gauged against the 
vectorial capacity indicators to determine the likelihood of sustained transmission of JEV for 
this vector.  Early studies in Britain have estimated the feeding rate of Ochlerotatus detritus on 
birds to be 3.7% (3-bird blood positives of 81-decernible tests), while the feeding rate on 
humans was 33.3% (27 of 81) (Service, 1971).  Feeding behaviour on other mammals are 1.2 % 
(1 of 81) for pigs and 49.4% (40 of 81) for bovids.  Despite the low feeding rate on JEV amplifiers 
(i.e. birds and pigs), there is still a sizeable population of the Ochlerotatus detritus in Cheshire 
County (Clarkson & Setzkorn, 2011; Medlock, Hansford, Anderson, et al., 2012), which may 
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make it possible for transmission to be sustained by this vector.  Nonetheless, other factors to 
be considered are survival of mosquitoes at optimal conditions.    
As mentioned earlier, Ochlerotatus detritus and JEV were selected primarily out of convenience.  
However, Ochlerotatus detritus is a relevant mosquito to study as it has high human biting rates 
(Clarkson & Setzkorn, 2011), and is considered a potential bridge vector for arboviruses such as 
WNV (Medlock et al., 2005; Osorio et al., 2012).  JEV, recognised as a virus with the potential to 
expand in range (van den Hurk et al., 2009), is also a relevant model to use; this is underscored 
by the recent detection of the JEV gene sequence in a pool of Culex pipiens in Italy.  In 2010, the 
detection of the NS5 gene RNA sequence of the JEV was reported from one pool of Culex 
pipiens mosquitoes collected in north-eastern Italy (Ravanini et al., 2012).  This report 
suggested that the threat of  the introduction of arboviral diseases of tropical origin to 
temperate regions is ever present and requires constant vigilance (Platonov et al., 2012).     
In the case of JEV, suitable vertebrate hosts for virus amplification are pigs and water-birds. The 
marsh where Ochlerotatus detritus was sourced is a protected conservation area that is 
frequented by several avian species including water birds such as the little egret and different 
varieties of ducks and geese and other aquatic avian.  However, the susceptibility of British 
birds to JEV is not known. 
Humans are considered dead-end hosts in the transmission of JEV and therefore its 
introduction in the UK would most likely be through transportation of infected mosquitoes on 
planes, ships or cars; trade in domestic animals and also infected migratory birds which may 
play a critical role in the long distance transportation of the virus (Platonov et al., 2012).  The 
demonstration of the presence of a competent local vector highlights the need for continued 
vigilance to prevent local transmission of arboviruses in the UK and suggests that mosquito 
control will form part of the intervention strategy in the event of disease emergence. 
Future studies will determine the vector competence of this mosquito at lower temperatures 
and evaluate the possibility of vertical transmission since Ochlerotatus detritus mosquitoes are 
available all year round and hibernate as eggs and larvae.  The data provided here will prove 
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useful for the development of Great Britain-specific models of the risk of mosquito-borne 
arbovirus outbreaks in Great Britain. 
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6 Overall discussion 
The principal topic of this thesis is JEV transmission, replication in a competent host, spread and 
its possible introduction into new areas. JEV causes high mortality, morbidity and disability in 
Asian countries and is considered to have the potential to expand into new areas as has already 
been demonstrated in its introduction into northern Australia. 
Several studies have been undertaken to understand the factors responsible for the different 
distribution patterns of JEV genotypes. These studies have utilised climate data (Schuh et al., 
2013), land use and land cover variables (Impoinvil et al., 2011) agricultural practices (Lindahl et 
al., 2012) and  deduced different explanations.  Some studies have also used sequence 
information to estimate the rate of evolution of JEV (Mohammed et al., 2011; Chen, 2012). 
However one limitation is the lack of sequence information representative of each genotype. 
Nevertheless, these studies have provided information for the background of this thesis. 
Rather than using evolutionary information only to explain the spread and expansion of JEV, 
this study has also addressed the potential difference that may occur in transmissibility of the 
different genotypes in mosquitoes. This study compares an old genotype V sequence, which 
had not been isolated for nearly 60 years; to a widespread genotype III. In addition, the 
possibility of emergence of JEV in Great Britain has been addressed in evaluating the 
competence of a local ‘temperate’ mosquito species Ochlerotatus detritus. Showing through 
experimental studies that temperate mosquito species are able to transmit exotic flaviviruses 
would be of public health importance. 
Chapter 3 provides a complete sequence of a genotype V isolate that had been characterized 
using antibody absorption test only but no sequence information was available. There are so far 
three genotype V isolates (i.e. Muar, XZ0934 and 10-1827) but, until now, there were only two 
complete genome sequences available. Hence the availability of the complete genome 
sequence for Tengah brings that number to three complete sequences available for genotype V. 
Muar may have been the only strain circulating in Singapore at that time (1952) and hence the 
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only difference between Muar and Tengah was the isolation from different patients. The two 
names were derived from the places where patients came from before they were admitted to 
Singapore general hospital. Muar is a town in Malaysia and Tengah is a town in Singapore. The 
towns are just 200 km apart. 
Previous studies on the evolutionary rate of JEV have only utilized one complete sequence for 
genotype V and genotype II. During the course of this study, the availability of three additional 
genotype II sequences and two genotype V sequences made it possible to evaluate the 
evolutionary rate of JEV in the hope of attaining a more comprehensive analysis for JEV 
genotypes. These results provide for the first time the time to the most recent common 
ancestor (TMRCA) for genotype II when using four complete sequences and for genotype V 
when using three complete genome sequences. The TMRCA for genotype II was estimated to 
have occurred in 1910 and that for genotype V in 1814. These results also show a higher 
evolutionary rate of GI than GIII. These data are in agreement with other studies that have 
reported the displacement of genotype III by genotype I (Chen et al., 2011). The results of the 
analysis suggest that it has a higher evolutionary rate, however this might be due to the lack of 
sequence information between the initial genotype V isolates (isolated in 1952) and the recent 
XZ0934 isolate (isolated in 2009), or it might be true that viruses in genotype V are evolving at a 
high rate. For this reason studies to assess any differences in virulence and viral replication 
rates within genotype V and between genotype V and other four genotypes are required. This 
should also be followed by assessing the efficacy of existing vaccines against these strains. 
Information to date suggests the current vaccines (which are all based on genotype III isolates) 
are effective against genotypes I-IV (Beasley et al., 2004), however genotype V is the most 
divergent, and there are few data available looking at potential efficacy of vaccines against the 
genotype.  In addition, the two earlier isolations of genotype V (Muar and Tengah) were from 
humans who had fatal outcomes, which suggest that genotype V has virulent strains capable of 
causing death hence it is important to assess the efficacy of existing vaccines against these 
strains. 
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The recent isolates of genotype V differ in sequence similarities with Muar in the envelope gene 
with 93.2% amino acid similarity with the Chinese isolate XZ0934 and 98.8% amino acid 
similarity with the Korean isolate 10-1827 (Takhampunya et al., 2011). This may indicate that 
this genotype is evolving and whether these differences are related to either higher virulence or 
lower virulence, or something else, is not known. Moreover, the isolation of the Korean isolate 
from Culex bitaeniorhynchus, a mosquito species previously unknown to carry JEV, may indicate 
that this genotype now has the ability to infect different mosquito species and possibly a 
variety of hosts too.  Indeed, a mutation in the envelope gene of Chikungunya virus, which is 
primarily transmitted by Aedes aegypti, is reported to be directly responsible for the adaptation 
of this virus to Aedes albopictus mosquitoes which then lead to an epidemic in Reunion Island 
in 2005-2006, a region that lacks the typical vector.  (Tsetsarkin et al., 2007). The E gene 
sequence homology between the Muar and Tengah isolated in 1952 to that of XZ0934 isolated 
in 2010 is 89.4% for nucleotide sequence and 93.2% for amino acid sequence (Li, Fu, et al., 
2011). Classification using phylogenetic studies as described by Chen and others (Chen et al., 
1990) states that the maximum genetic distance within a genotype is 6% of amino acids. This 
shows that the genetic distance between the isolates in 1952 and that in 2010 of 6.8% is right at 
the border or has surpassed that percentage.  Taking this into consideration may indicate that 
these viruses should be classified as different genotypes in JEV or the classification of JEV 
genotypes should be revisited. 
Chapter 3 attempts to address the lack of circulation of genotype V by comparing its infectivity 
in Culex quinquefaciatus mosquitoes with the most isolated genotype III.  There was no 
difference found between the two genotypes in their transmissibility in Culex quinquefasciatus 
mosquitoes. The fact that Muar was able to infect and be transmitted by Culex quinquefasciatus 
may indicate that the transmissibility by different species of mosquito may have not been the 
limiting factor in genotype distribution. The mosquito species used in this study does not have 
high efficiency for JEV compared to other mosquito species such as Culex tritaeniorhynchus.  A 
highly susceptible vector may have yielded different results.  Nevertheless, the same conditions 
were used for both genotypes.  Therefore, any differences in infectivity should have been 
apparent in this study. Differences in transmission in mosquitoes by different genotypes have 
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been reported for viruses such as WNV where the WN02 genotype had an extrinsic incubation 
period (EIP) that was 4 days shorter than that of NY99 genotype. This difference in the EIP of 
WN02 and NY99 provided a possible explanation of the displacement of NY99 by WN02 which 
was transmitted much earlier hence leading to more infection rates (Moudy et al., 2007). In 
another study, Dengue serotype 2 and 3 have been reported to infect a significantly high 
proportion of Aedes aegypti mosquitoes than dengue serotype 1 and 4 (Gubler et al., 1979). 
However, the amino acid difference between dengue serotypes is between 30 to 40%, and they 
are effectively closely related but different viruses; in contrast while amino acid difference 
between JEV genotypes is 9 to 12% (Tsarev et al., 2000) hence this may account for the 
differences in mosquito infectivity of dengue viruses. Some of the reasons that may have 
contributed to the lack of circulation of Muar may be that this virus has low infection and/or 
replication rates in pigs which are considered important amplifying host in the JEV cycle or low 
infection and replication rates in birds. It is possible that this virus circulates in non-migratory 
birds in the Indo-Malaysian region. Hence these factors should be investigated. 
 In addition to mosquito infectivity, virus spread and evolution is influenced by complex set of 
variables. There are several things to take into consideration, including climatic factors, 
specifically temperature, or replication in other hosts such as birds or pigs.  A sequence 
homology of 86% between Muar and the recently isolated Chinese strain, XZ0934, shows 
evolution may have aided in its spread to China and Korea. Hence comparing these sequences 
at a molecular level could provide vital information. 
With the concern of JEV expanding into different geographical regions, it is essential for 
European countries including Great Britain to investigate the potential of its resident 
‘temperate’ vectors to transmit the virus. In Chapter 4, the competence of Ochlerotatus 
detritus, a local British mosquito, to transmit JEV at two different temperatures was evaluated. I 
hypothesized that British mosquitoes were refractory to arbovirus infection. However this study 
was conducted as a proof-of-principle investigation to demonstrate that the indigenous 
Ochlerotatus detritus was a competent vector and has the potential to transmit JEV. Hence, 
given the results of this study it is possible to conclude that the absence of arbovirus circulation 
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in Great Britain is likely due to other factors rather than lack of competent vectors. Only one 
mosquito was tested in this study hence other local mosquito species should be evaluated. 
There was no difference in susceptibility of Ochlerotatus detritus at the different temperatures. 
However this may have been due to high mortality at 28 °C. Therefore while the temperature 
was conducive for the virus it was not conducive for the vector. Competence of British 
mosquitoes using overall Great Britain summer temperatures (~ 15-18°C) may provide different 
results from my findings. But studies with JEV using temperatures ranging from 20°C to 22°C 
have shown this virus was able to infect the mosquito albeit at slower rates. The question 
remains whether mosquitoes survive long enough during British summer temperatures to 
infect a vertebrate host? However as indicated on the map in figure 8, mosquito-borne viruses 
have been reported in areas that share the same climatic conditions as Great Britain or are 
even cooler. Since Ochlerotatus detritus overwinters as fourth instar larvae, it may be important 
to evaluate vertical transmission of JEV and other mosquito-borne viruses in this mosquito. 
Vertical transmission means that an infected female mosquito is able to pass on the virus to its 
offspring. In this case, the virus would overwinter in the fourth instar larvae in the winter 
months when conditions are not favourable and would thereby resume transmission in the 
summer. Vertical transmission of WNV has been shown in Culex mosquitoes which are believed 
to serve as overwintering reservoir host (Nelms et al., 2013). In the event of global-warming, 
the local mosquito population may actually decrease as shown by the high mortality of 
Ochlerotatus detritus at 28°C. It may take some time for the mosquitoes to adapt to warmer 
temperatures hence lowering chances of arboviral transmission. The serological detection of 
antibodies to WNV, Usutu virus and Sindbis virus in both migrant and non-migrant birds in 
Great Britain (Buckley et al., 2003), the detection of JEV RNA in mosquitoes in Italy (Ravanini et 
al., 2012), and the occasional importation of viruses such as dengue by returning travelers 
(Stephenson et al., 2003) may indicate that arbovirus are actually entering Great Britain. The 
fact that there are also competent vectors as evidenced in this study but still no autochthonous 
cases of any arboviruses reported in Great Britain may indicate that other factors should also be 
considered. 
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Vector competence is a single piece in the jigsaw of arbovirus transmission risk. Other factors to 
take into consideration would include population dynamics, mosquito survival rates, biting 
behaviors and distribution of vector in relation to host. However vector competence studies are 
useful for prioritizing which mosquitoes would require more entomological surveillance in the 
event of arbovirus emergence. 
6.1 Recommendations for future studies. 
 
Given the results from this work the following suggestions are made for future studies. 
1. Evolutionary studies performed in chapter 3 utilized only one sequence for genotype IV 
and only three for genotype V which are the only complete genome sequences available 
for these genotypes. Hence there is need for characterization of complete genome 
sequences for these genotypes. Evolutionary studies combined with more 
ecological/environmental type studies such as land-use, land-cover and animal 
populations may provide information on any relationship there may be between virus 
evolution and these factors.  
2. Following chapter 3, it will be important to evaluate if the comparison of JEV genotypes 
transmissibility in the principle vector Culex tritaeniorhynchus would yield different 
results to those reported here. Comparison of genotypes should also be performed 
using different mosquito species.  Growth curve studies can be done in vertebrate and 
mosquito cell lines, and live mosquitoes. 
3.  In chapter 4, evaluation of vector competence of other local British mosquitoes to 
different arboviruses beside JEV should be done. Vector competence should also be 
assessed at a wider range of temperatures. One limitation in my study was the small 
sample size of mosquitoes used. Hence future studies should consider using a higher 
number of mosquitoes. 
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7 Constraints 
Some of the challenges faced during this project were 
1. Short mosquito season in the UK 
The short mosquito season in the UK meant that mosquito collections could only be 
carried out during the summer. Hence when attempts to colonize failed I had to wait for 
the next mosquito season to obtain more mosquitoes. Similarly obtaining immatures 
from the field for infection experiments could only be done during the mosquito season. 
Hence not much work was possible in the winter. 
2. Availability of containment laboratories. 
All experiments involving JEV virus were carried out in the ACDP containment 
laboratories level 3. With the move of our department to a new Ronald Ross building, 
the new ACPD CL3 laboratories had to undergo thorough inspections before issuing of a 
licence and so they were not available for use. The maintenance of these new facilities 
also meant that no infection experiments could be carried out awaiting inspection and 
validation that they were safe to use. 
Due to the strict regulations of the use of ACDP CL3 facilities, work could only be done 
9.00am to 5.00pm and no weekend access. Hence time point experiments were difficult 
to set up. 
3. Experimental troubleshooting 
As this was the first time for mosquito infection experiments to be carried out by our 
group, a lot of time was a spent troubleshooting experimental procedure. The main 
challenges were in keeping plaque assays plates free from fungus contamination and 
also collecting saliva samples from individual mosquitoes at the different time points. 
This was done in the glove box and proved to be very cumbersome. Only twenty 
samples could be carried out in one day. Fungus contamination was overcome by 
addition of Fungizone (amphotecerine B) in the virus diluent media used to freeze 
mosquito samples and also in the Minimum essential medium used to overlay the 
plaque assay plates. Preparation of both media can be found in chapter 2 of this thesis. 
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Appendix I Attempt to establish laboratory colony of British 
mosquitoes 
 
The need to colonize British mosquitoes is of extreme importance in order to establish working 
infection models. Attempts to colonize British mosquitoes have proved very challenging. 
However this is consistent with previous attempts to colonize these mosquitoes (Michael 
Service, Pers.Comm.) The largest barrier to colonizing British mosquitoes is overcoming their 
eurygamic behaviour i.e. preference for open spaces. In the quest to colonize British 
mosquitoes, several approaches have been used. This has included, increasing the light cycles 
(16 hours light: 8 hours dark), rotating mosquito cages, shifting mosquitoes into large cages, 
putting dark backgrounds under mosquito cages and using stroboscopic blue light to stimulate 
mating. In the UK, there is only one well-known stenogamous (i.e. mating in confined spaces) 
mosquito, Culex molestus. This mosquito species is the urban from of Culex pipiens pipiens and 
is a likely bridge vector for WNV since it feeds on both birds and humans. A source to provide 
this species has been identified but has not materialized yet. While, mosquito colonies have 
been established with eurygamous population in other parts of the world, this has usually been 
accomplished with great difficulty and painstaking effort. Further efforts are continued to 
establish British mosquitoes.  
8.1.1 Establishment of laboratory colony of Ochlerotatus cantans 
 
Ochlerotatus cantans mosquitoes were collected from the woods in Leahurst, Neston and 
reared as described in the materials and methods section above. Whatman filter paper was 
provided as the oviposition substrate. Four eggs were laid after two weeks. The eggs were 
collected and dried for three days and then immersed in water for hatching (Service, 1970; 
Andreadis, 1990). After 24hrs none of the eggs hatched. This was repeated three times. To 
determine the viability of the eggs, a 3% sodium hypochlorite solution was prepared and the 
eggs submerged for 45 minutes (Impoinvil et al., 2007). They were observed under a 
microscope for presence of embryo. None of the eggs had any visible signs of segmentation, 
which would suggest embryo development. Eggs of Aedes aegypti were also tested for viability; 
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this was done as a positive control experiment. These eggs were found to be viable as indicated 
by the visibility of egg segmentation as shown in figure 22. These mosquitoes were kept for 
three months with blood meals provided every week. During the whole period only twelve eggs 
were collected and none of them hatched. Another attempt to colonize the mosquitoes was 
not possible since the availability of mosquitoes was low. 
 
 
 
Figure 21:  A) Segmentation of Head and abdomen in Aedes aegypti egg. B) No segmentation 
visible in Ochlerotatus cantans egg. 
 
8.1.2 Establishment of laboratory colony of Ochlerotatus detritus 
 
Ochlerotatus detritus mosquitoes were collected from the salt marsh water ponds in Parkgate, 
Cheshire and reared as described in the materials and methods section above. Whatman filter 
paper was provided as the oviposition substrate. Two eggs were laid after one week. Since the 
number of eggs was very low, the oviposition substrate (wet Whatman filter paper) was 
substituted with cotton wool soaked in water. With this, the number of eggs increased slightly. 
Eggs that were laid were collected and dried for three days and then immersed in water for 
hatching. After 24hrs none of the eggs hatched. The eggs were then dried again and immersed 
several times (Service, 1970; Andreadis, 1990). Hatching was not successful. To determine the 
viability of the eggs, a 3% sodium hypochlorite solution was prepared and the eggs submerged 
for 45 minutes. They were later observed under a microscope for presence of the embryo. 
None of the eggs had any visible sign of segmentation as shown in figure 22 above. Some of the 
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eggs did not bleach after 45 minutes or longer and so these were dissected under a microscope 
to observe for any cell differentiation. A positive control for egg viability was done using Aedes 
aegypti eggs. Mosquitoes were kept for seven weeks with blood meals provided every week. 
During the whole period about 30 eggs were collected in total and none of them hatched. 
 
8.1.3 Establishment of Laboratory colony of Culex pipiens pipiens 
 
Culex pipiens pipiens mosquitoes were collected from the cattle water troughs in Leahurst, 
Neston. Mosquitoes were reared as described in the materials and methods section above and 
maintained in a 30 × 30 × 30 cm cage to increase the density and encourage free mating. Cages 
were also rotated every evening. Water in small plastic cups, some with hay infusion and others 
with ordinary tap water, were provided for oviposition. After providing a blood meal two egg 
rafts were laid but none of the eggs hatched. Mosquitoes were then transferred to a 60 × 60 × 
60 cm cage according to a study by Krishnan, 1964 and the same procedure followed to obtain 
eggs. Eggs were obtained but failed to hatch. Since Cx pipiens pipiens are eurygamous (need 
open spaces for mating), a bigger walk-in cage (100 × 50 × 150cm) was fabricated and all Culex 
pipiens pipiens mosquitoes transferred into it. A blue stroboscopic light was also provided to 
encourage the mosquitoes to copulate naturally under laboratory conditions according to a 
study by Lardeux and others, 2007.  Several blood meals were provided and eggs laid but none 
of the eggs were viable hence none hatched.  
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Figure 22: A walk-in cage (100 × 50 × 150cm) fabricated in an attempt to establish a laboratory 
colony of Culex pipiens pipiens 
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Appendix II Tengah complete nucleotide sequence 
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2014 
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DKQINHHWHKAGSSLGKAFTTTLKGAQRLAALGDTAWDFGSIGGVFNSIGKAVHQVFG 
                     
GAFRTLFGGMSWITQGLMGALLLWMGINARDRSIALAFLATGGVLLFLATNVHADTGC 
                     
AIDVTRKEMRCGSGIFVHNDVEAWVDRYKYLPETPKSLAKIVHKAHKEGICGVRSVTR 
                     
LEHQMWEAVRDELNVLLKENAVDLSVVVDKPVGRYRPAPLRLSMTQEKFEMGWKAWGK 
                     
SILFAPELANSTFVIDGPETKECPDERRAWNSMQIEDFGFGITSTRVWLKIREERTDE 
                     
CDGAIIGTAVKGNMAVHSDLSYWIESHLNDTWKLERAVFGEIKSCTWPETHTLWGDGV 
                     
EESELIIPHTLAGPKSKHNRREGYKTQNQGPWDESEITLDFDYCPGTTVTIAEGCGKR 
                     
GPSIRTTTDSGKLITDWCCRSCTLPPLRFRTASGCWYGMEIRPMKHDESTLVKSQVNA 
                     
FNGEMIDPFQLGLLVIFLATQEVLRKRWTARLTIPAVLGALLVLMLGGITYTDLVRYV 
                     
VLVAAAFAEANNGGDVVHLALIAVFKIQPAFLVMSIASTNWTNQENIALVLGAAFFQM 
                     
ASTDLEFGIHGLLNAAATAWMVVRAITFPTTSTITMPILALLAPGMRALHLDTYRIFL 
                     
LIIGVCALLHERKKTMAKKKGAVLLGLALSSTGWFSPAIMAAGLMACNPNKKRGWPAT 
                     
EFLSAIGLMFAIVGGLAELDIDSMAIPFMLAGLMAVSYVVSGKATDMWLERAADISWE 
                     
VDAAITGSSQRLDVKLDDDGDFHLIDDPGVPWKIWVLRMSCIGLAAFTPWAIIPAAFG 
                     
YWLTLKTTKRGGVFWDTPSPKVYAKGDTTTGVYRIMARGILGVYQAGVGVMYENVFHT 
                     
LWHTTRGAAIMSGEGKLTPYWGSVKEDRITYGGPWRFDRKWNGVDDVQMIVVEPGKAA 
                     
VNVQTKPGVFRTPHGEIGAVSLDYPSGTSGSPILDVNGDIIGLYGNGVELGDGSYVSA 
                     
IVQGERQEEPVPDAYNPNMLKKRQLTVLDLHPGSGKTRKILPQIIRDAIQQRLRTAVL 
                     
APTRVVAAEMAEALRGLPVRYQTSAVQREHQGNEIVDVMCHATLTHRLMSPNRVPNYN 
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LFVMDEAHFTDPASIAARGYISTKVELGEAAAIFMTATPPGTTDPFPDSNAPIHDLQD 
                     
EIPDRAWSSGYEWITEYVGKTVWFVASVKMGNEIAVCLQRAGKRVIQLNRKSYDTEYP 
                     
KCKNGDWDFVITTDISEMGANFGASRVIDCRKSVKPTILEEGEGRVILSNPSPITSAS 
                     
AAQRRGRVGRNPNQVGDEYHYGGTTSEDDTNLAHWTEAKIMLDNIHLPNGLVAQLYGP 
                     
EREKAFTMDGEYRLRGEEKKNFLELIRTADLPVWLAYKVASNGIQYTDRRWCFDGPRT 
                     
NAILEDSTEVEIITRMGERKTLKPRWLDARVYADHQALKWFKDFAAGKRSAVSFLEVL 
                     
GRMPEHFMGKTREALDTMYLVATAEKGGKAHRMALEELPDALETVTLIAAIAVMTGGF 
                     
FLLMMQRKGIGKMGLGALVLTLATFFLWMAEVSGTKIAGTLLIALLLMVVLIPEPEKQ 
                     
RSQTDNQLAVFLICVLTVVGIVAANEYGMLEKTKEDIRSILGNRAQTSSVPGSLSSLA 
                     
LDLRPATAWALYGGSTVVLTPLLKHLITSEYVTTSLASINSQAGSLFVLPRGMPFTDL 
                     
DLTVGLVFLGCWGQVTLTTFLTAGVLAALHYGYMLPGWQAEALRAAQRRTAAGIMKNA 
                     
VVDGMVATDVPELERTTPLMQKKVGQVLLIGVSIAAFLVNPNVTTVREAGVLVTAATL 
                     
TLWDNGASAVWNSTTATGLCHVMRGSYLAGGSIAWTLIKNVDKPSLKRGRPGGRTLGE 
                     
QWKERLNAMNKEEFFKYRKEAIVEVDRTEARRARRENNKVGGHPVSRGSAKLRWIVEK 
                     
GFVSPVGKVVDLGCGRGGWCYYTATLKKVQEVKGYTKGGAGHEEPMLMQSYGWNLVTM 
                     
KSGVDVFYRPSEPSDTLLCDIGESSPSPDVEEQRTLRVLEMASEWLHRGPREFCIKVL 
                     
CPYMPKVIEKMETLQRRFGGGLVRVPLSRNSNHEMYWVSGAAGNVVHAVNMTSQVLLG 
                     
RMDRAVWRGPKYEEDVNLGSGTRAVGKGEVHSDQGKIKKRIEKLKDEYAATWHEDPEH 
                     
PYRTWTYHGSYEVKATGSASSLVNGVVKLMSKPWDAITSVTTMAMTDTTPFGQQRVFK 
                     
EKVDTKAPEPPAGVREVLDETTNWLWAYLSREKKPRLCTREEFVRKVNSNAALGAMFA 
                     
EQNQWSSAREAVSDPAFWDMVDVERENHLRGECHTCIYNMMGKREKKPGEFGKAKGSR 
                     
AIWFMWLGARYLEFEALGFLNEDHWLSRENSGGGVEGSGIQKLGYILRDISMKAGGKM 
                     
YADDTAGWDTRITRVDLDNEAKVLELLDGEHRMLARAIIELTYKHKVVKVMRPAAGGK 
                     
TVMDVISREDQRGSGQVVTYALNTFTNIAVQLVRLMEAEGVVGPQDVEQLPRKTKFAV 
                     
RTWLFENGEERVTRMAVSGDDCVVKPLDDRFANALHFLNAMSKVRKDIQEWKPSQGWH 
                     
DWQQVPFCSNHFQEIVMKDGRSLVVPCRGQDELIGRARISPGAGWNVRDTACLAKAYA 
                     
QMWLLLYFHRRDLRLMANAICSAVPVDWVPTGRTSWSIHSKGEWMTTEDMLQVWNRVW 
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IEENEWMRDKTPVASWTDVPYVGKREDIWCGSLIGTRTRATWAENIYAAINQVRAIIG 
                     NEKYVDYMTSLRRYEDTLVQEDRVI" 
     mat_peptide     96..476 
                     /product="C" 
                     /note="capsid protein" 
     mat_peptide     477..977 
                     /product="PrM/M" 
                     /note="premembrane/membrane protein" 
     mat_peptide     978..2477 
                     /product="E" 
                     /note="envelope glycoprotein" 
     mat_peptide     2478..3533 
                     /product="NS1" 
                     /note="nonstructural protein 1" 
     mat_peptide     3534..4214 
                     /product="NS2A" 
                     /note="nonstructural protein 2A" 
     mat_peptide     4215..4607 
                     /product="NS2B" 
                     /note="nonstructural protein 2B" 
     mat_peptide     4608..6464 
                     /product="NS3" 
                     /note="nonstructural protein 3" 
     mat_peptide     6465..6911 
                     /product="NS4A" 
                     /note="nonstructural protein 4A" 
     mat_peptide     6912..7679 
                     /product="NS4B" 
                     /note="nonstructural protein 4B" 
     mat_peptide     7680..10394 
                     /product="NS5" 
                     /note="nonstructural protein 5" 
     3'UTR           10398..10988 
BASE COUNT     3102 a   2401 c   3106 g   2379 t 
ORIGIN 
        1 agaagtttat ctgtgtgaac ttcttgactt agtatcgttg agaggaatcg agagattagt 
       61 gcagtttaaa cagtttttta gaacggaaga aaaccatgac taaaaaacca ggagggcccg 
      121 gtagaaaccg ggctatcaat atgctgaaac gcggtttacc ccgcgtatcc ccacttgtgg 
      181 gggtgaagag ggtaataatg aacttgctgg acggcagagg gccaatacga ttcgttttgg 
      241 ctctcttggc gtttttcaag ttcacagcat tggccccaac taaggcactt attagccgat 
      301 ggaaagcagt agagaagagc gtcgcgatga aacacctcac cagcttcaaa aaggaactgg 
      361 gaacgctcat caacgctgtg aataagaggg gcaaaaaaca aaacaaaaga ggaggaagta 
      421 atggaacaat tatttggatg ataggtttgg cagtcgtgtt cgccactgtg agtgcagtca 
      481 agctgtcaaa ctttcagggc aaggtgctga tgacaatcaa taacaccgac gtggctgatg 
      541 tgatcaccat tcccacctcg aaagggacca atagatgttg ggttcgggca atagatgtgg 
      601 gacacatgtg cgaggacaca atcacctacg aatgccctaa acttgatgct ggtaatgacc 
      661 cagaggacat tgactgttgg tgcgacaaac aagccgtgta tgtccagtat gggcgttgca 
      721 cgaggaccag gcactccagg agaagtagaa gatctgtgtc agtgcaaacc cacggagaaa 
      781 gctccctagt gaacaaaaaa gaagcttgga tggattcgac gaaagccacg cggtatctca 
      841 tgaaaacaga aaattggatc atacggaatc caggctatgc tctcgtggca gtggcactcg 
      901 gatggatgct tggcagcaac aacggccagc gtgtggtgtt cacaattctc ttgttgttgg 
      961 tcgcacccgc atacagcttt aactgcctag gcatgggcaa ccgcgacttc attgaaggag 
     1021 tcagcggagc cacgtgggta gacctggtgc tggaaggaga cagttgcctc accatcatgg 
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     1081 cgaacgataa accaacactg gacgtgcgca tgataaacat tgaagccacg caactggctg 
     1141 aagtacgaac ctattgctac cacgctacag tggctgacat ttcaacagta gcaagatgcc 
     1201 ccacgactgg agaagcccac aacacaagac gagccgatag cagttatgtt tgcaagcaag 
     1261 gctatacaga ccgtggatgg ggaaacggat gcgggttgtt tgggaaaggc agcattgaca 
     1321 catgcgctaa atttgtctgc agccacaagg ccattgggaa gataatacag ccagaaaata 
     1381 tcaaatatga agttggagta tttgtccatg gaaccacaac agccgagaac catggaaact 
     1441 actccgctca gattggagct tcccaggctg ccaagttcac catcacgccc aatgctcctt 
     1501 ccatcaccct gaagcttggg gactacggag aagtcacaat ggattgcgag cctcgtagtg 
     1561 gatttaacac tgaagcattt tatgtgctga ccgttgggac taagtcgttt ctagtccatc 
     1621 gcgaatggtt taatgatttg gcgcttccat ggctgtctcc atctagcaca aactggagaa 
     1681 acagagagat cttgctggaa tttgaagaag cccacgcgac gaaacagtct gttgttgcac 
     1741 ttggatcaca agagggagct ctacaccagg ctctggctgg cgccatagtg gtggagtatt 
     1801 ctagctcagt gaagttaact tctggccacc tcaaatgtag actaaaaatg gacaagttgg 
     1861 ccttgaaagg aaccacctat ggcatgtgca cagagaagtt ctccttttcg aaaaacccag 
     1921 ctgacactgg tcatggcacg gtcgtcatag aattgcagta cactggcact gatggaccgt 
     1981 gcaagatacc catctcttca gtggccagcc tgaatgattt gactccagtt ggcagattgg 
     2041 tgacagtcaa tccttttgtt gccacatcca ctgccaactc gaaagttttg gtggaacttg 
     2101 aaccaccgtt tggagattca ttcattgttg ttgggagagg agacaagcag attaaccacc 
     2161 attggcacaa ggcaggcagt tcgctgggaa aggcttttac cactaccctg aaaggtgccc 
     2221 agaggttagc tgcccttggc gacacggcct gggattttgg gtccattgga ggagttttta 
     2281 attccattgg caaggccgtg caccaggtgt ttggaggagc ttttagaaca ctttttggtg 
     2341 gcatgtcttg gataacacaa ggattgatgg gagcactgct gctgtggatg ggtatcaatg 
     2401 cgcgagaccg gtcgatcgca ctggcctttc ttgctacagg aggcgtgctc ttgtttctgg 
     2461 ctaccaatgt ccacgctgac actggctgcg ccattgatgt gactaggaaa gaaatgaggt 
     2521 gcggcagtgg catatttgtg cacaatgatg tggaggcttg ggtggacaga tacaagtatt 
     2581 tgcctgagac ccccaagtct ctggccaaaa tagttcacaa agcacataag gaaggcattt 
     2641 gcggagtgag atcagtcacc aggctggaac atcaaatgtg ggaagccgtc agagatgagt 
     2701 taaatgtcct actgaaggag aacgcagtag atcttagtgt ggtggtggac aaaccagtgg 
     2761 gaagataccg accagcgcca ctgcggctat ccatgaccca ggaaaagttt gagatgggtt 
     2821 ggaaagcatg ggggaagagc attctctttg caccagaact agccaattca acatttgtga 
     2881 ttgacggacc cgaaaccaaa gagtgtccag acgagcgcag agcatggaac agcatgcaga 
     2941 ttgaagactt tgggtttggc atcacgtcga ctcgagtgtg gttgaagatc agggaggagc 
     3001 gcacggatga atgtgatggc gccatcattg gcacggccgt caaaggaaat atggcggtgc 
     3061 acagtgactt gtcatactgg attgaaagcc atctcaatga cacctggaaa cttgaaagag 
     3121 ccgtgtttgg agagattaaa tcgtgcacct ggccagaaac acacacgctt tggggagatg 
     3181 gtgttgagga aagtgagtta ataataccac acacgctcgc aggacccaaa agtaagcaca 
     3241 atagaagaga ggggtataaa acacagaacc aaggaccatg ggatgagagt gaaatcaccc 
     3301 ttgactttga ctactgtccg gggacaacag ttaccattgc tgaaggatgt ggaaaaagag 
     3361 gaccctcaat cagaaccacc actgacagcg ggaaattaat cactgattgg tgctgtagga 
     3421 gctgtacttt gcccccgctg agatttagaa cagccagtgg ctgctggtat ggaatggaaa 
     3481 tccggcccat gaagcatgac gaatccacgc ttgtgaagtc acaagtcaat gcattcaatg 
     3541 gggagatgat tgatcctttt cagttgggcc ttctggtgat ctttctggcc acccaggagg 
     3601 tccttcgcaa gaggtggacg gccagactaa cgatccctgc ggttttgggg gccctacttg 
     3661 ttctgatgct tgggggcatc acctacactg atctggtgag atatgtggta ctagtggctg 
     3721 ctgccttcgc tgaagctaac aatggaggag atgtggtcca cttggctctg atcgccgttt 
     3781 ttaagattca gccggcattc ctagtcatga gcatagcaag taccaattgg actaaccagg 
     3841 agaacattgc tttagtgcta ggagctgctt tctttcagat ggcttcaacg gacttggagt 
     3901 ttggcatcca tgggttgctg aacgcagcgg cgacggcctg gatggtggtg cgggcgatta 
     3961 cgttccccac gacctccacc atcacgatgc ccattctagc tttgttggca ccaggaatga 
     4021 gagctcttca tctcgacacc tacagaattt ttctgctcat cattggagtc tgtgctctgc 
     4081 tgcatgaaag gaagaaaact atggcaaaaa agaaaggtgc tgtcctctta ggcctggccc 
     4141 tcagttctac tgggtggttt tcaccagcca ttatggctgc tgggctcatg gcttgcaacc 
     4201 caaacaagaa aagaggatgg ccagcgacag aattcctgtc tgcaattggg ctaatgtttg 
     4261 ccattgttgg gggtctggcc gagttggaca ttgactccat ggcaatacct tttatgttag 
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     4321 ctggacttat ggcagtgtcg tatgtggtgt caggaaaagc aacagacatg tggttggaac 
     4381 gcgcagccga cattagttgg gaagtggacg ccgcgatcac aggtagcagc cagaggttgg 
     4441 atgtcaaatt ggatgacgat ggagatttcc atcttattga tgacccaggc gtcccatgga 
     4501 aaatttgggt attgcgcatg tcttgtatag gattggccgc cttcacacca tgggccatta 
     4561 taccagcagc ttttggatac tggctgaccc tgaaaaccac gaagagggga ggcgtcttct 
     4621 gggacacacc atctcccaaa gtctacgcaa aaggagatac aaccacagga gtgtacagga 
     4681 taatggcgcg agggatcctt ggcgtctacc aagcaggcgt cggagtgatg tatgagaacg 
     4741 tgttccacac tctctggcac acgactagag gagccgccat aatgagtggt gaagggaaac 
     4801 taacaccgta ctggggaagt gtcaaggaag accgcataac ttatgggggt ccatggagat 
     4861 tcgaccgaaa atggaatgga gtggatgacg tgcagatgat tgtcgttgaa ccagggaagg 
     4921 cagccgtgaa cgtccaaaca aaaccaggag tgttccggac cccgcacgga gagatcggag 
     4981 ctgtcagctt agattatcct agtgggacat caggctcacc catcctggac gtcaacggtg 
     5041 acattattgg attgtatgga aacggagttg aacttggaga tggctcatat gtaagcgcca 
     5101 ttgtgcaggg tgaacgtcaa gaggaacccg tccctgatgc atacaatcca aacatgctca 
     5161 agaaaaggca gctgacagtg ttggacctgc atccaggatc gggcaaaaca aggaaaattt 
     5221 tgccccaaat catcagggat gctattcaac aacgcctcag aacagctgtt ttggcaccca 
     5281 ctcgtgtcgt cgcggcagag atggcagaag ctctgagagg actccccgtc agataccaaa 
     5341 cttcagcggt ccagcgggaa caccagggaa atgagatagt tgatgtcatg tgtcatgcca 
     5401 ctctaacgca tagactgatg tcaccaaacc gcgttcccaa ttacaacttg ttcgttatgg 
     5461 atgaggctca cttcactgac ccagctagca ttgctgcaag aggatacata tctaccaaag 
     5521 tggaattggg agaagctgcg gctattttta tgactgccac tccacccgga acgactgacc 
     5581 cgttcccgga ctccaatgct cccattcatg atttgcagga cgaaatccct gacagagcat 
     5641 ggagcagtgg gtatgaatgg ataactgagt atgtgggcaa gacagtatgg tttgtggcga 
     5701 gcgtaaaaat gggcaatgaa atcgcagtgt gcttacagag agctgggaag agggtcatcc 
     5761 agttgaatcg gaaatcttat gacaccgagt accctaaatg taagaatggg gattgggatt 
     5821 ttgtcatcac cacggacatt tctgagatgg gggccaactt cggagcgagc agagtgattg 
     5881 attgtaggaa aagtgtgaaa cccaccattt tggaggaggg agaaggaaga gtcattctca 
     5941 gtaatccatc gcccatcacc agtgcgagcg cagctcagcg gagaggcaga gtgggcagaa 
     6001 atccaaatca ggttggggat gagtaccatt atggaggtac cacgagtgag gatgacacca 
     6061 acctagccca ctggacagaa gccaagatca tgcttgataa catccacttg ccaaatggat 
     6121 tagtagctca actttatgga cctgaaaggg agaaggcctt cacaatggat ggtgagtatc 
     6181 gattgagggg tgaggaaaag aaaaattttc tggagctgat tagaacagcc gacctcccag 
     6241 tatggctggc ctacaaagtg gcgtcaaatg gaatacaata caccgatcgg agatggtgtt 
     6301 ttgatggtcc ccggacgaat gccatcttag aggacagcac tgaagtggag ataatcacca 
     6361 gaatgggaga gagaaaaact ctaaaaccaa gatggctgga cgcacgtgtg tatgcggatc 
     6421 accaggctct gaagtggttc aaggacttcg cggcagggaa gagatcagct gtcagctttc 
     6481 tagaggtgct tgggcgcatg ccggaacatt tcatggggaa aactcgtgaa gcccttgaca 
     6541 caatgtacct agttgccaca gcagagaaag gggggaaagc ccatcgaatg gctctagaag 
     6601 aattgccaga tgcactggaa acggtgacac tcattgcagc gatagccgtg atgacaggtg 
     6661 ggttcttctt gctcatgatg caacgaaagg ggatagggaa aatgggcctg ggcgcccttg 
     6721 tgctcaccct ggccaccttc ttcttgtgga tggcagaggt atcagggacg aaaatagccg 
     6781 gaaccctact catagcactg ttgctcatgg tggtactcat tccggagccg gagaaacaaa 
     6841 gatcccaaac ggacaatcag ttggccgtgt tcctgatctg cgtcctaact gtggtaggaa 
     6901 tcgtggctgc taatgaatat ggtatgcttg agaagacaaa ggaagacata aggagcatcc 
     6961 ttggcaacag ggctcagaca tccagcgtgc ctggaagtct gtcaagcctg gcgctcgatt 
     7021 tgcgaccagc gacagcttgg gctctatacg gaggcagcac agtggtttta actccactgc 
     7081 tgaaacactt gatcacttct gagtatgtga caacatctct agcttcaatc aactcacagg 
     7141 ccggctcact ctttgttcta ccaagaggca tgcccttcac agatttggat ctgacggttg 
     7201 gactcgtctt tctgggctgc tgggggcaag tcactcttac cacttttttg acagctggag 
     7261 tgctggcagc tttgcactac ggctacatgc tccctgggtg gcaagccgaa gctttgaggg 
     7321 cagctcaaag aagaacagcc gcgggcatca tgaagaacgc cgttgtggat gggatggtgg 
     7381 ccactgacgt gccagaactg gaaagaacaa cacctctaat gcagaaaaag gtggggcaag 
     7441 tgttgctaat aggagtaagc atagctgctt ttctcgtcaa ccctaatgtc acaacagtac 
     7501 gagaggccgg tgtgttggtg accgccgcca cgctcaccct atgggacaac ggagcaagtg 
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     7561 ctgtttggaa ttcaactaca gccacaggac tctgccacgt tatgcgaggc agctacttgg 
     7621 ctggtggttc aatagcctgg accctcatta aaaatgttga taaaccatct ctgaaaagag 
     7681 gaagacctgg aggaagaacg ctgggtgagc aatggaaaga aaggttgaac gccatgaaca 
     7741 aggaagagtt ttttaagtac aggaaagaag ccatagtcga ggtggaccgc acagaggcac 
     7801 gcagggctag acgagagaac aacaaagtgg gaggccatcc cgtgtcacga ggatcagcaa 
     7861 agctccgatg gatagtggag aaagggtttg tctcaccagt tggaaaggtc gtagatcttg 
     7921 gttgcgggcg gggaggttgg tgctattata cagccaccct gaaaaaagtc caggaagtca 
     7981 agggttacac aaaaggaggg gctggacatg aggaacctat gttgatgcaa agttacggct 
     8041 ggaatttggt cacaatgaag agtggagtgg acgtgttcta cagaccttca gagcccagtg 
     8101 acaccctgct ctgtgatata ggggagtctt ccccaagtcc tgacgtcgaa gaacaacgca 
     8161 ctttgcgagt tttggaaatg gcatcagagt ggttgcaccg agggcccagg gaattttgca 
     8221 taaaagtcct atgtccatac atgccaaagg tgatagaaaa gatggaaaca ctgcaacgcc 
     8281 gctttggagg tggactggtg cgtgttcctc tgtcacgcaa ttcgaaccat gagatgtact 
     8341 gggtcagtgg agccgctggg aatgtggtac acgctgtaaa catgaccagt caagtcttgc 
     8401 tagggcgaat ggaccgagca gtctggagag gacccaaata tgaggaagat gttaacttgg 
     8461 gaagcgggac tagagctgta ggaaaaggtg aggttcacag tgaccaaggg aaaataaaaa 
     8521 agcggataga gaaactgaaa gatgagtacg cagcaacctg gcatgaggat ccagaacacc 
     8581 cataccgcac ctggacatac catggaagtt acgaagtgaa agccaccggg tcagccagct 
     8641 cccttgtcaa tggagtggta aaactcatga gcaagccttg ggacgccatc accagtgtca 
     8701 ccactatggc catgactgat actactcctt ttggtcagca gagagttttc aaagaaaagg 
     8761 ttgacactaa agcgcctgaa ccacctgcag gagtccggga agtgctggac gagacgacca 
     8821 attggctgtg ggcctaccta tcaagagaga aaaaacctcg cttgtgcacg agagaggaat 
     8881 ttgttcggaa agtcaacagc aacgcggctc ttggggccat gtttgccgag cagaaccaat 
     8941 ggagctcagc cagagaggct gttagcgacc cggccttctg ggacatggtt gacgttgaaa 
     9001 gagagaacca cctacgaggg gagtgccata cttgcatcta taacatgatg gggaaaagag 
     9061 aaaagaaacc cggtgagttt gggaaggcca agggaagcag ggccatctgg ttcatgtggc 
     9121 ttggagctcg ctacctggaa tttgaggcac ttgggttctt gaacgaggac cattggttga 
     9181 gtagggagaa ttcaggagga ggagtggaag gctcaggcat acagaagcta gggtacatcc 
     9241 tgcgagacat ctcaatgaaa gctggaggaa aaatgtatgc tgatgacaca gctggctggg 
     9301 acactaggat cacaagggtt gatctggaca atgaggcgaa ggtactagag ctcttggatg 
     9361 gggaacatag gatgttggcc cgtgccataa tagaattgac ctacaaacac aaagttgtca 
     9421 aagtgatgag gccagcagcc ggtggaaaga ctgtaatgga tgtgatctcc agagaagacc 
     9481 aaagagggag tggacaagtg gttacatatg ctcttaacac cttcacaaac atagccgtcc 
     9541 aactggtaag gttaatggag gcagaaggag ttgttggccc gcaggacgta gaacagctcc 
     9601 caagaaaaac caagtttgca gtcaggacat ggctttttga aaatggagag gagagagtca 
     9661 ccagaatggc agtaagtggg gatgattgtg ttgtcaaacc actcgatgac agattcgcga 
     9721 atgctctgca tttcttgaat gcgatgtcaa aggtgaggaa agacatacag gaatggaaac 
     9781 catctcaagg ctggcatgac tggcagcaag tccctttctg ctcaaatcat ttccaggaga 
     9841 tcgtgatgaa agatggcaga agcctcgtcg tgccctgccg gggacaggat gaattaatag 
     9901 gcagagcccg gatttcacca ggagcaggat ggaacgtgag agacacggcc tgcttagcca 
     9961 aggcatacgc ccaaatgtgg ctcctcctct atttccaccg gagagacctg cgcctcatgg 
    10021 ccaacgcaat ctgttcagct gttccagtag actgggtgcc cacaggccgg acttcatggt 
    10081 cgatacactc aaaaggagaa tggatgacaa cagaagacat gttgcaggtg tggaacagag 
    10141 tatggattga agagaatgaa tggatgagag acaaaactcc cgtcgccagt tggaccgacg 
    10201 ttccttacgt cgggaaaagg gaagacatct ggtgtggcag cttgatcgga acgcgaacaa 
    10261 gagctacctg ggcagagaac atctatgcag caatcaacca agtgagggca ataattggaa 
    10321 acgaaaagta tgtggactac atgacatcac tcaggaggta tgaagacact ttggtccagg 
    10381 aagatagagt catttaaaga actcttgaaa acaaatgtaa atagtagtaa ttgtttagtg 
    10441 taaatagtgt aaataaataa atttagatag gaagtcaggc cgacgcgagt cgccaccgga 
    10501 agctgagtag acggtgctgc ctgcgcctca gccccaggag gactgggtta acaaatctga 
    10561 caaccgaagg taggaaagcc ctcagaaccg tctcggaaga aggtccctgc ttactggagg 
    10621 ttggaagacc gtgtcaggcc acgtaagtgc cacttcgctg aggagtgcag cctgtacagc 
    10681 cccgggagga ccgggtaaac aaagccgaaa aggcccccac ggcccaaacc tcatctagga 
    10741 tgcaatagat gaggcgtaag gactagaggt tagaggagac cccgtggaaa agaagatgcg 
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    10801 gcccaaactc tttcgaagct gtagaaggag tggaaggact agaggttaga ggagaccccg 
    10861 catttgcatc aaaacagcat attgacacct gggattagac taggagatct tctgatctat 
    10921 ctcaacatca gctacaaggc accgagcgcc gaagtatgta gctggtggtg gggaagaaca 
    10981 caggatct 
// 
